ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,Count,ont,comparison,geneID,symbol
hsa04010,MAPK signaling pathway,10/25,295/7852,9.543919181543508e-9,1.2502534127821995e-6,7.936522266757232e-7,10,kg,NAC,2353/3164/3725/3479/80310/4616/4804/2318/3303/3082,FOS/NR4A1/JUN/IGF1/PDGFD/GADD45B/NGFR/FLNC/HSPA1A/HGF
hsa04510,Focal adhesion,8/25,199/7852,1.1050031900248666e-7,7.237770894662876e-6,4.594486947998129e-6,8,kg,NAC,3725/3479/80310/2318/3679/3082/1277/1278,JUN/IGF1/PDGFD/FLNC/ITGA7/HGF/COL1A1/COL1A2
GO:0005583,fibrillar collagen trimer,3/26,11/19659,3.364653359293562e-7,9.925727409916007e-6,6.37513268076675e-6,3,cc,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0098643,banded collagen fibril,3/26,11/19659,3.364653359293562e-7,9.925727409916007e-6,6.37513268076675e-6,3,cc,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0071559,response to transforming growth factor beta,7/26,249/18493,3.899737744723896e-8,2.813660782818291e-5,1.6584147882825833e-5,7,bp,NAC,2353/3725/80310/3303/1277/1278/1281,FOS/JUN/PDGFD/HSPA1A/COL1A1/COL1A2/COL3A1
GO:0071560,cellular response to transforming growth factor beta stimulus,7/26,242/18493,3.206462282555902e-8,2.813660782818291e-5,1.6584147882825833e-5,7,bp,NAC,2353/3725/80310/3303/1277/1278/1281,FOS/JUN/PDGFD/HSPA1A/COL1A1/COL1A2/COL3A1
GO:0098644,complex of collagen trimers,3/26,19/19659,1.9621417424145267e-6,3.8588787600819026e-5,2.478494832523613e-5,3,cc,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0048407,platelet-derived growth factor binding,3/25,11/17632,4.1236236115421543e-7,4.6596946810426345e-5,2.474174166925293e-5,3,mf,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0019838,growth factor binding,5/25,137/17632,1.234022525827338e-6,6.365339703662593e-5,3.3798263913252706e-5,5,mf,NAC,3977/4804/1277/1278/1281,LIFR/NGFR/COL1A1/COL1A2/COL3A1
GO:0035014,phosphatidylinositol 3-kinase regulator activity,3/25,17/17632,1.6899131956626354e-6,6.365339703662593e-5,3.3798263913252706e-5,3,mf,NAC,9314/9021/8835,KLF4/SOCS3/SOCS2
R-HSA-8874081,MET activates PTK2 signaling,4/23,30/10554,4.524015791102284e-7,8.007507950251042e-5,4.0001823837114933e-5,4,re,NAC,3082/1277/1278/1281,HGF/COL1A1/COL1A2/COL3A1
GO:0046332,SMAD binding,4/25,80/17632,4.62226547438552e-6,1.3057899965139094e-4,6.93339821157828e-5,4,mf,NAC,2353/3725/1278/1281,FOS/JUN/COL1A2/COL3A1
R-HSA-8875878,MET promotes cell motility,4/23,41/10554,1.6454450230251083e-6,1.456218845377221e-4,7.274599049163638e-5,4,re,NAC,3082/1277/1278/1281,HGF/COL1A1/COL1A2/COL3A1
GO:0000302,response to reactive oxygen species,6/26,224/18493,5.553124476780624e-7,1.8767610085281287e-4,1.1061917021488332e-4,6,bp,NAC,2353/9314/3725/80310/3082/1277,FOS/KLF4/JUN/PDGFD/HGF/COL1A1
GO:0008637,apoptotic mitochondrial changes,5/26,121/18493,6.502983397533363e-7,1.8767610085281287e-4,1.1061917021488332e-4,5,bp,NAC,3725/3479/3303/3082/2810,JUN/IGF1/HSPA1A/HGF/SFN
GO:0061614,pri-miRNA transcription by RNA polymerase II,4/26,44/18493,4.0101522075827305e-7,1.8767610085281287e-4,1.1061917021488332e-4,4,bp,NAC,2353/9314/3725/4804,FOS/KLF4/JUN/NGFR
GO:0001836,release of cytochrome c from mitochondria,4/26,58/18493,1.2367110737567047e-6,2.502788212853511e-4,1.475181731032306e-4,4,bp,NAC,3725/3479/3082/2810,JUN/IGF1/HGF/SFN
GO:0001933,negative regulation of protein phosphorylation,7/26,408/18493,1.1064695360874885e-6,2.502788212853511e-4,1.475181731032306e-4,7,bp,NAC,9314/3725/10252/4616/9021/3082/2810,KLF4/JUN/SPRY1/GADD45B/SOCS3/HGF/SFN
GO:0042542,response to hydrogen peroxide,5/26,141/18493,1.3875471727531591e-6,2.502788212853511e-4,1.475181731032306e-4,5,bp,NAC,9314/3725/80310/3082/1277,KLF4/JUN/PDGFD/HGF/COL1A1
GO:0006979,response to oxidative stress,7/26,441/18493,1.8578197775418572e-6,2.905874392678521e-4,1.7127669032237258e-4,7,bp,NAC,2353/9314/3725/80310/3303/3082/1277,FOS/KLF4/JUN/PDGFD/HSPA1A/HGF/COL1A1
GO:0042326,negative regulation of phosphorylation,7/26,448/18493,2.062674056179087e-6,2.905874392678521e-4,1.7127669032237258e-4,7,bp,NAC,9314/3725/10252/4616/9021/3082/2810,KLF4/JUN/SPRY1/GADD45B/SOCS3/HGF/SFN
GO:0071230,cellular response to amino acid stimulus,4/26,67/18493,2.215150264689101e-6,2.905874392678521e-4,1.7127669032237258e-4,4,bp,NAC,80310/1277/1278/1281,PDGFD/COL1A1/COL1A2/COL3A1
GO:0034599,cellular response to oxidative stress,6/26,289/18493,2.4474001090513805e-6,2.9429986311342853e-4,1.7346484983451888e-4,6,bp,NAC,2353/9314/3725/80310/3303/3082,FOS/KLF4/JUN/PDGFD/HSPA1A/HGF
GO:0034614,cellular response to reactive oxygen species,5/26,162/18493,2.748784602508494e-6,3.051150908784428e-4,1.7983951083618325e-4,5,bp,NAC,2353/9314/3725/80310/3082,FOS/KLF4/JUN/PDGFD/HGF
GO:1901652,response to peptide,7/26,481/18493,3.3023109287538673e-6,3.4037390501370215e-4,2.006215962731673e-4,7,bp,NAC,9314/3164/3479/4804/9021/8835/1277,KLF4/NR4A1/IGF1/NGFR/SOCS3/SOCS2/COL1A1
hsa04151,PI3K-Akt signaling pathway,8/25,354/7852,8.687278831162634e-6,3.793445089607683e-4,2.4080527286380633e-4,8,kg,NAC,3164/3479/80310/4804/3679/3082/1277/1278,NR4A1/IGF1/PDGFD/NGFR/ITGA7/HGF/COL1A1/COL1A2
GO:0030020,extracellular matrix structural constituent conferring tensile strength,3/25,37/17632,1.8951622205206478e-5,4.283066618376664e-4,2.2741946646247775e-4,3,mf,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
R-HSA-3000480,Scavenging by Class A Receptors,3/23,19/10554,8.564094248733781e-6,5.052815606752931e-4,2.524154094363641e-4,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,6/26,340/18493,6.2357870997507265e-6,5.187238039770588e-4,3.0574376015863404e-4,6,bp,NAC,2353/3725/6424/3303/1278/1281,FOS/JUN/SFRP4/HSPA1A/COL1A2/COL3A1
GO:0007179,transforming growth factor beta receptor signaling pathway,5/26,193/18493,6.4705672013770324e-6,5.187238039770588e-4,3.0574376015863404e-4,5,bp,NAC,2353/3725/3303/1278/1281,FOS/JUN/HSPA1A/COL1A2/COL3A1
GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,4/26,84/18493,5.486729738261197e-6,5.187238039770588e-4,3.0574376015863404e-4,4,bp,NAC,9314/4804/3082/2810,KLF4/NGFR/HGF/SFN
GO:0070371,ERK1 and ERK2 cascade,6/26,341/18493,6.341533146094164e-6,5.187238039770588e-4,3.0574376015863404e-4,6,bp,NAC,9314/5320/3725/3479/10252/80310,KLF4/PLA2G2A/JUN/IGF1/SPRY1/PDGFD
GO:1902895,positive regulation of pri-miRNA transcription by RNA polymerase II,3/26,27/18493,7.056224006933571e-6,5.359016443160601e-4,3.1586864252644467e-4,3,bp,NAC,2353/3725/4804,FOS/JUN/NGFR
GO:0044420,extracellular matrix component,3/26,49/19659,3.63377319966495e-5,5.359815469505801e-4,3.442521978629953e-4,3,cc,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:2000117,negative regulation of cysteine-type endopeptidase activity,4/26,91/18493,7.549487593919595e-6,5.446955299012988e-4,3.210518934677386e-4,4,bp,NAC,9314/4804/3082/2810,KLF4/NGFR/HGF/SFN
GO:1901653,cellular response to peptide,6/26,356/18493,8.111131455446205e-6,5.573506042956606e-4,3.2851098827070346e-4,6,bp,NAC,9314/3164/3479/4804/9021/8835,KLF4/NR4A1/IGF1/NGFR/SOCS3/SOCS2
GO:0071229,cellular response to acid chemical,5/26,206/18493,8.8831664481170008e-06,5.82654962937856e-4,3.4342576507552806e-4,5,bp,NAC,9314/80310/1277/1278/1281,KLF4/PDGFD/COL1A1/COL1A2/COL3A1
hsa05202,Transcriptional misregulation in cancer,6/25,186/7852,1.9836464340348423e-5,6.496442071464108e-4,4.1238965339145405e-4,6,kg,NAC,3479/7102/4616/4804/7704/862,IGF1/TSPAN7/GADD45B/NGFR/ZBTB16/RUNX1T1
R-HSA-3000170,Syndecan interactions,3/23,27/10554,2.5558922202164342e-5,7.539882049638481e-4,3.766578008740009e-4,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
R-HSA-3000178,ECM proteoglycans,4/23,76/10554,1.9819088286830457e-5,7.539882049638481e-4,3.766578008740009e-4,4,re,NAC,3679/1277/1278/1281,ITGA7/COL1A1/COL1A2/COL3A1
R-HSA-6806834,Signaling by MET,4/23,79/10554,2.310996670171723e-5,7.539882049638481e-4,3.766578008740009e-4,4,re,NAC,3082/1277/1278/1281,HGF/COL1A1/COL1A2/COL3A1
R-HSA-216083,Integrin cell surface interactions,4/23,85/10554,3.087459919095541e-5,7.701012737535355e-4,3.84707148351454e-4,4,re,NAC,3679/1277/1278/1281,ITGA7/COL1A1/COL1A2/COL3A1
R-HSA-449147,Signaling by Interleukins,7/23,462/10554,3.915769188577299e-5,7.701012737535355e-4,3.84707148351454e-4,7,re,NAC,2353/3725/3977/9021/8835/3082/1278,FOS/JUN/LIFR/SOCS3/SOCS2/HGF/COL1A2
R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,7/23,455/10554,3.550170225877264e-5,7.701012737535355e-4,3.84707148351454e-4,7,re,NAC,3479/10252/80310/3082/1277/1278/1281,IGF1/SPRY1/PDGFD/HGF/COL1A1/COL1A2/COL3A1
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,4/26,106/18493,1.3833106369707889e-5,8.678770648473254e-4,5.115400433283283e-4,4,bp,NAC,9314/3479/80310/3082,KLF4/IGF1/PDGFD/HGF
GO:0043200,response to amino acid,4/26,111/18493,1.659781243965363e-5,9.979434729341745e-4,5.882031776859708e-4,4,bp,NAC,80310/1277/1278/1281,PDGFD/COL1A1/COL1A2/COL3A1
GO:1902893,regulation of pri-miRNA transcription by RNA polymerase II,3/26,37/18493,1.8570181825118306e-5,0.0010718708949458285,6.317771332503407e-4,3,bp,NAC,2353/3725/4804,FOS/JUN/NGFR
hsa04926,Relaxin signaling pathway,5/25,130/7852,4.689732398163934e-5,0.0012287098883189507,7.799765462209489e-4,5,kg,NAC,2353/3725/1277/1278/1281,FOS/JUN/COL1A1/COL1A2/COL3A1
GO:0007265,Ras protein signal transduction,6/26,430/18493,2.36724145800876e-5,0.0013138190091948618,7.743850599478049e-4,6,bp,NAC,3725/3479/10252/4804/1278/1281,JUN/IGF1/SPRY1/NGFR/COL1A2/COL3A1
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,4/23,108/10554,7.904765040375241e-5,0.0013991434121464177,6.989476456752845e-4,4,re,NAC,2353/9021/3082/1278,FOS/SOCS3/HGF/COL1A2
hsa05218,Melanoma,4/25,72/7852,7.107562619343762e-5,0.0015518178385567213,9.85083240224837e-4,4,kg,NAC,3479/80310/4616/3082,IGF1/PDGFD/GADD45B/HGF
R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,3/23,42/10554,9.819658251900907e-5,0.0015800722823513277,7.893313810140443e-4,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
R-HSA-8948216,Collagen chain trimerization,3/23,44/10554,1.1296370304381236e-4,0.0016662146198962323,8.32364127691249e-4,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0051346,negative regulation of hydrolase activity,6/26,458/18493,3.373987270391184e-5,0.0018032087522868439,0.001062838875039406,6,bp,NAC,9314/10252/4804/3953/3082/2810,KLF4/SPRY1/NGFR/LEPR/HGF/SFN
GO:0014065,phosphatidylinositol 3-kinase signaling,4/26,136/18493,3.6895057392857805e-5,0.0019014131363533505,0.0011207220441138762,4,bp,NAC,9314/3479/80310/3082,KLF4/IGF1/PDGFD/HGF
GO:0005581,collagen trimer,3/26,87/19659,2.0220277874883293e-4,0.002385992789236229,0.0015324842178858918,3,cc,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0030199,collagen fibril organization,3/26,52/18493,5.208490633173372e-5,0.0025326705745845534,0.0014927948530213512,3,bp,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0071900,regulation of protein serine/threonine kinase activity,6/26,496/18493,5.265427389988677e-5,0.0025326705745845534,0.0014927948530213512,6,bp,NAC,3479/10252/80310/4616/3082/2810,IGF1/SPRY1/PDGFD/GADD45B/HGF/SFN
GO:0010823,negative regulation of mitochondrion organization,3/26,53/18493,5.515854259280547e-5,0.002567541192303816,0.0015133481295411485,3,bp,NAC,3479/3303/3082,IGF1/HSPA1A/HGF
GO:0031102,neuron projection regeneration,3/26,55/18493,6.165748366935538e-5,0.0026168161451435236,0.0015423915419454843,3,bp,NAC,9314/3725/3082,KLF4/JUN/HGF
GO:0043551,regulation of phosphatidylinositol 3-kinase activity,3/26,54/18493,5.834872955642705e-5,0.0026168161451435236,0.0015423915419454843,3,bp,NAC,9314/9021/8835,KLF4/SOCS3/SOCS2
GO:0048146,positive regulation of fibroblast proliferation,3/26,55/18493,6.165748366935538e-5,0.0026168161451435236,0.0015423915419454843,3,bp,NAC,3725/3479/80310,JUN/IGF1/PDGFD
R-HSA-450341,Activation of the AP-1 family of transcription factors,2/23,10/10554,2.0228274310174054e-4,0.0027541573483852366,0.0013758502364814742,2,re,NAC,2353/3725,FOS/JUN
GO:0046677,response to antibiotic,5/26,323/18493,7.667001352177412e-5,0.0029761160566213495,0.0017541684164934536,5,bp,NAC,9314/3725/80310/3082/1277,KLF4/JUN/PDGFD/HGF/COL1A1
GO:0048015,phosphatidylinositol-mediated signaling,4/26,164/18493,7.654607982074094e-5,0.0029761160566213495,0.0017541684164934536,4,bp,NAC,9314/3479/80310/3082,KLF4/IGF1/PDGFD/HGF
GO:0060759,regulation of response to cytokine stimulus,4/26,165/18493,7.837311860818523e-5,0.0029761160566213495,0.0017541684164934536,4,bp,NAC,9314/3977/9021/3303,KLF4/LIFR/SOCS3/HSPA1A
GO:0070372,regulation of ERK1 and ERK2 cascade,5/26,324/18493,7.779760440867103e-5,0.0029761160566213495,0.0017541684164934536,5,bp,NAC,9314/5320/3725/10252/80310,KLF4/PLA2G2A/JUN/SPRY1/PDGFD
GO:0001101,response to acid chemical,5/26,332/18493,8.728672067582702e-5,0.0030230522180185273,0.0017818333093766424,5,bp,NAC,9314/80310/1277/1278/1281,KLF4/PDGFD/COL1A1/COL1A2/COL3A1
GO:0048017,inositol lipid-mediated signaling,4/26,167/18493,8.212233277264768e-5,0.0030230522180185273,0.0017818333093766424,4,bp,NAC,9314/3479/80310/3082,KLF4/IGF1/PDGFD/HGF
GO:0048659,smooth muscle cell proliferation,4/26,170/18493,8.798904584669311e-5,0.0030230522180185273,0.0017818333093766424,4,bp,NAC,9314/3725/3479/80310,KLF4/JUN/IGF1/PDGFD
GO:0048660,regulation of smooth muscle cell proliferation,4/26,168/18493,8.404518036979335e-5,0.0030230522180185273,0.0017818333093766424,4,bp,NAC,9314/3725/3479/80310,KLF4/JUN/IGF1/PDGFD
GO:0043405,regulation of MAP kinase activity,5/26,335/18493,9.106654678057993e-5,0.003038014701747755,0.0017906524266055263,5,bp,NAC,3479/10252/80310/4616/3082,IGF1/SPRY1/PDGFD/GADD45B/HGF
GO:0043550,regulation of lipid kinase activity,3/26,63/18493,9.263523692092946e-5,0.003038014701747755,0.0017906524266055263,3,bp,NAC,9314/9021/8835,KLF4/SOCS3/SOCS2
R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,3/23,61/10554,0.00029964600016504927,0.0031198436487772777,0.0015585302794962317,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
R-HSA-2586552,Signaling by Leptin,2/23,11/10554,2.4690669252717777e-4,0.0031198436487772777,0.0015585302794962317,2,re,NAC,3953/9021,LEPR/SOCS3
R-HSA-3000171,Non-integrin membrane-ECM interactions,3/23,59/10554,2.7143417653181974e-4,0.0031198436487772777,0.0015585302794962317,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
R-HSA-430116,GP1b-IX-V activation signalling,2/23,12/10554,2.958952646072211e-4,0.0031198436487772777,0.0015585302794962317,2,re,NAC,1277/1278,COL1A1/COL1A2
GO:0019207,kinase regulator activity,4/25,208/17632,1.9595447125305698e-4,0.0031632650359422055,0.0016796097535976314,4,mf,NAC,9314/9021/8835/2810,KLF4/SOCS3/SOCS2/SFN
GO:0046935,1-phosphatidylinositol-3-kinase regulator activity,2/25,14/17632,1.7381256937411334e-4,0.0031632650359422055,0.0016796097535976314,2,mf,NAC,9021/8835,SOCS3/SOCS2
GO:0010821,regulation of mitochondrion organization,4/26,176/18493,1.0063055532182837e-4,0.0032268864739866303,0.0019019763438605224,4,bp,NAC,3479/3303/3082/2810,IGF1/HSPA1A/HGF/SFN
GO:0005159,insulin-like growth factor receptor binding,2/25,16/17632,2.2880520273335295e-4,0.0032318734886086103,0.0017160390205001473,2,mf,NAC,3479/8835,IGF1/SOCS2
R-HSA-1442490,Collagen degradation,3/23,64/10554,3.4541109486383007e-4,0.0033965424328276624,0.001696756255471446,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:1903708,positive regulation of hemopoiesis,4/26,183/18493,1.1699302476673343e-4,0.0036700203203999205,0.0021631662245199224,4,bp,NAC,2353/3725/7704/3303,FOS/JUN/ZBTB16/HSPA1A
R-HSA-1650814,Collagen biosynthesis and modifying enzymes,3/23,67/10554,3.9546219498563795e-4,0.0036840425532872587,0.0018403780819276226,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,3/26,70/18493,1.2686335742939265e-4,0.0038138296827211165,0.0022479296667313434,3,bp,NAC,3479/80310/3082,IGF1/PDGFD/HGF
GO:0097201,negative regulation of transcription from RNA polymerase II promoter in response to stress,2/26,12/18493,1.2436771927850387e-4,0.0038138296827211165,0.0022479296667313434,2,bp,NAC,3725/3303,JUN/HSPA1A
GO:0031099,regeneration,4/26,188/18493,1.298078448866827e-4,0.0038227085749282276,0.0022531630218784026,4,bp,NAC,9314/3725/3479/3082,KLF4/JUN/IGF1/HGF
R-HSA-2214320,Anchoring fibril formation,2/23,15/10554,4.6887322336223894e-4,0.003951931454053157,0.001974203045735743,2,re,NAC,1277/1278,COL1A1/COL1A2
R-HSA-75892,Platelet Adhesion to exposed collagen,2/23,15/10554,4.6887322336223894e-4,0.003951931454053157,0.001974203045735743,2,re,NAC,1277/1278,COL1A1/COL1A2
GO:0050678,regulation of epithelial cell proliferation,5/26,368/18493,1.4154351276344634e-4,0.004084945778353061,0.002407729648691887,5,bp,NAC,3164/3725/3479/4804/2810,NR4A1/JUN/IGF1/NGFR/SFN
GO:0070208,protein heterotrimerization,2/26,13/18493,1.468529384585559e-4,0.00415507431756267,0.0024490644845100757,2,bp,NAC,1277/1278,COL1A1/COL1A2
GO:0005719,nuclear euchromatin,2/26,25/19659,4.952287075840471e-4,0.004552477117464875,0.0029239817346785996,2,cc,NAC,9314/3725,KLF4/JUN
GO:0005788,endoplasmic reticulum lumen,4/26,301/19659,6.172850328765932e-4,0.004552477117464875,0.0029239817346785996,4,cc,NAC,80310/1277/1278/1281,PDGFD/COL1A1/COL1A2/COL3A1
GO:0005942,phosphatidylinositol 3-kinase complex,2/26,27/19659,5.784761455335052e-4,0.004552477117464875,0.0029239817346785996,2,cc,NAC,9021/8835,SOCS3/SOCS2
hsa04933,AGE-RAGE signaling pathway in diabetic complications,4/25,100/7852,2.5510973180865724e-4,0.004774196409562014,0.0030306268891554765,4,kg,NAC,3725/1277/1278/1281,JUN/COL1A1/COL1A2/COL3A1
GO:0009612,response to mechanical stimulus,4/26,204/18493,1.776918571633354e-4,0.004930949036282557,0.0029063769349792516,4,bp,NAC,2353/3725/1277/1281,FOS/JUN/COL1A1/COL3A1
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,4/26,209/18493,1.9497160250252007e-4,0.005308377781342197,0.0031288392218875123,4,bp,NAC,9314/4804/3082/2810,KLF4/NGFR/HGF/SFN
R-HSA-2243919,Crosslinking of collagen fibrils,2/23,18/10554,6.8050311175809e-4,0.005474956853690088,0.002735036430032515,2,re,NAC,1277/1278,COL1A1/COL1A2
GO:0000791,euchromatin,2/26,33/19659,8.65952661539138e-4,0.005676800781201016,0.0036461164696384766,2,cc,NAC,9314/3725,KLF4/JUN
GO:0043062,extracellular structure organization,5/26,402/18493,2.1365305541794525e-4,0.005709284425335092,0.003365139742255356,5,bp,NAC,5320/3679/1277/1278/1281,PLA2G2A/ITGA7/COL1A1/COL1A2/COL3A1
GO:0045778,positive regulation of ossification,3/26,84/18493,2.179639364703163e-4,0.005718581096848481,0.0033706193429285276,3,bp,NAC,3479/7704/3082,IGF1/ZBTB16/HGF
GO:0045444,fat cell differentiation,4/26,217/18493,2.2510144657548377e-4,0.005800381918007555,0.0034188340006201293,4,bp,NAC,9314/3164/7704/862,KLF4/NR4A1/ZBTB16/RUNX1T1
R-HSA-422085,"Synthesis, secretion, and deacylation of Ghrelin",2/23,19/10554,7.595547608768373e-4,0.005845269246747835,0.0029200274560024866,2,re,NAC,9314/3479,KLF4/IGF1
GO:1903725,regulation of phospholipid metabolic process,3/26,86/18493,2.3366877101349442e-4,0.005915509413552148,0.003486691910967747,3,bp,NAC,9314/9021/8835,KLF4/SOCS3/SOCS2
GO:0051090,regulation of DNA-binding transcription factor activity,5/26,412/18493,2.3943466772755693e-4,0.005956969405704563,0.0035111290657688925,5,bp,NAC,2353/9314/3725/6424/3303,FOS/KLF4/JUN/SFRP4/HSPA1A
GO:0006469,negative regulation of protein kinase activity,4/26,222/18493,2.4555841652840925e-4,0.006005776187296519,0.0035398965308644902,4,bp,NAC,10252/4616/9021/2810,SPRY1/GADD45B/SOCS3/SFN
GO:0070412,R-SMAD binding,2/25,23/17632,0.00047947170622794193,0.0060200336448619374,0.0031964780415196133,2,mf,NAC,2353/3725,FOS/JUN
GO:0050673,epithelial cell proliferation,5/26,420/18493,2.6171916650488924e-4,0.006294345954442586,0.0037099839743149213,5,bp,NAC,3164/3725/3479/4804/2810,NR4A1/JUN/IGF1/NGFR/SFN
GO:0048145,regulation of fibroblast proliferation,3/26,90/18493,2.672394074371374e-4,0.006321745326750644,0.0037261335842831244,3,bp,NAC,3725/3479/80310,JUN/IGF1/PDGFD
GO:0045639,positive regulation of myeloid cell differentiation,3/26,91/18493,2.7609247288633873e-4,0.00632383235515852,0.003727363710813061,3,bp,NAC,2353/3725/3303,FOS/JUN/HSPA1A
GO:0048144,fibroblast proliferation,3/26,91/18493,2.7609247288633873e-4,0.00632383235515852,0.003727363710813061,3,bp,NAC,3725/3479/80310,JUN/IGF1/PDGFD
GO:2000116,regulation of cysteine-type endopeptidase activity,4/26,232/18493,2.904466796435463e-4,0.006548664980088083,0.0038598835057892336,4,bp,NAC,9314/4804/3082/2810,KLF4/NGFR/HGF/SFN
GO:0046488,phosphatidylinositol metabolic process,4/26,233/18493,2.952384283642781e-4,0.006554293109686973,0.0038632008116329833,4,bp,NAC,5320/9021/8835/3082,PLA2G2A/SOCS3/SOCS2/HGF
GO:0033002,muscle cell proliferation,4/26,236/18493,3.0995517476943015e-4,0.006602353910335143,0.0038915285841272166,4,bp,NAC,9314/3725/3479/80310,KLF4/JUN/IGF1/PDGFD
GO:0035994,response to muscle stretch,2/26,19/18493,3.2028050847086626e-4,0.006602353910335143,0.0038915285841272166,2,bp,NAC,2353/3725,FOS/JUN
GO:0046426,negative regulation of JAK-STAT cascade,2/26,19/18493,3.2028050847086626e-4,0.006602353910335143,0.0038915285841272166,2,bp,NAC,9021/8835,SOCS3/SOCS2
GO:0070301,cellular response to hydrogen peroxide,3/26,94/18493,3.0378433686741274e-4,0.006602353910335143,0.0038915285841272166,3,bp,NAC,9314/80310/3082,KLF4/PDGFD/HGF
GO:0090201,negative regulation of release of cytochrome c from mitochondria,2/26,19/18493,3.2028050847086626e-4,0.006602353910335143,0.0038915285841272166,2,bp,NAC,3479/3082,IGF1/HGF
GO:0005667,transcription factor complex,4/26,356/19659,0.001153312780012075,0.006804545402071243,0.0043704484295194425,4,cc,NAC,2353/9314/3164/3725,FOS/KLF4/NR4A1/JUN
GO:0033673,negative regulation of kinase activity,4/26,244/18493,3.5177416681724395e-4,0.0068739136468731156,0.004051590054837129,4,bp,NAC,10252/4616/9021/2810,SPRY1/GADD45B/SOCS3/SFN
GO:0048661,positive regulation of smooth muscle cell proliferation,3/26,98/18493,3.434135005162927e-4,0.0068739136468731156,0.004051590054837129,3,bp,NAC,3725/3479/80310,JUN/IGF1/PDGFD
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,4/26,245/18493,3.5727201906824926e-4,0.0068739136468731156,0.004051590054837129,4,bp,NAC,3479/80310/9021/3082,IGF1/PDGFD/SOCS3/HGF
GO:0051591,response to cAMP,3/26,98/18493,3.434135005162927e-4,0.0068739136468731156,0.004051590054837129,3,bp,NAC,2353/3725/1277,FOS/JUN/COL1A1
GO:1904893,negative regulation of STAT cascade,2/26,20/18493,3.555596607305838e-4,0.0068739136468731156,0.004051590054837129,2,bp,NAC,9021/8835,SOCS3/SOCS2
R-HSA-1474290,Collagen formation,3/23,90/10554,9.386416748216311e-4,0.006922482351809529,0.0034581535388165364,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0045637,regulation of myeloid cell differentiation,4/26,248/18493,3.741358571694024e-4,0.007103658445992732,0.004187005160566165,4,bp,NAC,2353/3725/7704/3303,FOS/JUN/ZBTB16/HSPA1A
GO:0010951,negative regulation of endopeptidase activity,4/26,250/18493,3.8569102118520937e-4,0.007227949916496846,0.004260264458204363,4,bp,NAC,9314/4804/3082/2810,KLF4/NGFR/HGF/SFN
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,3/26,104/18493,4.0887605177065967e-4,0.007564206957757204,0.004458459511885195,3,bp,NAC,3479/3303/3082,IGF1/HSPA1A/HGF
GO:0001077,"proximal promoter DNA-binding transcription activator activity, RNA polymerase II-specific",4/25,298/17632,7.643015809842861e-4,0.007851461695565849,0.004168917714459742,4,mf,NAC,2353/9314/3164/3725,FOS/KLF4/NR4A1/JUN
GO:0002020,protease binding,3/25,125/17632,7.137957542434322e-4,0.007851461695565849,0.004168917714459742,3,mf,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0043406,positive regulation of MAP kinase activity,4/26,258/18493,4.3448281890347447e-4,0.007936186173135617,0.004677709762478446,4,bp,NAC,3479/80310/4616/3082,IGF1/PDGFD/GADD45B/HGF
GO:0006644,phospholipid metabolic process,5/26,473/18493,4.5195456906635574e-4,0.008085600737235821,0.004765776996525181,5,bp,NAC,9314/5320/9021/8835/3082,KLF4/PLA2G2A/SOCS3/SOCS2/HGF
GO:0010466,negative regulation of peptidase activity,4/26,261/18493,4.538694800527385e-4,0.008085600737235821,0.004765776996525181,4,bp,NAC,9314/4804/3082/2810,KLF4/NGFR/HGF/SFN
R-HSA-6783589,Interleukin-6 family signaling,2/23,24/10554,0.0012178516079491212,0.00829075902334594,0.0041416815816893195,2,re,NAC,3977/9021,LIFR/SOCS3
R-HSA-982772,Growth hormone receptor signaling,2/23,24/10554,0.0012178516079491212,0.00829075902334594,0.0041416815816893195,2,re,NAC,9021/8835,SOCS3/SOCS2
GO:0045606,positive regulation of epidermal cell differentiation,2/26,23/18493,4.7222938427312407e-4,0.008310085384220952,0.004898091687967706,2,bp,NAC,6424/2810,SFRP4/SFN
GO:0046854,phosphatidylinositol phosphorylation,3/26,111/18493,4.948021140757426e-4,0.008602403019413212,0.005070388182285353,3,bp,NAC,9021/8835/3082,SOCS3/SOCS2/HGF
GO:0034504,protein localization to nucleus,4/26,269/18493,5.085874669431168e-4,0.00873680612855854,0.005149607434712261,4,bp,NAC,3479/4804/7704/1277,IGF1/NGFR/ZBTB16/COL1A1
GO:2000679,positive regulation of transcription regulatory region DNA binding,2/26,24/18493,5.147142054650042e-4,0.00873803057042354,0.0051503291395136016,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0050878,regulation of body fluid levels,5/26,493/18493,5.458892979708451e-4,0.009054232838757809,0.005336703602667185,5,bp,NAC,8835/2810/1277/1278/1281,SOCS2/SFN/COL1A1/COL1A2/COL3A1
GO:0051348,negative regulation of transferase activity,4/26,274/18493,5.450885762645357e-4,0.009054232838757809,0.005336703602667185,4,bp,NAC,10252/4616/9021/2810,SPRY1/GADD45B/SOCS3/SFN
GO:0001085,RNA polymerase II transcription factor binding,3/25,140/17632,9.914564026934432e-4,0.00933621445869659,0.004957282013467216,3,mf,NAC,2353/9314/3725,FOS/KLF4/JUN
GO:0051101,regulation of DNA binding,3/26,122/18493,6.518791779729293e-4,0.010585574334556255,0.00623929975002477,3,bp,NAC,9314/3725/3479,KLF4/JUN/IGF1
GO:0051450,myoblast proliferation,2/26,27/18493,6.528871211195473e-4,0.010585574334556255,0.00623929975002477,2,bp,NAC,3479/3082,IGF1/HGF
GO:0046834,lipid phosphorylation,3/26,125/18493,6.9962346675628e-4,0.011018588852965777,0.006494525143667321,3,bp,NAC,9021/8835/3082,SOCS3/SOCS2/HGF
GO:0070570,regulation of neuron projection regeneration,2/26,28/18493,7.025018534115395e-4,0.011018588852965777,0.006494525143667321,2,bp,NAC,9314/3082,KLF4/HGF
GO:1904646,cellular response to amyloid-beta,2/26,28/18493,7.025018534115395e-4,0.011018588852965777,0.006494525143667321,2,bp,NAC,3479/4804,IGF1/NGFR
GO:0005201,extracellular matrix structural constituent,3/25,155/17632,0.0013295722844183738,0.01155705139532894,0.006136487466546341,3,mf,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
hsa04014,Ras signaling pathway,5/25,232/7852,7.061545425600956e-4,0.011563280634421564,0.007340290639769414,5,kg,NAC,5320/3479/80310/4804/3082,PLA2G2A/IGF1/PDGFD/NGFR/HGF
GO:0044798,nuclear transcription factor complex,3/26,198/19659,0.002205602660530915,0.011830050633756726,0.007598248399915116,3,cc,NAC,2353/9314/3725,FOS/KLF4/JUN
GO:0046425,regulation of JAK-STAT cascade,3/26,129/18493,7.666790774025444e-4,0.011895891491310446,0.0070116207644737505,3,bp,NAC,3479/9021/8835,IGF1/SOCS3/SOCS2
GO:1904892,regulation of STAT cascade,3/26,133/18493,8.377026175745529e-4,0.012859626352766806,0.007579660862264712,3,bp,NAC,3479/9021/8835,IGF1/SOCS3/SOCS2
GO:0048011,neurotrophin TRK receptor signaling pathway,2/26,31/18493,8.619515401914339e-4,0.012956209088502492,0.007636588206959196,2,bp,NAC,10252/4804,SPRY1/NGFR
GO:1904645,response to amyloid-beta,2/26,31/18493,8.619515401914339e-4,0.012956209088502492,0.007636588206959196,2,bp,NAC,3479/4804,IGF1/NGFR
GO:0001837,epithelial to mesenchymal transition,3/26,135/18493,8.747312918779858e-4,0.013012755197731273,0.007669917350378866,3,bp,NAC,10252/3082/1277,SPRY1/HGF/COL1A1
GO:0008083,growth factor activity,3/25,166/17632,0.001618616185195928,0.013064544923367134,0.00693692650798255,3,mf,NAC,3479/80310/3082,IGF1/PDGFD/HGF
GO:0001102,RNA polymerase II activating transcription factor binding,2/25,44/17632,0.0017604127715535923,0.013261776212370395,0.00704165108621437,2,mf,NAC,2353/3725,FOS/JUN
R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,2/23,31/10554,0.0020328804138083725,0.013326660490521553,0.00665738615048356,2,re,NAC,2353/3725,FOS/JUN
GO:0046683,response to organophosphorus,3/26,137/18493,9.127864513741696e-4,0.013440314789111497,0.007921927526426734,3,bp,NAC,2353/3725/1277,FOS/JUN/COL1A1
R-HSA-2871796,FCERI mediated MAPK activation,2/23,32/10554,0.0021655368485783443,0.013689286507084533,0.006838537416563193,2,re,NAC,2353/3725,FOS/JUN
R-HSA-76002,"Platelet activation, signaling and aggregation",4/23,262/10554,0.0022651460529956318,0.01382520177173196,0.006906434426556555,4,re,NAC,3479/3082/1277/1278,IGF1/HGF/COL1A1/COL1A2
GO:0050728,negative regulation of inflammatory response,3/26,139/18493,9.518793750758369e-4,0.013874363012469018,0.008177762201608466,3,bp,NAC,9314/9021/3082,KLF4/SOCS3/HGF
GO:0044344,cellular response to fibroblast growth factor stimulus,3/26,142/18493,0.001012488981690801,0.014184675733784718,0.0083606652754845915,3,bp,NAC,3164/10252/1277,NR4A1/SPRY1/COL1A1
GO:0071236,cellular response to antibiotic,3/26,141/18493,9.92021236427811e-4,0.014184675733784718,0.0083606652754845915,3,bp,NAC,9314/80310/3082,KLF4/PDGFD/HGF
GO:0071902,positive regulation of protein serine/threonine kinase activity,4/26,323/18493,0.0010079575778362284,0.014184675733784718,0.0083606652754845915,4,bp,NAC,3479/80310/4616/3082,IGF1/PDGFD/GADD45B/HGF
GO:1902107,positive regulation of leukocyte differentiation,3/26,142/18493,0.001012488981690801,0.014184675733784718,0.0083606652754845915,3,bp,NAC,2353/3725/7704,FOS/JUN/ZBTB16
GO:0046627,negative regulation of insulin receptor signaling pathway,2/26,34/18493,0.0010372112380042243,0.014254245870858053,0.008401670980525447,2,bp,NAC,9021/8835,SOCS3/SOCS2
GO:1900077,negative regulation of cellular response to insulin stimulus,2/26,34/18493,0.0010372112380042243,0.014254245870858053,0.008401670980525447,2,bp,NAC,9021/8835,SOCS3/SOCS2
GO:0007259,JAK-STAT cascade,3/26,147/18493,0.0011188506086335418,0.015231145549605668,0.008977470623395252,3,bp,NAC,3479/9021/8835,IGF1/SOCS3/SOCS2
R-HSA-114604,GPVI-mediated activation cascade,2/23,35/10554,0.0025874756656253067,0.01526610642718931,0.007626244067106168,2,re,NAC,1277/1278,COL1A1/COL1A2
GO:0071774,response to fibroblast growth factor,3/26,148/18493,0.0011409369940042868,0.015386654975216692,0.009069130262227878,3,bp,NAC,3164/10252/1277,NR4A1/SPRY1/COL1A1
R-HSA-1266695,Interleukin-7 signaling,2/23,36/10554,0.002736056783117819,0.015599404569177066,0.007792744477019766,2,re,NAC,8835/3082,SOCS2/HGF
R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,3/23,132/10554,0.0028202313345404863,0.015599404569177066,0.007792744477019766,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0014074,response to purine-containing compound,3/26,151/18493,0.0012088483565785466,0.015873523344346593,0.009356097940863001,3,bp,NAC,2353/3725/1277,FOS/JUN/COL1A1
GO:0030168,platelet activation,3/26,152/18493,0.001232040619935425,0.015873523344346593,0.009356097940863001,3,bp,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0045684,positive regulation of epidermis development,2/26,37/18493,0.0012281552520958785,0.015873523344346593,0.009356097940863001,2,bp,NAC,6424/2810,SFRP4/SFN
GO:0071276,cellular response to cadmium ion,2/26,37/18493,0.0012281552520958785,0.015873523344346593,0.009356097940863001,2,bp,NAC,2353/3725,FOS/JUN
GO:0097696,STAT cascade,3/26,151/18493,0.0012088483565785466,0.015873523344346593,0.009356097940863001,3,bp,NAC,3479/9021/8835,IGF1/SOCS3/SOCS2
hsa05224,Breast cancer,4/25,147/7852,0.0010982144724536146,0.015985121765713723,0.010147244833197141,4,kg,NAC,2353/3725/3479/4616,FOS/JUN/IGF1/GADD45B
GO:0001959,regulation of cytokine-mediated signaling pathway,3/26,155/18493,0.0013033011685559073,0.016643040586072338,0.009809663196955502,3,bp,NAC,3977/9021/3303,LIFR/SOCS3/HSPA1A
GO:0030198,extracellular matrix organization,4/26,348/18493,0.0013279507085605933,0.01666289454306901,0.009821365423496195,4,bp,NAC,3679/1277/1278/1281,ITGA7/COL1A1/COL1A2/COL3A1
GO:2001236,regulation of extrinsic apoptotic signaling pathway,3/26,156/18493,0.0013276202598713727,0.01666289454306901,0.009821365423496195,3,bp,NAC,3479/3303/3082,IGF1/HSPA1A/HGF
R-HSA-202733,Cell surface interactions at the vascular wall,3/23,137/10554,0.0031333527721407925,0.016686805321347302,0.008335959839388483,3,re,NAC,7102/1277/1278,TSPAN7/COL1A1/COL1A2
R-HSA-76009,Platelet Aggregation (Plug Formation),2/23,39/10554,0.003205375033479143,0.016686805321347302,0.008335959839388483,2,re,NAC,1277/1278,COL1A1/COL1A2
R-HSA-1474228,Degradation of the extracellular matrix,3/23,140/10554,0.00333111867501463,0.016845943013645413,0.008415457705300118,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0038179,neurotrophin signaling pathway,2/26,39/18493,0.0013641030199527842,0.016968971187860928,0.010001771688946004,2,bp,NAC,10252/4804,SPRY1/NGFR
hsa04115,p53 signaling pathway,3/25,72/7852,0.0014711919657841223,0.01718898365290049,0.01091144804000915,3,kg,NAC,3479/4616/2810,IGF1/GADD45B/SFN
hsa04630,JAK-STAT signaling pathway,4/25,162/7852,0.0015745633880519532,0.01718898365290049,0.01091144804000915,4,kg,NAC,3977/3953/9021/8835,LIFR/LEPR/SOCS3/SOCS2
hsa04917,Prolactin signaling pathway,3/25,70/7852,0.0013559981796457715,0.01718898365290049,0.01091144804000915,3,kg,NAC,2353/9021/8835,FOS/SOCS3/SOCS2
GO:0031093,platelet alpha granule lumen,2/26,67/19659,0.00352745901900539,0.017343340176776502,0.011139344270543337,2,cc,NAC,3479/3082,IGF1/HGF
GO:0045861,negative regulation of proteolysis,4/26,359/18493,0.0014890844517971048,0.01836537490549763,0.010824833441763928,4,bp,NAC,9314/4804/3082/2810,KLF4/NGFR/HGF/SFN
R-HSA-1474244,Extracellular matrix organization,4/23,301/10554,0.0037405787053817977,0.01839117863479384,0.009187386293920206,4,re,NAC,3679/1277/1278/1281,ITGA7/COL1A1/COL1A2/COL3A1
GO:1901028,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,2/26,41/18493,0.0015069291725371356,0.018427955898060056,0.010861719637912628,2,bp,NAC,3303/2810,HSPA1A/SFN
hsa01521,EGFR tyrosine kinase inhibitor resistance,3/25,79/7852,0.001922273219895039,0.019370599369711545,0.012296322621190936,3,kg,NAC,3479/80310/3082,IGF1/PDGFD/HGF
GO:0006650,glycerophospholipid metabolic process,4/26,367/18493,0.0016145545887667693,0.019578170349499564,0.01153967366407386,4,bp,NAC,5320/9021/8835/3082,PLA2G2A/SOCS3/SOCS2/HGF
hsa04512,ECM-receptor interaction,3/25,82/7852,0.0021392368807805337,0.020017145098732137,0.012706745382079863,3,kg,NAC,3679/1277/1278,ITGA7/COL1A1/COL1A2
hsa05132,Salmonella infection,3/25,86/7852,0.002451453871713274,0.02007127857465243,0.01274110893850978,3,kg,NAC,2353/3725/2318,FOS/JUN/FLNC
hsa05210,Colorectal cancer,3/25,86/7852,0.002451453871713274,0.02007127857465243,0.01274110893850978,3,kg,NAC,2353/3725/4616,FOS/JUN/GADD45B
hsa04974,Protein digestion and absorption,3/25,90/7852,0.002790615500847906,0.021504154741827982,0.013650688827677063,3,kg,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0000982,"transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding",4/25,447/17632,0.003378719608937317,0.021749137800106223,0.01154821476111835,4,mf,NAC,2353/9314/3164/3725,FOS/KLF4/NR4A1/JUN
GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",4/25,449/17632,0.003433236538271253,0.021749137800106223,0.01154821476111835,4,mf,NAC,2353/9314/3164/3725,FOS/KLF4/NR4A1/JUN
GO:0004860,protein kinase inhibitor activity,2/25,62/17632,0.0034644644283355047,0.021749137800106223,0.01154821476111835,2,mf,NAC,9021/2810,SOCS3/SFN
GO:0014911,positive regulation of smooth muscle cell migration,2/26,45/18493,0.001813069891294302,0.021802165442813982,0.012850530457594702,2,bp,NAC,3479/80310,IGF1/PDGFD
GO:0001503,ossification,4/26,380/18493,0.0018339385806591592,0.02182533713753593,0.012864188209599177,4,bp,NAC,3479/7704/3082/1277,IGF1/ZBTB16/HGF/COL1A1
GO:0001936,regulation of endothelial cell proliferation,3/26,175/18493,0.0018452467988769117,0.02182533713753593,0.012864188209599177,3,bp,NAC,3164/3725/4804,NR4A1/JUN/NGFR
GO:0031103,axon regeneration,2/26,46/18493,0.0018938468543398528,0.02186256808649926,0.012886132701529274,2,bp,NAC,9314/3725,KLF4/JUN
GO:0031952,regulation of protein autophosphorylation,2/26,46/18493,0.0018938468543398528,0.02186256808649926,0.012886132701529274,2,bp,NAC,3725/80310,JUN/PDGFD
GO:1900744,regulation of p38MAPK cascade,2/26,46/18493,0.0018938468543398528,0.02186256808649926,0.012886132701529274,2,bp,NAC,4616/3082,GADD45B/HGF
GO:0018108,peptidyl-tyrosine phosphorylation,4/26,387/18493,0.0019602920572727644,0.02245001141781428,0.013232380804314067,4,bp,NAC,3479/80310/9021/3082,IGF1/PDGFD/SOCS3/HGF
GO:0090199,regulation of release of cytochrome c from mitochondria,2/26,47/18493,0.001976311432800251,0.02245525509866742,0.01323547151017491,2,bp,NAC,3479/3082,IGF1/HGF
GO:0018212,peptidyl-tyrosine modification,4/26,390/18493,0.0020162544494757807,0.022730118520262122,0.013397480223490386,4,bp,NAC,3479/80310/9021/3082,IGF1/PDGFD/SOCS3/HGF
GO:0061138,morphogenesis of a branching epithelium,3/26,182/18493,0.0020635568973251146,0.022730630556031608,0.01339778202522051,3,bp,NAC,10252/9021/3082,SPRY1/SOCS3/HGF
GO:1904707,positive regulation of vascular smooth muscle cell proliferation,2/26,48/18493,0.002060459092746181,0.022730630556031608,0.01339778202522051,2,bp,NAC,3725/3479,JUN/IGF1
GO:2001233,regulation of apoptotic signaling pathway,4/26,391/18493,0.0020351531306613104,0.022730630556031608,0.01339778202522051,4,bp,NAC,3479/3303/3082/2810,IGF1/HSPA1A/HGF/SFN
GO:0019210,kinase inhibitor activity,2/25,66/17632,0.0039162157649020694,0.023291177970207046,0.012366997152322326,2,mf,NAC,9021/2810,SOCS3/SFN
hsa01522,Endocrine resistance,3/25,98/7852,0.003552806148840712,0.02355456758487691,0.01495227673125975,3,kg,NAC,2353/3725/3479,FOS/JUN/IGF1
hsa04015,Rap1 signaling pathway,4/25,206/7852,0.003775923047957367,0.02355456758487691,0.01495227673125975,4,kg,NAC,3479/80310/4804/3082,IGF1/PDGFD/NGFR/HGF
hsa05146,Amoebiasis,3/25,96/7852,0.0033515482480605454,0.02355456758487691,0.01495227673125975,3,kg,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
hsa05231,Choline metabolism in cancer,3/25,99/7852,0.003656161609572612,0.02355456758487691,0.01495227673125975,3,kg,NAC,2353/3725/80310,FOS/JUN/PDGFD
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,3/26,186/18493,0.0021952359540203894,0.023997920315541075,0.014144742032284488,3,bp,NAC,3479/9021/3082,IGF1/SOCS3/HGF
GO:0001935,endothelial cell proliferation,3/26,190/18493,0.002332044577724225,0.024385074823594616,0.014372936832960898,3,bp,NAC,3164/3725/4804,NR4A1/JUN/NGFR
GO:0002040,sprouting angiogenesis,3/26,189/18493,0.002297357691445265,0.024385074823594616,0.014372936832960898,3,bp,NAC,9314/3164/4804,KLF4/NR4A1/NGFR
GO:0007517,muscle organ development,4/26,403/18493,0.00227164992422424,0.024385074823594616,0.014372936832960898,4,bp,NAC,2353/3479/3679/1281,FOS/IGF1/ITGA7/COL3A1
GO:0030099,myeloid cell differentiation,4/26,405/18493,0.0023128387448893375,0.024385074823594616,0.014372936832960898,4,bp,NAC,2353/3725/7704/3303,FOS/JUN/ZBTB16/HSPA1A
GO:0097345,mitochondrial outer membrane permeabilization,2/26,51/18493,0.0023229553506595056,0.024385074823594616,0.014372936832960898,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:2000677,regulation of transcription regulatory region DNA binding,2/26,51/18493,0.0023229553506595056,0.024385074823594616,0.014372936832960898,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0002763,positive regulation of myeloid leukocyte differentiation,2/26,52/18493,0.002413790168432614,0.02487928009320187,0.014664228993184604,2,bp,NAC,2353/3725,FOS/JUN
GO:0038066,p38MAPK cascade,2/26,52/18493,0.002413790168432614,0.02487928009320187,0.014664228993184604,2,bp,NAC,4616/3082,GADD45B/HGF
GO:0017053,transcriptional repressor complex,2/26,84/19659,0.005485512072940408,0.024895785561806466,0.015990156649866777,2,cc,NAC,3725/7704,JUN/ZBTB16
GO:0030278,regulation of ossification,3/26,193/18493,0.0024380592692930924,0.024951202309148456,0.014706621049561917,3,bp,NAC,3479/7704/3082,IGF1/ZBTB16/HGF
GO:0043588,skin development,4/26,412/18493,0.002461080457797292,0.025009430285926,0.014740941511491563,4,bp,NAC,2810/1277/1278/1281,SFN/COL1A1/COL1A2/COL3A1
GO:0001558,regulation of cell growth,4/26,416/18493,0.0025486798568932776,0.025184097360289787,0.014843892962114125,4,bp,NAC,3479/8835/3303/2810,IGF1/SOCS2/HSPA1A/SFN
GO:0001763,morphogenesis of a branching structure,3/26,196/18493,0.0025470273758190563,0.025184097360289787,0.014843892962114125,3,bp,NAC,10252/9021/3082,SPRY1/SOCS3/HGF
GO:0043434,response to peptide hormone,4/26,417/18493,0.0025709122565865427,0.025184097360289787,0.014843892962114125,4,bp,NAC,3164/9021/8835/1277,NR4A1/SOCS3/SOCS2/COL1A1
GO:0046579,positive regulation of Ras protein signal transduction,2/26,53/18493,0.002506285526308685,0.025184097360289787,0.014843892962114125,2,bp,NAC,3479/1281,IGF1/COL3A1
GO:0052548,regulation of endopeptidase activity,4/26,417/18493,0.0025709122565865427,0.025184097360289787,0.014843892962114125,4,bp,NAC,9314/4804/3082/2810,KLF4/NGFR/HGF/SFN
GO:0070206,protein trimerization,2/26,54/18493,0.0026004369415683843,0.025184097360289787,0.014843892962114125,2,bp,NAC,1277/1278,COL1A1/COL1A2
GO:1903706,regulation of hemopoiesis,4/26,418/18493,0.0025932785058628,0.025184097360289787,0.014843892962114125,4,bp,NAC,2353/3725/7704/3303,FOS/JUN/ZBTB16/HSPA1A
GO:0007266,Rho protein signal transduction,3/26,199/18493,0.002658977268909207,0.0252637448826288,0.014890838432479174,3,bp,NAC,4804/1278/1281,NGFR/COL1A2/COL3A1
GO:0031348,negative regulation of defense response,3/26,199/18493,0.002658977268909207,0.0252637448826288,0.014890838432479174,3,bp,NAC,9314/9021/3082,KLF4/SOCS3/HGF
GO:1901342,regulation of vasculature development,4/26,421/18493,0.0026611844921410797,0.0252637448826288,0.014890838432479174,4,bp,NAC,9314/80310/4804/3082,KLF4/PDGFD/NGFR/HGF
GO:0050839,cell adhesion molecule binding,4/25,486/17632,0.004553611003095182,0.02572790216748778,0.013660833009285547,4,mf,NAC,3479/3303/2810/1281,IGF1/HSPA1A/SFN/COL3A1
GO:0050727,regulation of inflammatory response,4/26,425/18493,0.002753624795758313,0.02597046130901468,0.015307387925508889,4,bp,NAC,9314/5320/9021/3082,KLF4/PLA2G2A/SOCS3/HGF
GO:0050679,positive regulation of epithelial cell proliferation,3/26,203/18493,0.002812930307492767,0.026357522296831578,0.015535527603924511,3,bp,NAC,3164/3725/3479,NR4A1/JUN/IGF1
GO:0046626,regulation of insulin receptor signaling pathway,2/26,57/18493,0.0028927828316837106,0.026758241193074322,0.01577171746289095,2,bp,NAC,9021/8835,SOCS3/SOCS2
GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,2/26,57/18493,0.0028927828316837106,0.026758241193074322,0.01577171746289095,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:0031091,platelet alpha granule,2/26,91/19659,0.006407400861680958,0.027002617917084037,0.017343340678234176,2,cc,NAC,3479/3082,IGF1/HGF
GO:0009266,response to temperature stimulus,3/26,208/18493,0.0030129945320917745,0.027173444436302693,0.016016444617961537,3,bp,NAC,2353/3479/3303,FOS/IGF1/HSPA1A
GO:0043388,positive regulation of DNA binding,2/26,58/18493,0.0029935138188266256,0.027173444436302693,0.016016444617961537,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0045604,regulation of epidermal cell differentiation,2/26,58/18493,0.0029935138188266256,0.027173444436302693,0.016016444617961537,2,bp,NAC,6424/2810,SFRP4/SFN
GO:0060348,bone development,3/26,208/18493,0.0030129945320917745,0.027173444436302693,0.016016444617961537,3,bp,NAC,3479/6424/1277,IGF1/SFRP4/COL1A1
GO:0034113,heterotypic cell-cell adhesion,2/26,59/18493,0.0030958785767943708,0.027407072308676547,0.0161541484665796,2,bp,NAC,9314/3679,KLF4/ITGA7
GO:0048762,mesenchymal cell differentiation,3/26,210/18493,0.0030954172603497054,0.027407072308676547,0.0161541484665796,3,bp,NAC,10252/3082/1277,SPRY1/HGF/COL1A1
GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,2/26,59/18493,0.0030958785767943708,0.027407072308676547,0.0161541484665796,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:0033613,activating transcription factor binding,2/25,76/17632,0.005158492888166101,0.02775760458870331,0.014738551109046006,2,mf,NAC,2353/3725,FOS/JUN
GO:0052547,regulation of peptidase activity,4/26,442/18493,0.003171295408699545,0.02790353216313075,0.016446769513666446,4,bp,NAC,9314/4804/3082/2810,KLF4/NGFR/HGF/SFN
GO:0051057,positive regulation of small GTPase mediated signal transduction,2/26,60/18493,0.00319987267358795,0.02798434101810553,0.016494399491285894,2,bp,NAC,3479/1281,IGF1/COL3A1
GO:0001649,osteoblast differentiation,3/26,214/18493,0.003264414666637887,0.02822381362332333,0.016635548315020062,3,bp,NAC,3479/3082/1277,IGF1/HGF/COL1A1
GO:0035794,positive regulation of mitochondrial membrane permeability,2/26,61/18493,0.0033054916856144444,0.02822381362332333,0.016635548315020062,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:0045669,positive regulation of osteoblast differentiation,2/26,61/18493,0.0033054916856144444,0.02822381362332333,0.016635548315020062,2,bp,NAC,3479/3082,IGF1/HGF
GO:1900076,regulation of cellular response to insulin stimulus,2/26,61/18493,0.0033054916856144444,0.02822381362332333,0.016635548315020062,2,bp,NAC,9021/8835,SOCS3/SOCS2
hsa04668,TNF signaling pathway,3/25,110/7852,0.004916175500716879,0.029273590481541413,0.018582672945293463,3,kg,NAC,2353/3725/9021,FOS/JUN/SOCS3
GO:0046686,response to cadmium ion,2/26,63/18493,0.0035215868029441306,0.029430564244668646,0.01734682562621167,2,bp,NAC,2353/3725,FOS/JUN
GO:0051054,positive regulation of DNA metabolic process,3/26,220/18493,0.0035284044451335244,0.029430564244668646,0.01734682562621167,3,bp,NAC,9314/3725/3082,KLF4/JUN/HGF
GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,2/26,63/18493,0.0035215868029441306,0.029430564244668646,0.01734682562621167,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:1905710,positive regulation of membrane permeability,2/26,63/18493,0.0035215868029441306,0.029430564244668646,0.01734682562621167,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:0046486,glycerolipid metabolic process,4/26,459/18493,0.0036306087246427924,0.029766865850338352,0.017545046946838377,4,bp,NAC,5320/9021/8835/3082,PLA2G2A/SOCS3/SOCS2/HGF
GO:0046578,regulation of Ras protein signal transduction,3/26,222/18493,0.003619229092407411,0.029766865850338352,0.017545046946838377,3,bp,NAC,3479/10252/1281,IGF1/SPRY1/COL3A1
GO:2001234,negative regulation of apoptotic signaling pathway,3/26,222/18493,0.003619229092407411,0.029766865850338352,0.017545046946838377,3,bp,NAC,3479/3303/3082,IGF1/HSPA1A/HGF
GO:0097191,extrinsic apoptotic signaling pathway,3/26,224/18493,0.003711479910785027,0.03025799723877285,0.01783452731438776,3,bp,NAC,3479/3303/3082,IGF1/HSPA1A/HGF
GO:0051219,phosphoprotein binding,2/25,82/17632,0.005979863903773381,0.030714755505745095,0.01630871973756377,2,mf,NAC,9021/2810,SOCS3/SFN
GO:0030858,positive regulation of epithelial cell differentiation,2/26,66/18493,0.00385780623521891,0.030926746652338265,0.018228698468168884,2,bp,NAC,6424/2810,SFRP4/SFN
GO:0032677,regulation of interleukin-8 production,2/26,66/18493,0.00385780623521891,0.030926746652338265,0.018228698468168884,2,bp,NAC,9314/3303,KLF4/HSPA1A
GO:2000573,positive regulation of DNA biosynthetic process,2/26,66/18493,0.00385780623521891,0.030926746652338265,0.018228698468168884,2,bp,NAC,9314/3082,KLF4/HGF
GO:1904018,positive regulation of vasculature development,3/26,228/18493,0.003900288614574456,0.031094566137187515,0.01832761384458366,3,bp,NAC,9314/80310/3082,KLF4/PDGFD/HGF
GO:0046824,positive regulation of nucleocytoplasmic transport,2/26,67/18493,0.003973082312237696,0.031500866904170303,0.018567093743713466,2,bp,NAC,3479/2810,IGF1/SFN
GO:0002009,morphogenesis of an epithelium,4/26,479/18493,0.004226965440674965,0.03275430938119028,0.01930589195025112,4,bp,NAC,9314/10252/9021/3082,KLF4/SPRY1/SOCS3/HGF
GO:0040014,regulation of multicellular organism growth,2/26,69/18493,0.004208412662419664,0.03275430938119028,0.01930589195025112,2,bp,NAC,3479/8835,IGF1/SOCS2
GO:0060395,SMAD protein signal transduction,2/26,69/18493,0.004208412662419664,0.03275430938119028,0.01930589195025112,2,bp,NAC,2353/3725,FOS/JUN
GO:0071300,cellular response to retinoic acid,2/26,69/18493,0.004208412662419664,0.03275430938119028,0.01930589195025112,2,bp,NAC,9314/1277,KLF4/COL1A1
GO:0097237,cellular response to toxic substance,3/26,235/18493,0.004244667951685782,0.03275430938119028,0.01930589195025112,3,bp,NAC,9314/80310/3082,KLF4/PDGFD/HGF
GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,2/26,70/18493,0.004328458230213493,0.03304743505924905,0.019478664717418562,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:0048678,response to axon injury,2/26,70/18493,0.004328458230213493,0.03304743505924905,0.019478664717418562,2,bp,NAC,9314/3725,KLF4/JUN
R-HSA-186797,Signaling by PDGF,2/23,58/10554,0.006973122210441071,0.033357908952650533,0.016664075837184922,2,re,NAC,80310/1281,PDGFD/COL3A1
GO:0016049,cell growth,4/26,485/18493,0.004418116728838526,0.03355443389323154,0.019777497600562487,4,bp,NAC,3479/8835/3303/2810,IGF1/SOCS2/HSPA1A/SFN
hsa04960,Aldosterone-regulated sodium reabsorption,2/25,37/7852,0.006054482787408179,0.0344842280500205,0.02189034966614399,2,kg,NAC,3479/2810,IGF1/SFN
GO:0004896,cytokine receptor activity,2/25,92/17632,0.007472475348931004,0.03518290476788347,0.01868118837232751,2,mf,NAC,3977/3953,LIFR/LEPR
GO:0031625,ubiquitin protein ligase binding,3/25,286/17632,0.0074584946963161015,0.03518290476788347,0.01868118837232751,3,mf,NAC,3725/4804/3303,JUN/NGFR/HSPA1A
GO:0032637,interleukin-8 production,2/26,73/18493,0.004698064445908373,0.03530889060128011,0.020811601273541477,2,bp,NAC,9314/3303,KLF4/HSPA1A
GO:0046902,regulation of mitochondrial membrane permeability,2/26,73/18493,0.004698064445908373,0.03530889060128011,0.020811601273541477,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:0070374,positive regulation of ERK1 and ERK2 cascade,3/26,245/18493,0.00476796991811084,0.03564860410276654,0.021011833617854157,3,bp,NAC,5320/3725/80310,PLA2G2A/JUN/PDGFD
GO:0062023,collagen-containing extracellular matrix,3/26,332/19659,0.009306803602339018,0.0366067608358668,0.023511924890119627,3,cc,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0043618,regulation of transcription from RNA polymerase II promoter in response to stress,2/26,75/18493,0.004952316632852609,0.036647143083109304,0.02160038779673365,2,bp,NAC,3725/3303,JUN/HSPA1A
GO:0070373,negative regulation of ERK1 and ERK2 cascade,2/26,75/18493,0.004952316632852609,0.036647143083109304,0.02160038779673365,2,bp,NAC,9314/10252,KLF4/SPRY1
GO:0010507,negative regulation of autophagy,2/26,76/18493,0.005081784217314083,0.037413339926450115,0.022051995959128785,2,bp,NAC,3953/3082,LEPR/HGF
hsa04611,Platelet activation,3/25,124/7852,0.006860281320827712,0.03744570220951793,0.023770272997604792,3,kg,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0000980,RNA polymerase II distal enhancer sequence-specific DNA binding,2/25,100/17632,0.008775394194381288,0.038139213229426365,0.020250909679341435,2,mf,NAC,3725/7704,JUN/ZBTB16
GO:0044389,ubiquitin-like protein ligase binding,3/25,301/17632,0.008578613447737306,0.038139213229426365,0.020250909679341435,3,mf,NAC,3725/4804/3303,JUN/NGFR/HSPA1A
GO:0043491,protein kinase B signaling,3/26,253/18493,0.005213634922304823,0.03818921417708558,0.02250930813370183,3,bp,NAC,9314/3479/3082,KLF4/IGF1/HGF
GO:1900182,positive regulation of protein localization to nucleus,2/26,78/18493,0.005345380913632476,0.03895648817359426,0.022961551186682836,2,bp,NAC,3479/4804,IGF1/NGFR
hsa04380,Osteoclast differentiation,3/25,128/7852,0.007488664433496725,0.03924060163152284,0.02490966274721016,3,kg,NAC,2353/3725/9021,FOS/JUN/SOCS3
R-HSA-450294,MAP kinase activation,2/23,64/10554,0.008437333040335502,0.03930020916156274,0.019632575495517512,2,re,NAC,2353/3725,FOS/JUN
R-HSA-6796648,TP53 Regulates Transcription of DNA Repair Genes,2/23,65/10554,0.008693705188707011,0.03945604662567028,0.019710424719335734,2,re,NAC,2353/3725,FOS/JUN
GO:0031668,cellular response to extracellular stimulus,3/26,258/18493,0.00550456525394888,0.03991501337411173,0.023526520630471805,3,bp,NAC,2353/3725/1277,FOS/JUN/COL1A1
GO:0042509,regulation of tyrosine phosphorylation of STAT protein,2/26,80/18493,0.0056151644690696535,0.04011228875676985,0.023642797764503808,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:0071277,cellular response to calcium ion,2/26,80/18493,0.0056151644690696535,0.04011228875676985,0.023642797764503808,2,bp,NAC,2353/3725,FOS/JUN
GO:1903671,negative regulation of sprouting angiogenesis,2/26,80/18493,0.0056151644690696535,0.04011228875676985,0.023642797764503808,2,bp,NAC,9314/4804,KLF4/NGFR
GO:0043620,regulation of DNA-templated transcription in response to stress,2/26,81/18493,0.0057523656580052256,0.04029448371117252,0.023750186262995514,2,bp,NAC,3725/3303,JUN/HSPA1A
GO:0045682,regulation of epidermis development,2/26,81/18493,0.0057523656580052256,0.04029448371117252,0.023750186262995514,2,bp,NAC,6424/2810,SFRP4/SFN
GO:0090559,regulation of membrane permeability,2/26,81/18493,0.0057523656580052256,0.04029448371117252,0.023750186262995514,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:1901216,positive regulation of neuron death,2/26,81/18493,0.0057523656580052256,0.04029448371117252,0.023750186262995514,2,bp,NAC,2353/3725,FOS/JUN
GO:0061448,connective tissue development,3/26,263/18493,0.005805136366713244,0.040467689744769136,0.023852276553797618,3,bp,NAC,80310/7704/1277,PDGFD/ZBTB16/COL1A1
hsa04210,Apoptosis,3/25,136/7852,0.008845647796498974,0.04100076842087355,0.026027004461623225,3,kg,NAC,2353/3725/4616,FOS/JUN/GADD45B
hsa04550,Signaling pathways regulating pluripotency of stem cells,3/25,139/7852,0.00938948895134509,0.04100076842087355,0.026027004461623225,3,kg,NAC,9314/3479/3977,KLF4/IGF1/LIFR
hsa04915,Estrogen signaling pathway,3/25,138/7852,0.00920606920749287,0.04100076842087355,0.026027004461623225,3,kg,NAC,2353/3725/3303,FOS/JUN/HSPA1A
hsa04930,Type II diabetes mellitus,2/25,46/7852,0.009245843808330904,0.04100076842087355,0.026027004461623225,2,kg,NAC,9021/8835,SOCS3/SOCS2
hsa05162,Measles,3/25,138/7852,0.00920606920749287,0.04100076842087355,0.026027004461623225,3,kg,NAC,2353/3725/3303,FOS/JUN/HSPA1A
GO:1902105,regulation of leukocyte differentiation,3/26,265/18493,0.005928084136966047,0.04112608370020195,0.024240344041844972,3,bp,NAC,2353/3725/7704,FOS/JUN/ZBTB16
GO:0007260,tyrosine phosphorylation of STAT protein,2/26,83/18493,0.006031365607564913,0.041444097960553185,0.024427786520864414,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:0014910,regulation of smooth muscle cell migration,2/26,83/18493,0.006031365607564913,0.041444097960553185,0.024427786520864414,2,bp,NAC,3479/80310,IGF1/PDGFD
GO:0060485,mesenchyme development,3/26,269/18493,0.006178671826119906,0.04225508741749301,0.024905796136217934,3,bp,NAC,10252/3082/1277,SPRY1/HGF/COL1A1
GO:0003705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",2/25,108/17632,0.010172713953946583,0.042574691733183845,0.022606031008770188,2,mf,NAC,3725/7704,JUN/ZBTB16
GO:0001822,kidney development,3/26,271/18493,0.0063063225734645905,0.04279184261474537,0.025222167875926804,3,bp,NAC,10252/80310/7704,SPRY1/PDGFD/ZBTB16
GO:0046427,positive regulation of JAK-STAT cascade,2/26,85/18493,0.006316467412987362,0.04279184261474537,0.025222167875926804,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:0042826,histone deacetylase binding,2/25,112/17632,0.010906109847434847,0.04401394331286206,0.02337023538736039,2,mf,NAC,9314/3303,KLF4/HSPA1A
GO:0006112,energy reserve metabolic process,2/26,87/18493,0.006607637299804015,0.044142688072301824,0.02601837689201581,2,bp,NAC,3479/3953,IGF1/LEPR
GO:1904705,regulation of vascular smooth muscle cell proliferation,2/26,87/18493,0.006607637299804015,0.044142688072301824,0.02601837689201581,2,bp,NAC,3725/3479,JUN/IGF1
GO:1990874,vascular smooth muscle cell proliferation,2/26,87/18493,0.006607637299804015,0.044142688072301824,0.02601837689201581,2,bp,NAC,3725/3479,JUN/IGF1
GO:1904894,positive regulation of STAT cascade,2/26,88/18493,0.006755487254497064,0.04492243367852195,0.02647797090290385,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:0014909,smooth muscle cell migration,2/26,90/18493,0.007055696218338768,0.04649027234275271,0.027402079040700432,2,bp,NAC,3479/80310,IGF1/PDGFD
GO:0090287,regulation of cellular response to growth factor stimulus,3/26,282/18493,0.007036753416791276,0.04649027234275271,0.027402079040700432,3,bp,NAC,10252/6424/3303,SPRY1/SFRP4/HSPA1A
R-HSA-448424,Interleukin-17 signaling,2/23,72/10554,0.010585037942551685,0.0468387928957912,0.023398504925640568,2,re,NAC,2353/3725,FOS/JUN
GO:0060070,canonical Wnt signaling pathway,3/26,284/18493,0.0071747550369914235,0.04705987053808466,0.027737808946837653,3,bp,NAC,9314/6424/1277,KLF4/SFRP4/COL1A1
GO:0001158,enhancer sequence-specific DNA binding,2/25,119/17632,0.012244275734028608,0.0477104537222494,0.025332984277300567,2,mf,NAC,3725/7704,JUN/ZBTB16
GO:0072001,renal system development,3/26,286/18493,0.0073143677083983595,0.04775851856660105,0.02814960280250476,3,bp,NAC,10252/80310/7704,SPRY1/PDGFD/ZBTB16
GO:0043255,regulation of carbohydrate biosynthetic process,2/26,92/18493,0.007361889390847577,0.04785228104050925,0.028204867841654067,2,bp,NAC,3479/3953,IGF1/LEPR
hsa04932,Non-alcoholic fatty liver disease (NAFLD),3/25,149/7852,0.011342633111313286,0.04793177218006582,0.030426757751910002,3,kg,NAC,3725/3953/9021,JUN/LEPR/SOCS3
GO:0055006,cardiac cell development,2/26,93/18493,0.007517219636365039,0.048642815853250004,0.028670821176223514,2,bp,NAC,3479/10252,IGF1/SPRY1
GO:0030258,lipid modification,3/26,291/18493,0.007670478795209005,0.04941295045306515,0.029124750312635696,3,bp,NAC,9021/8835/3082,SOCS3/SOCS2/HGF
GO:0005178,integrin binding,2/25,126/17632,0.013650899366926974,0.049759729950411224,0.02642109554889092,2,mf,NAC,3479/1281,IGF1/COL3A1
GO:0019955,cytokine binding,2/25,125/17632,0.013445814020995392,0.049759729950411224,0.02642109554889092,2,mf,NAC,3977/3953,LIFR/LEPR
GO:0001206,"distal enhancer DNA-binding transcription repressor activity, RNA polymerase II-specific",1/25,10/17632,0.01409221429259111,0.04976313172071235,0.02642290179860833,1,mf,NAC,7704,ZBTB16
GO:1903037,regulation of leukocyte cell-cell adhesion,3/26,293/18493,0.007815767162532045,0.04978875504842619,0.029346255300819468,3,bp,NAC,9314/3479/7704,KLF4/IGF1/ZBTB16
GO:1990823,response to leukemia inhibitory factor,2/26,95/18493,0.00783232667774965,0.04978875504842619,0.029346255300819468,2,bp,NAC,9314/9021,KLF4/SOCS3
GO:1990830,cellular response to leukemia inhibitory factor,2/26,95/18493,0.00783232667774965,0.04978875504842619,0.029346255300819468,2,bp,NAC,9314/9021,KLF4/SOCS3
GO:0060326,cell chemotaxis,3/26,295/18493,0.007962687443755253,0.05039542974271416,0.029703838663685336,3,bp,NAC,3164/80310/3082,NR4A1/PDGFD/HGF
GO:0090263,positive regulation of canonical Wnt signaling pathway,2/26,97/18493,0.008153334854825663,0.05137669081010233,0.030282208975863648,2,bp,NAC,6424/1277,SFRP4/COL1A1
GO:0005035,death receptor activity,1/25,11/17632,0.015490903127155398,0.05148447215789882,0.027336887871450704,1,mf,NAC,4804,NGFR
GO:0035326,enhancer binding,2/25,133/17632,0.015124609376005719,0.05148447215789882,0.027336887871450704,2,mf,NAC,3725/7704,JUN/ZBTB16
GO:0007229,integrin-mediated signaling pathway,2/26,99/18493,0.008480211160893121,0.053204107413777284,0.031359316329526966,2,bp,NAC,3679/1281,ITGA7/COL3A1
GO:0001823,mesonephros development,2/26,101/18493,0.008812922715775351,0.054579602913578676,0.032170054458308034,2,bp,NAC,10252/7704,SPRY1/ZBTB16
GO:0002042,cell migration involved in sprouting angiogenesis,2/26,101/18493,0.008812922715775351,0.054579602913578676,0.032170054458308034,2,bp,NAC,9314/3164,KLF4/NR4A1
GO:0007631,feeding behavior,2/26,101/18493,0.008812922715775351,0.054579602913578676,0.032170054458308034,2,bp,NAC,2353/3953,FOS/LEPR
GO:0071375,cellular response to peptide hormone stimulus,3/26,307/18493,0.008878723394150264,0.05475212759725997,0.0322717431510275,3,bp,NAC,3164/9021/8835,NR4A1/SOCS3/SOCS2
GO:0043235,receptor complex,3/26,396/19659,0.014958762188329887,0.05516043556946646,0.03542864728814974,3,cc,NAC,3977/3953/3679,LIFR/LEPR/ITGA7
GO:0014812,muscle cell migration,2/26,103/18493,0.009151436765411131,0.05619371596803516,0.03312143743091688,2,bp,NAC,3479/80310,IGF1/PDGFD
GO:2000278,regulation of DNA biosynthetic process,2/26,104/18493,0.009322859524502123,0.05700375548244307,0.03359888713558303,2,bp,NAC,9314/3082,KLF4/HGF
GO:0032526,response to retinoic acid,2/26,105/18493,0.009495720681448227,0.05781571706046325,0.0340774697340003,2,bp,NAC,9314/1277,KLF4/COL1A1
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,2/23,85/10554,0.014533166347420445,0.05846296462485042,0.029205406057017165,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,2/23,85/10554,0.014533166347420445,0.05846296462485042,0.029205406057017165,2,re,NAC,2353/3725,FOS/JUN
R-HSA-8951664,Neddylation,3/23,234/10554,0.0137343641658896,0.05846296462485042,0.029205406057017165,3,re,NAC,7704/9021/8835,ZBTB16/SOCS3/SOCS2
R-HSA-975871,MyD88 cascade initiated on plasma membrane,2/23,85/10554,0.014533166347420445,0.05846296462485042,0.029205406057017165,2,re,NAC,2353/3725,FOS/JUN
GO:0043502,regulation of muscle adaptation,2/26,106/18493,0.009670016177280897,0.05862955186477451,0.03455715644070307,2,bp,NAC,9314/3479,KLF4/IGF1
GO:1903829,positive regulation of cellular protein localization,3/26,318/18493,0.009770944004812914,0.05899360752696667,0.03477173642760993,3,bp,NAC,3479/4804/2810,IGF1/NGFR/SFN
GO:0051056,regulation of small GTPase mediated signal transduction,3/26,321/18493,0.01002308443747072,0.0602637951802927,0.03552040449770325,3,bp,NAC,3479/10252/1281,IGF1/SPRY1/COL3A1
R-HSA-1257604,PIP3 activates AKT signaling,3/23,260/10554,0.018183559212940837,0.060293547179274466,0.030119880838888228,3,re,NAC,3164/3725/3082,NR4A1/JUN/HGF
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,2/23,95/10554,0.017938972307705282,0.060293547179274466,0.030119880838888228,2,re,NAC,2353/3725,FOS/JUN
R-HSA-166166,MyD88-independent TLR4 cascade ,2/23,100/10554,0.019757207550270727,0.060293547179274466,0.030119880838888228,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,2/23,98/10554,0.019020866234964802,0.060293547179274466,0.030119880838888228,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,2/23,99/10554,0.019387538125425756,0.060293547179274466,0.030119880838888228,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,2/23,98/10554,0.019020866234964802,0.060293547179274466,0.030119880838888228,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,2/23,94/10554,0.017584427296475285,0.060293547179274466,0.030119880838888228,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,2/23,95/10554,0.017938972307705282,0.060293547179274466,0.030119880838888228,2,re,NAC,2353/3725,FOS/JUN
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,2/23,98/10554,0.019020866234964802,0.060293547179274466,0.030119880838888228,2,re,NAC,2353/3725,FOS/JUN
R-HSA-2219528,PI3K/AKT Signaling in Cancer,2/23,97/10554,0.01865720551231241,0.060293547179274466,0.030119880838888228,2,re,NAC,3164/3082,NR4A1/HGF
R-HSA-2980736,Peptide hormone metabolism,2/23,89/10554,0.015857971258945936,0.060293547179274466,0.030119880838888228,2,re,NAC,9314/3479,KLF4/IGF1
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,2/23,100/10554,0.019757207550270727,0.060293547179274466,0.030119880838888228,2,re,NAC,2353/3725,FOS/JUN
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,2/23,93/10554,0.01723294839470518,0.060293547179274466,0.030119880838888228,2,re,NAC,2353/3725,FOS/JUN
R-HSA-975155,MyD88 dependent cascade initiated on endosome,2/23,94/10554,0.017584427296475285,0.060293547179274466,0.030119880838888228,2,re,NAC,2353/3725,FOS/JUN
GO:0001655,urogenital system development,3/26,322/18493,0.010107974655331852,0.060522022521343824,0.03567260765017749,3,bp,NAC,10252/80310/7704,SPRY1/PDGFD/ZBTB16
GO:0032147,activation of protein kinase activity,3/26,323/18493,0.010193287315433381,0.060780634694918886,0.035825037628839373,3,bp,NAC,3479/4616/3082,IGF1/GADD45B/HGF
GO:0035259,glucocorticoid receptor binding,1/25,14/17632,0.019675549395094527,0.06175936337904671,0.032792582325157554,1,mf,NAC,3164,NR4A1
GO:0035497,cAMP response element binding,1/25,14/17632,0.019675549395094527,0.06175936337904671,0.032792582325157554,1,mf,NAC,3725,JUN
GO:0007159,leukocyte cell-cell adhesion,3/26,327/18493,0.010538771063986947,0.06196023333629588,0.03652031114689942,3,bp,NAC,9314/3479/7704,KLF4/IGF1/ZBTB16
GO:0010721,negative regulation of cell development,3/26,326/18493,0.010451764301966262,0.06196023333629588,0.03652031114689942,3,bp,NAC,3479/4804/1281,IGF1/NGFR/COL3A1
GO:0010906,regulation of glucose metabolic process,2/26,111/18493,0.01056286722157227,0.06196023333629588,0.03652031114689942,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0060349,bone morphogenesis,2/26,111/18493,0.01056286722157227,0.06196023333629588,0.03652031114689942,2,bp,NAC,6424/1277,SFRP4/COL1A1
GO:0001938,positive regulation of endothelial cell proliferation,2/26,112/18493,0.01074568394865054,0.062024087751610925,0.03655794791793531,2,bp,NAC,3164/3725,NR4A1/JUN
GO:0032102,negative regulation of response to external stimulus,3/26,329/18493,0.010714058772327756,0.062024087751610925,0.03655794791793531,3,bp,NAC,9314/9021/3082,KLF4/SOCS3/HGF
GO:0046822,regulation of nucleocytoplasmic transport,2/26,112/18493,0.01074568394865054,0.062024087751610925,0.03655794791793531,2,bp,NAC,3479/2810,IGF1/SFN
GO:0071496,cellular response to external stimulus,3/26,328/18493,0.010626202414938862,0.062024087751610925,0.03655794791793531,3,bp,NAC,2353/3725/1277,FOS/JUN/COL1A1
GO:0002761,regulation of myeloid leukocyte differentiation,2/26,114/18493,0.011115531837862864,0.06364965254776235,0.037516080722611506,2,bp,NAC,2353/3725,FOS/JUN
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,2/26,114/18493,0.011115531837862864,0.06364965254776235,0.037516080722611506,2,bp,NAC,9314/2810,KLF4/SFN
GO:0007596,blood coagulation,3/26,334/18493,0.011159729994958009,0.06365015961551149,0.0375163795961143,3,bp,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
R-HSA-193697,p75NTR regulates axonogenesis,1/23,10/10554,0.021589324685911016,0.0636885078234375,0.03181584690555308,1,re,NAC,4804,NGFR
R-HSA-8875656,MET receptor recycling,1/23,10/10554,0.021589324685911016,0.0636885078234375,0.03181584690555308,1,re,NAC,3082,HGF
GO:0070997,neuron death,3/26,335/18493,0.011250144940021111,0.06391322499389945,0.03767143436194388,3,bp,NAC,2353/3725/4804,FOS/JUN/NGFR
GO:0005161,platelet-derived growth factor receptor binding,1/25,15/17632,0.021066633017817082,0.06433863597333325,0.034162107596460135,1,mf,NAC,80310,PDGFD
R-HSA-1059683,Interleukin-6 signaling,1/23,11/10554,0.023723566485249536,0.06460109642906413,0.03227173416616941,1,re,NAC,9021,SOCS3
R-HSA-193692,Regulated proteolysis of p75NTR,1/23,11/10554,0.023723566485249536,0.06460109642906413,0.03227173416616941,1,re,NAC,4804,NGFR
R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),2/23,110/10554,0.023615795732753214,0.06460109642906413,0.03227173416616941,2,re,NAC,2353/3725,FOS/JUN
R-HSA-8851805,MET activates RAS signaling,1/23,11/10554,0.023723566485249536,0.06460109642906413,0.03227173416616941,1,re,NAC,3082,HGF
R-HSA-8875555,MET activates RAP1 and RAC1,1/23,11/10554,0.023723566485249536,0.06460109642906413,0.03227173416616941,1,re,NAC,3082,HGF
GO:0047498,calcium-dependent phospholipase A2 activity,1/25,16/17632,0.02245582153882253,0.06506430343299861,0.03454741775203467,1,mf,NAC,5320,PLA2G2A
GO:0071837,HMG box domain binding,1/25,16/17632,0.02245582153882253,0.06506430343299861,0.03454741775203467,1,mf,NAC,3725,JUN
GO:0031589,cell-substrate adhesion,3/26,338/18493,0.011523958236925529,0.0652120460230727,0.03843697938260404,3,bp,NAC,3679/1277/1281,ITGA7/COL1A1/COL3A1
GO:0007599,hemostasis,3/26,339/18493,0.011616086765344456,0.06547661407184395,0.03859291984538783,3,bp,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0038095,Fc-epsilon receptor signaling pathway,2/26,117/18493,0.011680779921769474,0.06548672174728948,0.038598877464208266,2,bp,NAC,2353/3725,FOS/JUN
GO:0050817,coagulation,3/26,340/18493,0.011708644636729512,0.06548672174728948,0.038598877464208266,3,bp,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0090575,RNA polymerase II transcription factor complex,2/26,161/19659,0.01904539088569858,0.06609870954448331,0.042454122098151637,2,cc,NAC,2353/3725,FOS/JUN
GO:0001704,formation of primary germ layer,2/26,118/18493,0.01187197371356712,0.06614385354701681,0.03898620101833868,2,bp,NAC,9314/3679,KLF4/ITGA7
GO:0030674,"protein binding, bridging",2/25,168/17632,0.02345274358651932,0.06625400063191708,0.03517911537977898,2,mf,NAC,8835/1278,SOCS2/COL1A2
R-HSA-9006925,Intracellular signaling by second messengers,3/23,293/10554,0.024870795509629267,0.06669895159400575,0.033319726041608586,3,re,NAC,3164/3725/3082,NR4A1/JUN/HGF
hsa04213,Longevity regulating pathway - multiple species,2/25,62/7852,0.01637643819920027,0.0670410438779761,0.04255719137292175,2,kg,NAC,3479/3303,IGF1/HSPA1A
GO:0010631,epithelial cell migration,3/26,346/18493,0.01227302859318294,0.06785433049794247,0.03999438234842434,3,bp,NAC,9314/3164/3725,KLF4/NR4A1/JUN
GO:0043500,muscle adaptation,2/26,120/18493,0.012258504180606082,0.06785433049794247,0.03999438234842434,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0045667,regulation of osteoblast differentiation,2/26,121/18493,0.012453832961833932,0.06807151880275138,0.04012239646396259,2,bp,NAC,3479/3082,IGF1/HGF
GO:1900180,regulation of protein localization to nucleus,2/26,121/18493,0.012453832961833932,0.06807151880275138,0.04012239646396259,2,bp,NAC,3479/4804,IGF1/NGFR
GO:1902807,negative regulation of cell cycle G1/S phase transition,2/26,121/18493,0.012453832961833932,0.06807151880275138,0.04012239646396259,2,bp,NAC,9314/2810,KLF4/SFN
GO:0090132,epithelium migration,3/26,349/18493,0.012561045925989521,0.06839845008001087,0.04031509476941225,3,bp,NAC,9314/3164/3725,KLF4/NR4A1/JUN
GO:0009913,epidermal cell differentiation,3/26,351/18493,0.012755221345477796,0.06919467820121977,0.04078440382724994,3,bp,NAC,9314/6424/2810,KLF4/SFRP4/SFN
GO:0035690,cellular response to drug,3/26,355/18493,0.013148777381585567,0.07079733493144766,0.04172903426677588,3,bp,NAC,9314/80310/3082,KLF4/PDGFD/HGF
GO:0090130,tissue migration,3/26,355/18493,0.013148777381585567,0.07079733493144766,0.04172903426677588,3,bp,NAC,9314/3164/3725,KLF4/NR4A1/JUN
GO:0045666,positive regulation of neuron differentiation,3/26,356/18493,0.013248252685314843,0.07106776440486735,0.04188842954308117,3,bp,NAC,4804/8835/3082,NGFR/SOCS2/HGF
R-HSA-209543,p75NTR recruits signalling complexes,1/23,13/10554,0.027978698435795257,0.07177144381356174,0.035853709666007656,1,re,NAC,4804,NGFR
R-HSA-209560,NF-kB is activated and signals survival,1/23,13/10554,0.027978698435795257,0.07177144381356174,0.035853709666007656,1,re,NAC,4804,NGFR
R-HSA-75035,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,1/23,13/10554,0.027978698435795257,0.07177144381356174,0.035853709666007656,1,re,NAC,2810,SFN
GO:0042476,odontogenesis,2/26,126/18493,0.013450955150054133,0.0718878825241782,0.042371819731944406,2,bp,NAC,1277/1278,COL1A1/COL1A2
GO:0002576,platelet degranulation,2/26,128/18493,0.01385928755337101,0.07201670821788345,0.04244775157023003,2,bp,NAC,3479/3082,IGF1/HGF
GO:0030177,positive regulation of Wnt signaling pathway,2/26,128/18493,0.01385928755337101,0.07201670821788345,0.04244775157023003,2,bp,NAC,6424/1277,SFRP4/COL1A1
GO:0032355,response to estradiol,2/26,127/18493,0.013654447854522469,0.07201670821788345,0.04244775157023003,2,bp,NAC,8835/1277,SOCS2/COL1A1
GO:0038063,collagen-activated tyrosine kinase receptor signaling pathway,1/26,10/18493,0.013974136036734142,0.07201670821788345,0.04244775157023003,1,bp,NAC,1277,COL1A1
GO:0043687,post-translational protein modification,3/26,361/18493,0.013752162531310612,0.07201670821788345,0.04244775157023003,3,bp,NAC,7704/9021/8835,ZBTB16/SOCS3/SOCS2
GO:0045598,regulation of fat cell differentiation,2/26,128/18493,0.01385928755337101,0.07201670821788345,0.04244775157023003,2,bp,NAC,7704/862,ZBTB16/RUNX1T1
GO:0060281,regulation of oocyte development,1/26,10/18493,0.013974136036734142,0.07201670821788345,0.04244775157023003,1,bp,NAC,3479,IGF1
GO:0090193,positive regulation of glomerulus development,1/26,10/18493,0.013974136036734142,0.07201670821788345,0.04244775157023003,1,bp,NAC,80310,PDGFD
GO:0098722,asymmetric stem cell division,1/26,10/18493,0.013974136036734142,0.07201670821788345,0.04244775157023003,1,bp,NAC,7704,ZBTB16
GO:1905879,regulation of oogenesis,1/26,10/18493,0.013974136036734142,0.07201670821788345,0.04244775157023003,1,bp,NAC,3479,IGF1
GO:0019887,protein kinase regulator activity,2/25,180/17632,0.026657099713780736,0.0721564548805273,0.038313161883465834,2,mf,NAC,9021/2810,SOCS3/SFN
GO:0030506,ankyrin binding,1/25,20/17632,0.027993674045424966,0.0721564548805273,0.038313161883465834,1,mf,NAC,2318,FLNC
GO:0048018,receptor ligand activity,3/25,478/17632,0.029257388438571178,0.0721564548805273,0.038313161883465834,3,mf,NAC,3479/80310/3082,IGF1/PDGFD/HGF
GO:0051427,hormone receptor binding,2/25,185/17632,0.028042142347542525,0.0721564548805273,0.038313161883465834,2,mf,NAC,3164/8835,NR4A1/SOCS2
GO:0102567,"phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)",1/25,21/17632,0.02937342411065713,0.0721564548805273,0.038313161883465834,1,mf,NAC,5320,PLA2G2A
GO:0102568,"phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)",1/25,21/17632,0.02937342411065713,0.0721564548805273,0.038313161883465834,1,mf,NAC,5320,PLA2G2A
GO:1902850,microtubule cytoskeleton organization involved in mitosis,2/26,129/18493,0.014065470364016158,0.07222944389777693,0.042573141240401034,2,bp,NAC,10252/3303,SPRY1/HSPA1A
GO:0005158,insulin receptor binding,1/25,22/17632,0.03075129387371589,0.07260766588634847,0.038552742948503624,1,mf,NAC,3479,IGF1
GO:0044183,protein binding involved in protein folding,1/25,23/17632,0.03212728579041968,0.07260766588634847,0.038552742948503624,1,mf,NAC,3303,HSPA1A
GO:0051787,misfolded protein binding,1/25,23/17632,0.03212728579041968,0.07260766588634847,0.038552742948503624,1,mf,NAC,3303,HSPA1A
GO:0060090,molecular adaptor activity,2/25,196/17632,0.03118962596072751,0.07260766588634847,0.038552742948503624,2,mf,NAC,8835/1278,SOCS2/COL1A2
GO:0000185,activation of MAPKKK activity,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,4616,GADD45B
GO:0003334,keratinocyte development,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,2810,SFN
GO:0007006,mitochondrial membrane organization,2/26,131/18493,0.014481849827954267,0.0729150591086704,0.042977253353616865,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:0008286,insulin receptor signaling pathway,2/26,132/18493,0.01469203875363543,0.0729150591086704,0.042977253353616865,2,bp,NAC,9021/8835,SOCS3/SOCS2
GO:0009629,response to gravity,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,2353,FOS
GO:0010675,regulation of cellular carbohydrate metabolic process,2/26,134/18493,0.015116395729542799,0.0729150591086704,0.042977253353616865,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0033197,response to vitamin E,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,1277,COL1A1
GO:0034115,negative regulation of heterotypic cell-cell adhesion,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,9314,KLF4
GO:0035630,bone mineralization involved in bone maturation,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,3479,IGF1
GO:0040015,negative regulation of multicellular organism growth,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,8835,SOCS2
GO:0042532,negative regulation of tyrosine phosphorylation of STAT protein,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,9021,SOCS3
GO:0044341,sodium-dependent phosphate transport,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,6424,SFRP4
GO:0045995,regulation of embryonic development,2/26,130/18493,0.014272992411395315,0.0729150591086704,0.042977253353616865,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0051098,regulation of binding,3/26,369/18493,0.014581138757629066,0.0729150591086704,0.042977253353616865,3,bp,NAC,9314/3725/3479,KLF4/JUN/IGF1
GO:0051291,protein heterooligomerization,2/26,132/18493,0.01469203875363543,0.0729150591086704,0.042977253353616865,2,bp,NAC,1277/1278,COL1A1/COL1A2
GO:0051386,regulation of neurotrophin TRK receptor signaling pathway,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,10252,SPRY1
GO:0060992,response to fungicide,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,9314,KLF4
GO:0061469,regulation of type B pancreatic cell proliferation,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,3164,NR4A1
GO:0070587,regulation of cell-cell adhesion involved in gastrulation,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,9314,KLF4
GO:0071901,negative regulation of protein serine/threonine kinase activity,2/26,134/18493,0.015116395729542799,0.0729150591086704,0.042977253353616865,2,bp,NAC,10252/2810,SPRY1/SFN
GO:0072567,chemokine (C-X-C motif) ligand 2 production,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,9314,KLF4
GO:0090084,negative regulation of inclusion body assembly,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,3303,HSPA1A
GO:1904995,negative regulation of leukocyte adhesion to vascular endothelial cell,1/26,11/18493,0.015361176693718503,0.0729150591086704,0.042977253353616865,1,bp,NAC,9314,KLF4
hsa04920,Adipocytokine signaling pathway,2/25,69/7852,0.020043340913753097,0.07293549054726821,0.046298945385570014,2,kg,NAC,3953/9021,LEPR/SOCS3
hsa05031,Amphetamine addiction,2/25,68/7852,0.019500073363702467,0.07293549054726821,0.046298945385570014,2,kg,NAC,2353/3725,FOS/JUN
hsa05211,Renal cell carcinoma,2/25,69/7852,0.020043340913753097,0.07293549054726821,0.046298945385570014,2,kg,NAC,3725/3082,JUN/HGF
hsa05221,Acute myeloid leukemia,2/25,66/7852,0.018432789924209964,0.07293549054726821,0.046298945385570014,2,kg,NAC,7704/862,ZBTB16/RUNX1T1
R-HSA-2559580,Oxidative Stress Induced Senescence,2/23,125/10554,0.02993408548322105,0.07399486552000806,0.03696442880571322,2,re,NAC,2353/3725,FOS/JUN
R-HSA-3371568,Attenuation phase,1/23,14/10554,0.030099606313223615,0.07399486552000806,0.03696442880571322,1,re,NAC,3303,HSPA1A
R-HSA-877312,Regulation of IFNG signaling,1/23,14/10554,0.030099606313223615,0.07399486552000806,0.03696442880571322,1,re,NAC,9021,SOCS3
GO:0000979,RNA polymerase II core promoter sequence-specific DNA binding,1/25,24/17632,0.03350140231351817,0.0742285972828932,0.03941341448649197,1,mf,NAC,2353,FOS
GO:0001889,liver development,2/26,137/18493,0.01576282144007488,0.07457623389517393,0.04395637523237447,2,bp,NAC,3725/3082,JUN/HGF
GO:0045765,regulation of angiogenesis,3/26,381/18493,0.01587730717871059,0.07487239953882152,0.044130939801851246,3,bp,NAC,9314/4804/3082,KLF4/NGFR/HGF
hsa04662,B cell receptor signaling pathway,2/25,71/7852,0.021148913999379286,0.07487858740320774,0.047532409842132674,2,kg,NAC,2353/3725,FOS/JUN
GO:0007612,learning,2/26,141/18493,0.016643023780861382,0.07528028122614192,0.04437135151965763,2,bp,NAC,2353/3725,FOS/JUN
GO:0010639,negative regulation of organelle organization,3/26,384/18493,0.01621127408606319,0.07528028122614192,0.04437135151965763,3,bp,NAC,3479/3303/3082,IGF1/HSPA1A/HGF
GO:0019216,regulation of lipid metabolic process,3/26,388/18493,0.016662758693433862,0.07528028122614192,0.04437135151965763,3,bp,NAC,9314/9021/8835,KLF4/SOCS3/SOCS2
GO:0022407,regulation of cell-cell adhesion,3/26,388/18493,0.016662758693433862,0.07528028122614192,0.04437135151965763,3,bp,NAC,9314/3479/7704,KLF4/IGF1/ZBTB16
GO:0031953,negative regulation of protein autophosphorylation,1/26,12/18493,0.01674634114594009,0.07528028122614192,0.04437135151965763,1,bp,NAC,3725,JUN
GO:0033160,"positive regulation of protein import into nucleus, translocation",1/26,12/18493,0.01674634114594009,0.07528028122614192,0.04437135151965763,1,bp,NAC,3479,IGF1
GO:0043922,negative regulation by host of viral transcription,1/26,12/18493,0.01674634114594009,0.07528028122614192,0.04437135151965763,1,bp,NAC,3725,JUN
GO:0060670,branching involved in labyrinthine layer morphogenesis,1/26,12/18493,0.01674634114594009,0.07528028122614192,0.04437135151965763,1,bp,NAC,9021,SOCS3
GO:0060707,trophoblast giant cell differentiation,1/26,12/18493,0.01674634114594009,0.07528028122614192,0.04437135151965763,1,bp,NAC,9021,SOCS3
GO:0061008,hepaticobiliary system development,2/26,140/18493,0.01642102374477012,0.07528028122614192,0.04437135151965763,2,bp,NAC,3725/3082,JUN/HGF
GO:0061430,bone trabecula morphogenesis,1/26,12/18493,0.01674634114594009,0.07528028122614192,0.04437135151965763,1,bp,NAC,1277,COL1A1
GO:0070586,cell-cell adhesion involved in gastrulation,1/26,12/18493,0.01674634114594009,0.07528028122614192,0.04437135151965763,1,bp,NAC,9314,KLF4
GO:1901298,regulation of hydrogen peroxide-mediated programmed cell death,1/26,12/18493,0.01674634114594009,0.07528028122614192,0.04437135151965763,1,bp,NAC,3082,HGF
GO:1901722,regulation of cell proliferation involved in kidney development,1/26,12/18493,0.01674634114594009,0.07528028122614192,0.04437135151965763,1,bp,NAC,80310,PDGFD
GO:2001223,negative regulation of neuron migration,1/26,12/18493,0.01674634114594009,0.07528028122614192,0.04437135151965763,1,bp,NAC,1281,COL3A1
GO:0048545,response to steroid hormone,3/26,390/18493,0.01689115990606915,0.0756954774672602,0.044616074547577225,3,bp,NAC,2353/3164/1277,FOS/NR4A1/COL1A1
R-HSA-111447,Activation of BAD and translocation to mitochondria ,1/23,15/10554,0.03221608724821423,0.07602996590578558,0.0379810712821052,1,re,NAC,2810,SFN
R-HSA-114608,Platelet degranulation ,2/23,129/10554,0.031721705877550126,0.07602996590578558,0.0379810712821052,2,re,NAC,3479/3082,IGF1/HGF
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,2/23,130/10554,0.03217515958037488,0.07602996590578558,0.0379810712821052,2,re,NAC,2353/3725,FOS/JUN
GO:0002693,positive regulation of cellular extravasation,1/26,13/18493,0.01812963182989724,0.07627130825230821,0.044955478037615376,1,bp,NAC,80310,PDGFD
GO:0009408,response to heat,2/26,145/18493,0.017543919359842428,0.07627130825230821,0.044955478037615376,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0010839,negative regulation of keratinocyte proliferation,1/26,13/18493,0.01812963182989724,0.07627130825230821,0.044955478037615376,1,bp,NAC,2810,SFN
GO:0014745,negative regulation of muscle adaptation,1/26,13/18493,0.01812963182989724,0.07627130825230821,0.044955478037615376,1,bp,NAC,9314,KLF4
GO:0031643,positive regulation of myelination,1/26,13/18493,0.01812963182989724,0.07627130825230821,0.044955478037615376,1,bp,NAC,3082,HGF
GO:0035264,multicellular organism growth,2/26,147/18493,0.018002051692453603,0.07627130825230821,0.044955478037615376,2,bp,NAC,3479/8835,IGF1/SOCS2
GO:0038065,collagen-activated signaling pathway,1/26,13/18493,0.01812963182989724,0.07627130825230821,0.044955478037615376,1,bp,NAC,1277,COL1A1
GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway,1/26,13/18493,0.01812963182989724,0.07627130825230821,0.044955478037615376,1,bp,NAC,3479,IGF1
GO:0045414,regulation of interleukin-8 biosynthetic process,1/26,13/18493,0.01812963182989724,0.07627130825230821,0.044955478037615376,1,bp,NAC,9314,KLF4
GO:0051592,response to calcium ion,2/26,146/18493,0.017772348276347206,0.07627130825230821,0.044955478037615376,2,bp,NAC,2353/3725,FOS/JUN
GO:0055062,phosphate ion homeostasis,1/26,13/18493,0.01812963182989724,0.07627130825230821,0.044955478037615376,1,bp,NAC,6424,SFRP4
GO:0060537,muscle tissue development,3/26,395/18493,0.01746993068047221,0.07627130825230821,0.044955478037615376,3,bp,NAC,2353/3479/1281,FOS/IGF1/COL3A1
GO:0060712,spongiotrophoblast layer development,1/26,13/18493,0.01812963182989724,0.07627130825230821,0.044955478037615376,1,bp,NAC,9021,SOCS3
GO:0061029,eyelid development in camera-type eye,1/26,13/18493,0.01812963182989724,0.07627130825230821,0.044955478037615376,1,bp,NAC,3725,JUN
GO:0070431,nucleotide-binding oligomerization domain containing 2 signaling pathway,1/26,13/18493,0.01812963182989724,0.07627130825230821,0.044955478037615376,1,bp,NAC,3303,HSPA1A
GO:0072109,glomerular mesangium development,1/26,13/18493,0.01812963182989724,0.07627130825230821,0.044955478037615376,1,bp,NAC,80310,PDGFD
GO:0072505,divalent inorganic anion homeostasis,1/26,13/18493,0.01812963182989724,0.07627130825230821,0.044955478037615376,1,bp,NAC,6424,SFRP4
GO:0072506,trivalent inorganic anion homeostasis,1/26,13/18493,0.01812963182989724,0.07627130825230821,0.044955478037615376,1,bp,NAC,6424,SFRP4
GO:0090192,regulation of glomerulus development,1/26,13/18493,0.01812963182989724,0.07627130825230821,0.044955478037615376,1,bp,NAC,80310,PDGFD
GO:0098727,maintenance of cell number,2/26,147/18493,0.018002051692453603,0.07627130825230821,0.044955478037615376,2,bp,NAC,9314/3479,KLF4/IGF1
GO:1903670,regulation of sprouting angiogenesis,2/26,143/18493,0.017090900029196065,0.07627130825230821,0.044955478037615376,2,bp,NAC,9314/4804,KLF4/NGFR
R-HSA-193639,p75NTR signals via NF-kB,1/23,16/10554,0.034328150061886054,0.07691243748042824,0.03842191346033882,1,re,NAC,4804,NGFR
R-HSA-205043,NRIF signals cell death from the nucleus,1/23,16/10554,0.034328150061886054,0.07691243748042824,0.03842191346033882,1,re,NAC,4804,NGFR
R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,2/23,134/10554,0.03401479618769307,0.07691243748042824,0.03842191346033882,2,re,NAC,2353/3725,FOS/JUN
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,2/23,134/10554,0.03401479618769307,0.07691243748042824,0.03842191346033882,2,re,NAC,3479/3082,IGF1/HGF
GO:0000187,activation of MAPK activity,2/26,150/18493,0.018698771557264522,0.07820964451342814,0.04609796313735999,2,bp,NAC,3479/3082,IGF1/HGF
GO:0031214,biomineral tissue development,2/26,150/18493,0.018698771557264522,0.07820964451342814,0.04609796313735999,2,bp,NAC,3479/1277,IGF1/COL1A1
R-HSA-1482922,Acyl chain remodelling of PI,1/23,17/10554,0.03643580355861997,0.078648014998484575,0.03928892809915376,1,re,NAC,5320,PLA2G2A
R-HSA-416993,Trafficking of GluR2-containing AMPA receptors,1/23,17/10554,0.03643580355861997,0.078648014998484575,0.03928892809915376,1,re,NAC,7102,TSPAN7
R-HSA-6788467,IL-6-type cytokine receptor ligand interactions,1/23,17/10554,0.03643580355861997,0.078648014998484575,0.03928892809915376,1,re,NAC,3977,LIFR
hsa05133,Pertussis,2/25,76/7852,0.024021929196967013,0.07867181812006696,0.04994032648843143,2,kg,NAC,2353/3725,FOS/JUN
hsa05140,Leishmaniasis,2/25,74/7852,0.022854233198012285,0.07867181812006696,0.04994032648843143,2,kg,NAC,2353/3725,FOS/JUN
hsa05214,Glioma,2/25,75/7852,0.023435027350032285,0.07867181812006696,0.04994032648843143,2,kg,NAC,3479/4616,IGF1/GADD45B
GO:0030856,regulation of epithelial cell differentiation,2/26,151/18493,0.01893353562707237,0.07896269338111396,0.04654182168139481,2,bp,NAC,6424/2810,SFRP4/SFN
GO:0010421,hydrogen peroxide-mediated programmed cell death,1/26,14/18493,0.019511051179054273,0.07957295143085558,0.04690151712888449,1,bp,NAC,3082,HGF
GO:0020027,hemoglobin metabolic process,1/26,14/18493,0.019511051179054273,0.07957295143085558,0.04690151712888449,1,bp,NAC,9314,KLF4
GO:0034374,low-density lipoprotein particle remodeling,1/26,14/18493,0.019511051179054273,0.07957295143085558,0.04690151712888449,1,bp,NAC,5320,PLA2G2A
GO:0034392,negative regulation of smooth muscle cell apoptotic process,1/26,14/18493,0.019511051179054273,0.07957295143085558,0.04690151712888449,1,bp,NAC,3479,IGF1
GO:0042228,interleukin-8 biosynthetic process,1/26,14/18493,0.019511051179054273,0.07957295143085558,0.04690151712888449,1,bp,NAC,9314,KLF4
GO:0051052,regulation of DNA metabolic process,3/26,412/18493,0.019521015111935464,0.07957295143085558,0.04690151712888449,3,bp,NAC,9314/3725/3082,KLF4/JUN/HGF
GO:0061051,positive regulation of cell growth involved in cardiac muscle cell development,1/26,14/18493,0.019511051179054273,0.07957295143085558,0.04690151712888449,1,bp,NAC,3479,IGF1
GO:0097468,programmed cell death in response to reactive oxygen species,1/26,14/18493,0.019511051179054273,0.07957295143085558,0.04690151712888449,1,bp,NAC,3082,HGF
hsa05205,Proteoglycans in cancer,3/25,201/7852,0.02511324572161179,0.08023988267149133,0.05093572302971326,3,kg,NAC,3479/2318/3082,IGF1/FLNC/HGF
R-HSA-446353,Cell-extracellular matrix interactions,1/23,18/10554,0.03853905652608214,0.0812072976799588,0.04056742792219172,1,re,NAC,2318,FLNC
R-HSA-6804114,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,1/23,18/10554,0.03853905652608214,0.0812072976799588,0.04056742792219172,1,re,NAC,2810,SFN
GO:0031012,extracellular matrix,3/26,490/19659,0.026154301906616727,0.08121599013107299,0.052163704633695414,3,cc,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0043034,costamere,1/26,19/19659,0.024842807380342724,0.08121599013107299,0.052163704633695414,1,cc,NAC,2318,FLNC
GO:0014067,negative regulation of phosphatidylinositol 3-kinase signaling,1/26,15/18493,0.020890601623847926,0.08373649484225712,0.04935557342710271,1,bp,NAC,9314,KLF4
GO:0034616,response to laminar fluid shear stress,1/26,15/18493,0.020890601623847926,0.08373649484225712,0.04935557342710271,1,bp,NAC,9314,KLF4
GO:0035729,cellular response to hepatocyte growth factor stimulus,1/26,15/18493,0.020890601623847926,0.08373649484225712,0.04935557342710271,1,bp,NAC,3082,HGF
GO:0045721,negative regulation of gluconeogenesis,1/26,15/18493,0.020890601623847926,0.08373649484225712,0.04935557342710271,1,bp,NAC,3953,LEPR
GO:0048569,post-embryonic animal organ development,1/26,15/18493,0.020890601623847926,0.08373649484225712,0.04935557342710271,1,bp,NAC,9314,KLF4
GO:0090316,positive regulation of intracellular protein transport,2/26,158/18493,0.020611841299527336,0.08373649484225712,0.04935557342710271,2,bp,NAC,3479/2810,IGF1/SFN
GO:0043433,negative regulation of DNA-binding transcription factor activity,2/26,160/18493,0.02110248298445717,0.08411846117837486,0.04958071023972491,2,bp,NAC,9314/6424,KLF4/SFRP4
GO:0090288,negative regulation of cellular response to growth factor stimulus,2/26,160/18493,0.02110248298445717,0.08411846117837486,0.04958071023972491,2,bp,NAC,10252/3303,SPRY1/HSPA1A
R-HSA-1482925,Acyl chain remodelling of PG,1/23,19/10554,0.040637917735260154,0.08462248751930644,0.04227349956361428,1,re,NAC,5320,PLA2G2A
GO:0006109,regulation of carbohydrate metabolic process,2/26,162/18493,0.021598015773672086,0.08538612811344883,0.050327892559847286,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0050680,negative regulation of epithelial cell proliferation,2/26,162/18493,0.021598015773672086,0.08538612811344883,0.050327892559847286,2,bp,NAC,4804/2810,NGFR/SFN
GO:0051302,regulation of cell division,2/26,162/18493,0.021598015773672086,0.08538612811344883,0.050327892559847286,2,bp,NAC,80310/2810,PDGFD/SFN
GO:0030307,positive regulation of cell growth,2/26,163/18493,0.021847607234984495,0.08566874250022453,0.050494469810833734,2,bp,NAC,3479/2810,IGF1/SFN
GO:0035051,cardiocyte differentiation,2/26,163/18493,0.021847607234984495,0.08566874250022453,0.050494469810833734,2,bp,NAC,3479/10252,IGF1/SPRY1
GO:0055002,striated muscle cell development,2/26,163/18493,0.021847607234984495,0.08566874250022453,0.050494469810833734,2,bp,NAC,3479/2318,IGF1/FLNC
R-HSA-9018519,Estrogen-dependent gene expression,2/23,150/10554,0.0417728409477291,0.08597433543893084,0.042948820558252686,2,re,NAC,2353/3725,FOS/JUN
GO:0001832,blastocyst growth,1/26,16/18493,0.022268285591689918,0.08637939814195847,0.050913341137763024,1,bp,NAC,3479,IGF1
GO:0033158,"regulation of protein import into nucleus, translocation",1/26,16/18493,0.022268285591689918,0.08637939814195847,0.050913341137763024,1,bp,NAC,3479,IGF1
GO:0048012,hepatocyte growth factor receptor signaling pathway,1/26,16/18493,0.022268285591689918,0.08637939814195847,0.050913341137763024,1,bp,NAC,3082,HGF
GO:0090083,regulation of inclusion body assembly,1/26,16/18493,0.022268285591689918,0.08637939814195847,0.050913341137763024,1,bp,NAC,3303,HSPA1A
GO:0048732,gland development,3/26,434/18493,0.022367244415494467,0.08653065332857511,0.051002493262930805,3,bp,NAC,3725/8835/3082,JUN/SOCS2/HGF
GO:0031960,response to corticosteroid,2/26,166/18493,0.022603638389049302,0.08697880052106172,0.051266638086601646,2,bp,NAC,2353/1277,FOS/COL1A1
GO:2000045,regulation of G1/S transition of mitotic cell cycle,2/26,166/18493,0.022603638389049302,0.08697880052106172,0.051266638086601646,2,bp,NAC,9314/2810,KLF4/SFN
GO:0009314,response to radiation,3/26,443/18493,0.023594225885228165,0.08816135464226402,0.05196365360976718,3,bp,NAC,2353/3725/1281,FOS/JUN/COL3A1
GO:0010744,positive regulation of macrophage derived foam cell differentiation,1/26,17/18493,0.023644105506968938,0.08816135464226402,0.05196365360976718,1,bp,NAC,5320,PLA2G2A
GO:0035728,response to hepatocyte growth factor,1/26,17/18493,0.023644105506968938,0.08816135464226402,0.05196365360976718,1,bp,NAC,3082,HGF
GO:0036149,phosphatidylinositol acyl-chain remodeling,1/26,17/18493,0.023644105506968938,0.08816135464226402,0.05196365360976718,1,bp,NAC,5320,PLA2G2A
GO:0043901,negative regulation of multi-organism process,2/26,169/18493,0.023370478914225376,0.08816135464226402,0.05196365360976718,2,bp,NAC,3725/3479,JUN/IGF1
GO:0043923,positive regulation by host of viral transcription,1/26,17/18493,0.023644105506968938,0.08816135464226402,0.05196365360976718,1,bp,NAC,3725,JUN
GO:0044320,cellular response to leptin stimulus,1/26,17/18493,0.023644105506968938,0.08816135464226402,0.05196365360976718,1,bp,NAC,3953,LEPR
GO:0045725,positive regulation of glycogen biosynthetic process,1/26,17/18493,0.023644105506968938,0.08816135464226402,0.05196365360976718,1,bp,NAC,3479,IGF1
GO:0050821,protein stabilization,2/26,169/18493,0.023370478914225376,0.08816135464226402,0.05196365360976718,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0070102,interleukin-6-mediated signaling pathway,1/26,17/18493,0.023644105506968938,0.08816135464226402,0.05196365360976718,1,bp,NAC,9021,SOCS3
GO:0070886,positive regulation of calcineurin-NFAT signaling cascade,1/26,17/18493,0.023644105506968938,0.08816135464226402,0.05196365360976718,1,bp,NAC,3479,IGF1
GO:0106058,positive regulation of calcineurin-mediated signaling,1/26,17/18493,0.023644105506968938,0.08816135464226402,0.05196365360976718,1,bp,NAC,3479,IGF1
R-HSA-168898,Toll-like Receptor Cascades,2/23,155/10554,0.04432308750187834,0.08818547290088692,0.04405340305485877,2,re,NAC,2353/3725,FOS/JUN
R-HSA-3700989,Transcriptional Regulation by TP53,3/23,365/10554,0.04352847030162658,0.08818547290088692,0.04405340305485877,3,re,NAC,2353/3725/2810,FOS/JUN/SFN
R-HSA-6807004,Negative regulation of MET activity,1/23,21/10554,0.04482249987948406,0.08818547290088692,0.04405340305485877,1,re,NAC,3082,HGF
R-HSA-8939211,ESR-mediated signaling,2/23,156/10554,0.044840070966552674,0.08818547290088692,0.04405340305485877,2,re,NAC,2353/3725,FOS/JUN
GO:0001710,mesodermal cell fate commitment,1/26,18/18493,0.025018063791057865,0.0909346751901675,0.05359829124532614,1,bp,NAC,9314,KLF4
GO:0031293,membrane protein intracellular domain proteolysis,1/26,18/18493,0.025018063791057865,0.0909346751901675,0.05359829124532614,1,bp,NAC,4804,NGFR
GO:0032717,negative regulation of interleukin-8 production,1/26,18/18493,0.025018063791057865,0.0909346751901675,0.05359829124532614,1,bp,NAC,9314,KLF4
GO:0036148,phosphatidylglycerol acyl-chain remodeling,1/26,18/18493,0.025018063791057865,0.0909346751901675,0.05359829124532614,1,bp,NAC,5320,PLA2G2A
GO:0042110,T cell activation,3/26,451/18493,0.02471544891280064,0.0909346751901675,0.05359829124532614,3,bp,NAC,3479/7704/3953,IGF1/ZBTB16/LEPR
GO:0043931,ossification involved in bone maturation,1/26,18/18493,0.025018063791057865,0.0909346751901675,0.05359829124532614,1,bp,NAC,3479,IGF1
GO:0045655,regulation of monocyte differentiation,1/26,18/18493,0.025018063791057865,0.0909346751901675,0.05359829124532614,1,bp,NAC,3725,JUN
GO:0050769,positive regulation of neurogenesis,3/26,453/18493,0.02500025250828647,0.0909346751901675,0.05359829124532614,3,bp,NAC,4804/8835/3082,NGFR/SOCS2/HGF
GO:0060749,mammary gland alveolus development,1/26,18/18493,0.025018063791057865,0.0909346751901675,0.05359829124532614,1,bp,NAC,8835,SOCS2
GO:0061377,mammary gland lobule development,1/26,18/18493,0.025018063791057865,0.0909346751901675,0.05359829124532614,1,bp,NAC,8835,SOCS2
GO:0055001,muscle cell development,2/26,176/18493,0.025201266332139243,0.09137042039516816,0.05385512614749671,2,bp,NAC,3479/2318,IGF1/FLNC
GO:0001667,ameboidal-type cell migration,3/26,456/18493,0.02543083173735282,0.09187399624620081,0.05415194147202849,3,bp,NAC,9314/3164/3725,KLF4/NR4A1/JUN
GO:0007088,regulation of mitotic nuclear division,2/26,177/18493,0.02546749722694409,0.09187399624620081,0.05415194147202849,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0007369,gastrulation,2/26,181/18493,0.026544004061072702,0.09207451408684593,0.05427012976049278,2,bp,NAC,9314/3679,KLF4/ITGA7
GO:0008356,asymmetric cell division,1/26,19/18493,0.026390162862312327,0.09207451408684593,0.05427012976049278,1,bp,NAC,7704,ZBTB16
GO:0008544,epidermis development,3/26,458/18493,0.025720133827990394,0.09207451408684593,0.05427012976049278,3,bp,NAC,9314/6424/2810,KLF4/SFRP4/SFN
GO:0010560,positive regulation of glycoprotein biosynthetic process,1/26,19/18493,0.026390162862312327,0.09207451408684593,0.05427012976049278,1,bp,NAC,3479,IGF1
GO:0016055,Wnt signaling pathway,3/26,463/18493,0.02645126128037823,0.09207451408684593,0.05427012976049278,3,bp,NAC,9314/6424/1277,KLF4/SFRP4/COL1A1
GO:0016525,negative regulation of angiogenesis,2/26,178/18493,0.02573488996491759,0.09207451408684593,0.05427012976049278,2,bp,NAC,9314/4804,KLF4/NGFR
GO:0044342,type B pancreatic cell proliferation,1/26,19/18493,0.026390162862312327,0.09207451408684593,0.05427012976049278,1,bp,NAC,3164,NR4A1
GO:0045821,positive regulation of glycolytic process,1/26,19/18493,0.026390162862312327,0.09207451408684593,0.05427012976049278,1,bp,NAC,3479,IGF1
GO:0051099,positive regulation of binding,2/26,181/18493,0.026544004061072702,0.09207451408684593,0.05427012976049278,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0070875,positive regulation of glycogen metabolic process,1/26,19/18493,0.026390162862312327,0.09207451408684593,0.05427012976049278,1,bp,NAC,3479,IGF1
GO:0072111,cell proliferation involved in kidney development,1/26,19/18493,0.026390162862312327,0.09207451408684593,0.05427012976049278,1,bp,NAC,80310,PDGFD
GO:1901673,regulation of mitotic spindle assembly,1/26,19/18493,0.026390162862312327,0.09207451408684593,0.05427012976049278,1,bp,NAC,3303,HSPA1A
GO:1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,1/26,19/18493,0.026390162862312327,0.09207451408684593,0.05427012976049278,1,bp,NAC,3303,HSPA1A
GO:1905288,vascular associated smooth muscle cell apoptotic process,1/26,19/18493,0.026390162862312327,0.09207451408684593,0.05427012976049278,1,bp,NAC,3479,IGF1
GO:1905459,regulation of vascular associated smooth muscle cell apoptotic process,1/26,19/18493,0.026390162862312327,0.09207451408684593,0.05427012976049278,1,bp,NAC,3479,IGF1
GO:2000181,negative regulation of blood vessel morphogenesis,2/26,180/18493,0.026273146892732097,0.09207451408684593,0.05427012976049278,2,bp,NAC,9314/4804,KLF4/NGFR
hsa05410,Hypertrophic cardiomyopathy (HCM),2/25,85/7852,0.029572115951096125,0.09223683784746649,0.05855130727159383,2,kg,NAC,3479/3679,IGF1/ITGA7
GO:0043409,negative regulation of MAPK cascade,2/26,182/18493,0.026816009029558815,0.09235203109702475,0.054433702539589304,2,bp,NAC,9314/10252,KLF4/SPRY1
GO:0043534,blood vessel endothelial cell migration,2/26,182/18493,0.026816009029558815,0.09235203109702475,0.054433702539589304,2,bp,NAC,9314/3164,KLF4/NR4A1
GO:0198738,cell-cell signaling by wnt,3/26,465/18493,0.026746860906914867,0.09235203109702475,0.054433702539589304,3,bp,NAC,9314/6424/1277,KLF4/SFRP4/COL1A1
R-HSA-1482801,Acyl chain remodelling of PS,1/23,23/10554,0.048989619826701136,0.0932383087024312,0.04657756723761059,1,re,NAC,5320,PLA2G2A
R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,1/23,23/10554,0.048989619826701136,0.0932383087024312,0.04657756723761059,1,re,NAC,3725,JUN
R-HSA-8863678,Neurodegenerative Diseases,1/23,23/10554,0.048989619826701136,0.0932383087024312,0.04657756723761059,1,re,NAC,3725,JUN
GO:0006091,generation of precursor metabolites and energy,3/26,471/18493,0.02764445292618136,0.0933759081849957,0.055037191387443216,3,bp,NAC,3479/3953/862,IGF1/LEPR/RUNX1T1
GO:0030813,positive regulation of nucleotide catabolic process,1/26,20/18493,0.027760405136079802,0.0933759081849957,0.055037191387443216,1,bp,NAC,3479,IGF1
GO:0032682,negative regulation of chemokine production,1/26,20/18493,0.027760405136079802,0.0933759081849957,0.055037191387443216,1,bp,NAC,9314,KLF4
GO:0051131,chaperone-mediated protein complex assembly,1/26,20/18493,0.027760405136079802,0.0933759081849957,0.055037191387443216,1,bp,NAC,3303,HSPA1A
GO:0051197,positive regulation of coenzyme metabolic process,1/26,20/18493,0.027760405136079802,0.0933759081849957,0.055037191387443216,1,bp,NAC,3479,IGF1
GO:0060602,branch elongation of an epithelium,1/26,20/18493,0.027760405136079802,0.0933759081849957,0.055037191387443216,1,bp,NAC,10252,SPRY1
GO:0061436,establishment of skin barrier,1/26,20/18493,0.027760405136079802,0.0933759081849957,0.055037191387443216,1,bp,NAC,2810,SFN
GO:0070977,bone maturation,1/26,20/18493,0.027760405136079802,0.0933759081849957,0.055037191387443216,1,bp,NAC,3479,IGF1
GO:0071248,cellular response to metal ion,2/26,184/18493,0.027363448399925848,0.0933759081849957,0.055037191387443216,2,bp,NAC,2353/3725,FOS/JUN
GO:1902806,regulation of cell cycle G1/S phase transition,2/26,185/18493,0.027638875835492016,0.0933759081849957,0.055037191387443216,2,bp,NAC,9314/2810,KLF4/SFN
GO:0038093,Fc receptor signaling pathway,2/26,187/18493,0.028193128843102152,0.09461089516417769,0.05576511164070145,2,bp,NAC,2353/3725,FOS/JUN
GO:0010975,regulation of neuron projection development,3/26,478/18493,0.028712097873024797,0.09466857733027159,0.05579911039344891,3,bp,NAC,9314/4804/3082,KLF4/NGFR/HGF
GO:0032332,positive regulation of chondrocyte differentiation,1/26,21/18493,0.02912879302469895,0.09466857733027159,0.05579911039344891,1,bp,NAC,7704,ZBTB16
GO:0036120,cellular response to platelet-derived growth factor stimulus,1/26,21/18493,0.02912879302469895,0.09466857733027159,0.05579911039344891,1,bp,NAC,80310,PDGFD
GO:0036150,phosphatidylserine acyl-chain remodeling,1/26,21/18493,0.02912879302469895,0.09466857733027159,0.05579911039344891,1,bp,NAC,5320,PLA2G2A
GO:0046827,positive regulation of protein export from nucleus,1/26,21/18493,0.02912879302469895,0.09466857733027159,0.05579911039344891,1,bp,NAC,2810,SFN
GO:0048745,smooth muscle tissue development,1/26,21/18493,0.02912879302469895,0.09466857733027159,0.05579911039344891,1,bp,NAC,1281,COL3A1
GO:0050434,positive regulation of viral transcription,1/26,21/18493,0.02912879302469895,0.09466857733027159,0.05579911039344891,1,bp,NAC,3725,JUN
GO:0050900,leukocyte migration,3/26,478/18493,0.028712097873024797,0.09466857733027159,0.05579911039344891,3,bp,NAC,80310/1277/1278,PDGFD/COL1A1/COL1A2
GO:0055093,response to hyperoxia,1/26,21/18493,0.02912879302469895,0.09466857733027159,0.05579911039344891,1,bp,NAC,1277,COL1A1
GO:0060713,labyrinthine layer morphogenesis,1/26,21/18493,0.02912879302469895,0.09466857733027159,0.05579911039344891,1,bp,NAC,9021,SOCS3
GO:0071498,cellular response to fluid shear stress,1/26,21/18493,0.02912879302469895,0.09466857733027159,0.05579911039344891,1,bp,NAC,9314,KLF4
GO:0071897,DNA biosynthetic process,2/26,189/18493,0.028751889626866412,0.09466857733027159,0.05579911039344891,2,bp,NAC,9314/3082,KLF4/HGF
GO:1901654,response to ketone,2/26,190/18493,0.029032951808240257,0.09466857733027159,0.05579911039344891,2,bp,NAC,2353/9314,FOS/KLF4
GO:1904994,regulation of leukocyte adhesion to vascular endothelial cell,1/26,21/18493,0.02912879302469895,0.09466857733027159,0.05579911039344891,1,bp,NAC,9314,KLF4
GO:0003714,transcription corepressor activity,2/25,238/17632,0.04440308207779516,0.09472195928902108,0.050294845640188185,2,mf,NAC,3303/862,HSPA1A/RUNX1T1
GO:0097718,disordered domain specific binding,1/25,32/17632,0.044427113648832894,0.09472195928902108,0.050294845640188185,1,mf,NAC,3303,HSPA1A
GO:1901991,negative regulation of mitotic cell cycle phase transition,2/26,191/18493,0.029315130595403308,0.09506007516666735,0.056029865218417206,2,bp,NAC,9314/2810,KLF4/SFN
R-HSA-3371571,HSF1-dependent transactivation,1/23,24/10554,0.051066653227516245,0.09514523811863554,0.04753018139735585,1,re,NAC,3303,HSPA1A
R-HSA-8940973,RUNX2 regulates osteoblast differentiation,1/23,24/10554,0.051066653227516245,0.09514523811863554,0.04753018139735585,1,re,NAC,1277,COL1A1
GO:1901343,negative regulation of vasculature development,2/26,192/18493,0.029598422556450822,0.09576350616358416,0.05644447822896451,2,bp,NAC,9314/4804,KLF4/NGFR
GO:0030291,protein serine/threonine kinase inhibitor activity,1/25,33/17632,0.045784461498763473,0.0958082249881532,0.05087162388751498,1,mf,NAC,2810,SFN
GO:0001759,organ induction,1/26,22/18493,0.03049532893750495,0.09608026125943155,0.0566311785371271,1,bp,NAC,10252,SPRY1
GO:0007623,circadian rhythm,2/26,193/18493,0.029882824266264,0.09608026125943155,0.0566311785371271,2,bp,NAC,3725/4804,JUN/NGFR
GO:0032069,regulation of nuclease activity,1/26,22/18493,0.03049532893750495,0.09608026125943155,0.0566311785371271,1,bp,NAC,3303,HSPA1A
GO:0033561,regulation of water loss via skin,1/26,22/18493,0.03049532893750495,0.09608026125943155,0.0566311785371271,1,bp,NAC,2810,SFN
GO:0035265,organ growth,2/26,195/18493,0.030454943265575258,0.09608026125943155,0.0566311785371271,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0036119,response to platelet-derived growth factor,1/26,22/18493,0.03049532893750495,0.09608026125943155,0.0566311785371271,1,bp,NAC,80310,PDGFD
GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway,1/26,22/18493,0.03049532893750495,0.09608026125943155,0.0566311785371271,1,bp,NAC,10252,SPRY1
GO:0044321,response to leptin,1/26,22/18493,0.03049532893750495,0.09608026125943155,0.0566311785371271,1,bp,NAC,3953,LEPR
GO:0070841,inclusion body assembly,1/26,22/18493,0.03049532893750495,0.09608026125943155,0.0566311785371271,1,bp,NAC,3303,HSPA1A
GO:0071677,positive regulation of mononuclear cell migration,1/26,22/18493,0.03049532893750495,0.09608026125943155,0.0566311785371271,1,bp,NAC,80310,PDGFD
GO:0072012,glomerulus vasculature development,1/26,22/18493,0.03049532893750495,0.09608026125943155,0.0566311785371271,1,bp,NAC,80310,PDGFD
GO:2000050,regulation of non-canonical Wnt signaling pathway,1/26,22/18493,0.03049532893750495,0.09608026125943155,0.0566311785371271,1,bp,NAC,6424,SFRP4
R-HSA-182971,EGFR downregulation,1/23,25/10554,0.05313934714734225,0.09696561283587195,0.04843955681363809,1,re,NAC,10252,SPRY1
R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,1/23,25/10554,0.05313934714734225,0.09696561283587195,0.04843955681363809,1,re,NAC,3164,NR4A1
hsa04657,IL-17 signaling pathway,2/25,93/7852,0.03489429288485487,0.0972585610194891,0.06173906243904893,2,kg,NAC,2353/3725,FOS/JUN
hsa04658,Th1 and Th2 cell differentiation,2/25,92/7852,0.03420975179847813,0.0972585610194891,0.06173906243904893,2,kg,NAC,2353/3725,FOS/JUN
hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,2/25,89/7852,0.03218884999585737,0.0972585610194891,0.06173906243904893,2,kg,NAC,2353/3725,FOS/JUN
hsa05323,Rheumatoid arthritis,2/25,91/7852,0.03353063854039619,0.0972585610194891,0.06173906243904893,2,kg,NAC,2353/3725,FOS/JUN
hsa05414,Dilated cardiomyopathy (DCM),2/25,91/7852,0.03353063854039619,0.0972585610194891,0.06173906243904893,2,kg,NAC,3479/3679,IGF1/ITGA7
GO:0002573,myeloid leukocyte differentiation,2/26,197/18493,0.03103146032768363,0.09747779400944233,0.05745490575893015,2,bp,NAC,2353/3725,FOS/JUN
GO:0061564,axon development,3/26,493/18493,0.03107400224833227,0.09747779400944233,0.05745490575893015,3,bp,NAC,9314/3725/4804,KLF4/JUN/NGFR
GO:0000132,establishment of mitotic spindle orientation,1/26,23/18493,0.03186001528083404,0.09816222230194935,0.057858318284258,1,bp,NAC,10252,SPRY1
GO:0002691,regulation of cellular extravasation,1/26,23/18493,0.03186001528083404,0.09816222230194935,0.057858318284258,1,bp,NAC,80310,PDGFD
GO:0034505,tooth mineralization,1/26,23/18493,0.03186001528083404,0.09816222230194935,0.057858318284258,1,bp,NAC,1277,COL1A1
GO:0045766,positive regulation of angiogenesis,2/26,200/18493,0.03190442291033558,0.09816222230194935,0.057858318284258,2,bp,NAC,9314/3082,KLF4/HGF
GO:0051412,response to corticosterone,1/26,23/18493,0.03186001528083404,0.09816222230194935,0.057858318284258,1,bp,NAC,2353,FOS
GO:0060396,growth hormone receptor signaling pathway,1/26,23/18493,0.03186001528083404,0.09816222230194935,0.057858318284258,1,bp,NAC,8835,SOCS2
GO:0060445,branching involved in salivary gland morphogenesis,1/26,23/18493,0.03186001528083404,0.09816222230194935,0.057858318284258,1,bp,NAC,3082,HGF
GO:0061050,regulation of cell growth involved in cardiac muscle cell development,1/26,23/18493,0.03186001528083404,0.09816222230194935,0.057858318284258,1,bp,NAC,3479,IGF1
GO:1903020,positive regulation of glycoprotein metabolic process,1/26,23/18493,0.03186001528083404,0.09816222230194935,0.057858318284258,1,bp,NAC,3479,IGF1
GO:0051783,regulation of nuclear division,2/26,201/18493,0.03219758011664855,0.09885342150707203,0.058265721689254264,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0002092,positive regulation of receptor internalization,1/26,24/18493,0.03322285445802409,0.09905078302258008,0.0583820495913081,1,bp,NAC,6424,SFRP4
GO:0006006,glucose metabolic process,2/26,204/18493,0.03308351366818172,0.09905078302258008,0.0583820495913081,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0032869,cellular response to insulin stimulus,2/26,204/18493,0.03308351366818172,0.09905078302258008,0.0583820495913081,2,bp,NAC,9021/8835,SOCS3/SOCS2
GO:0032897,negative regulation of viral transcription,1/26,24/18493,0.03322285445802409,0.09905078302258008,0.0583820495913081,1,bp,NAC,3725,JUN
GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,1/26,24/18493,0.03322285445802409,0.09905078302258008,0.0583820495913081,1,bp,NAC,3479,IGF1
GO:0045672,positive regulation of osteoclast differentiation,1/26,24/18493,0.03322285445802409,0.09905078302258008,0.0583820495913081,1,bp,NAC,2353,FOS
GO:0048679,regulation of axon regeneration,1/26,24/18493,0.03322285445802409,0.09905078302258008,0.0583820495913081,1,bp,NAC,9314,KLF4
GO:0048799,animal organ maturation,1/26,24/18493,0.03322285445802409,0.09905078302258008,0.0583820495913081,1,bp,NAC,3479,IGF1
GO:0050870,positive regulation of T cell activation,2/26,202/18493,0.03249181654919556,0.09905078302258008,0.0583820495913081,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0061437,renal system vasculature development,1/26,24/18493,0.03322285445802409,0.09905078302258008,0.0583820495913081,1,bp,NAC,80310,PDGFD
GO:0061440,kidney vasculature development,1/26,24/18493,0.03322285445802409,0.09905078302258008,0.0583820495913081,1,bp,NAC,80310,PDGFD
GO:0071378,cellular response to growth hormone stimulus,1/26,24/18493,0.03322285445802409,0.09905078302258008,0.0583820495913081,1,bp,NAC,8835,SOCS2
GO:1900739,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1/26,24/18493,0.03322285445802409,0.09905078302258008,0.0583820495913081,1,bp,NAC,2810,SFN
GO:1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1/26,24/18493,0.03322285445802409,0.09905078302258008,0.0583820495913081,1,bp,NAC,2810,SFN
GO:0004623,phospholipase A2 activity,1/25,35/17632,0.04849360651568846,0.09963231884132356,0.05290211619893286,1,mf,NAC,5320,PLA2G2A
R-HSA-912694,Regulation of IFNA signaling,1/23,26/10554,0.055207710241236274,0.09971188482345734,0.04981146788682972,1,re,NAC,9021,SOCS3
GO:0051216,cartilage development,2/26,206/18493,0.03367948748425261,0.10020515554593097,0.05906245444878158,2,bp,NAC,7704/1277,ZBTB16/COL1A1
GO:0016051,carbohydrate biosynthetic process,2/26,209/18493,0.03458140868895334,0.10041145657660931,0.059184051438086104,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0031116,positive regulation of microtubule polymerization,1/26,25/18493,0.03458384886942123,0.10041145657660931,0.059184051438086104,1,bp,NAC,3303,HSPA1A
GO:0034114,regulation of heterotypic cell-cell adhesion,1/26,25/18493,0.03458384886942123,0.10041145657660931,0.059184051438086104,1,bp,NAC,9314,KLF4
GO:0055083,monovalent inorganic anion homeostasis,1/26,25/18493,0.03458384886942123,0.10041145657660931,0.059184051438086104,1,bp,NAC,6424,SFRP4
GO:0060330,regulation of response to interferon-gamma,1/26,25/18493,0.03458384886942123,0.10041145657660931,0.059184051438086104,1,bp,NAC,9021,SOCS3
GO:0060334,regulation of interferon-gamma-mediated signaling pathway,1/26,25/18493,0.03458384886942123,0.10041145657660931,0.059184051438086104,1,bp,NAC,9021,SOCS3
GO:0060343,trabecula formation,1/26,25/18493,0.03458384886942123,0.10041145657660931,0.059184051438086104,1,bp,NAC,1277,COL1A1
GO:0071241,cellular response to inorganic substance,2/26,207/18493,0.033979069813065,0.10041145657660931,0.059184051438086104,2,bp,NAC,2353/3725,FOS/JUN
GO:1901032,negative regulation of response to reactive oxygen species,1/26,25/18493,0.03458384886942123,0.10041145657660931,0.059184051438086104,1,bp,NAC,3082,HGF
GO:1903206,negative regulation of hydrogen peroxide-induced cell death,1/26,25/18493,0.03458384886942123,0.10041145657660931,0.059184051438086104,1,bp,NAC,3082,HGF
GO:2000027,regulation of animal organ morphogenesis,2/26,208/18493,0.034279711320647284,0.10041145657660931,0.059184051438086104,2,bp,NAC,10252/3082,SPRY1/HGF
GO:2001039,negative regulation of cellular response to drug,1/26,25/18493,0.03458384886942123,0.10041145657660931,0.059184051438086104,1,bp,NAC,3082,HGF
GO:0017147,Wnt-protein binding,1/25,36/17632,0.049845408518138123,0.10058091361695728,0.05340579484086228,1,mf,NAC,6424,SFRP4
GO:0042056,chemoattractant activity,1/25,37/17632,0.051195366735179104,0.10149256914167085,0.05388985972124117,1,mf,NAC,3082,HGF
GO:0001958,endochondral ossification,1/26,26/18493,0.03594300091238167,0.10149853290913259,0.059824790889287036,1,bp,NAC,1277,COL1A1
GO:0006817,phosphate ion transport,1/26,26/18493,0.03594300091238167,0.10149853290913259,0.059824790889287036,1,bp,NAC,6424,SFRP4
GO:0031954,positive regulation of protein autophosphorylation,1/26,26/18493,0.03594300091238167,0.10149853290913259,0.059824790889287036,1,bp,NAC,80310,PDGFD
GO:0033137,negative regulation of peptidyl-serine phosphorylation,1/26,26/18493,0.03594300091238167,0.10149853290913259,0.059824790889287036,1,bp,NAC,3082,HGF
GO:0036075,replacement ossification,1/26,26/18493,0.03594300091238167,0.10149853290913259,0.059824790889287036,1,bp,NAC,1277,COL1A1
GO:0036152,phosphatidylethanolamine acyl-chain remodeling,1/26,26/18493,0.03594300091238167,0.10149853290913259,0.059824790889287036,1,bp,NAC,5320,PLA2G2A
GO:0042026,protein refolding,1/26,26/18493,0.03594300091238167,0.10149853290913259,0.059824790889287036,1,bp,NAC,3303,HSPA1A
GO:0051194,positive regulation of cofactor metabolic process,1/26,26/18493,0.03594300091238167,0.10149853290913259,0.059824790889287036,1,bp,NAC,3479,IGF1
GO:0060259,regulation of feeding behavior,1/26,26/18493,0.03594300091238167,0.10149853290913259,0.059824790889287036,1,bp,NAC,3953,LEPR
GO:0060669,embryonic placenta morphogenesis,1/26,26/18493,0.03594300091238167,0.10149853290913259,0.059824790889287036,1,bp,NAC,9021,SOCS3
GO:0060706,cell differentiation involved in embryonic placenta development,1/26,26/18493,0.03594300091238167,0.10149853290913259,0.059824790889287036,1,bp,NAC,9021,SOCS3
GO:0090169,regulation of spindle assembly,1/26,26/18493,0.03594300091238167,0.10149853290913259,0.059824790889287036,1,bp,NAC,3303,HSPA1A
GO:1901988,negative regulation of cell cycle phase transition,2/26,211/18493,0.035187957768536365,0.10149853290913259,0.059824790889287036,2,bp,NAC,9314/2810,KLF4/SFN
GO:1903588,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/26,26/18493,0.03594300091238167,0.10149853290913259,0.059824790889287036,1,bp,NAC,4804,NGFR
GO:0032388,positive regulation of intracellular transport,2/26,214/18493,0.03610561777104575,0.1015602464787895,0.059861165813080874,2,bp,NAC,3479/2810,IGF1/SFN
GO:1903039,positive regulation of leukocyte cell-cell adhesion,2/26,214/18493,0.03610561777104575,0.1015602464787895,0.059861165813080874,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0001046,core promoter sequence-specific DNA binding,1/25,38/17632,0.05254348357698757,0.10236920076206199,0.05435532783826301,1,mf,NAC,2353,FOS
hsa05215,Prostate cancer,2/25,97/7852,0.03768596998267076,0.1028512930777056,0.0652892901015568,2,kg,NAC,3479/80310,IGF1/PDGFD
GO:0035902,response to immobilization stress,1/26,27/18493,0.03730031298127667,0.10330969603067608,0.06089231819147702,1,bp,NAC,2353,FOS
GO:0036151,phosphatidylcholine acyl-chain remodeling,1/26,27/18493,0.03730031298127667,0.10330969603067608,0.06089231819147702,1,bp,NAC,5320,PLA2G2A
GO:0040001,establishment of mitotic spindle localization,1/26,27/18493,0.03730031298127667,0.10330969603067608,0.06089231819147702,1,bp,NAC,10252,SPRY1
GO:0042104,positive regulation of activated T cell proliferation,1/26,27/18493,0.03730031298127667,0.10330969603067608,0.06089231819147702,1,bp,NAC,3479,IGF1
GO:0043921,modulation by host of viral transcription,1/26,27/18493,0.03730031298127667,0.10330969603067608,0.06089231819147702,1,bp,NAC,3725,JUN
GO:0052472,modulation by host of symbiont transcription,1/26,27/18493,0.03730031298127667,0.10330969603067608,0.06089231819147702,1,bp,NAC,3725,JUN
GO:1903792,negative regulation of anion transport,1/26,27/18493,0.03730031298127667,0.10330969603067608,0.06089231819147702,1,bp,NAC,6424,SFRP4
GO:2000144,"positive regulation of DNA-templated transcription, initiation",1/26,27/18493,0.03730031298127667,0.10330969603067608,0.06089231819147702,1,bp,NAC,3725,JUN
GO:0001844,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1/26,28/18493,0.03865578746749332,0.10465347338760388,0.06168436116072796,1,bp,NAC,2810,SFN
GO:0005979,regulation of glycogen biosynthetic process,1/26,28/18493,0.03865578746749332,0.10465347338760388,0.06168436116072796,1,bp,NAC,3479,IGF1
GO:0007020,microtubule nucleation,1/26,28/18493,0.03865578746749332,0.10465347338760388,0.06168436116072796,1,bp,NAC,3303,HSPA1A
GO:0007160,cell-matrix adhesion,2/26,222/18493,0.03859806005458923,0.10465347338760388,0.06168436116072796,2,bp,NAC,3679/1281,ITGA7/COL3A1
GO:0010962,regulation of glucan biosynthetic process,1/26,28/18493,0.03865578746749332,0.10465347338760388,0.06168436116072796,1,bp,NAC,3479,IGF1
GO:0034368,protein-lipid complex remodeling,1/26,28/18493,0.03865578746749332,0.10465347338760388,0.06168436116072796,1,bp,NAC,5320,PLA2G2A
GO:0034369,plasma lipoprotein particle remodeling,1/26,28/18493,0.03865578746749332,0.10465347338760388,0.06168436116072796,1,bp,NAC,5320,PLA2G2A
GO:0035025,positive regulation of Rho protein signal transduction,1/26,28/18493,0.03865578746749332,0.10465347338760388,0.06168436116072796,1,bp,NAC,1281,COL3A1
GO:0035116,embryonic hindlimb morphogenesis,1/26,28/18493,0.03865578746749332,0.10465347338760388,0.06168436116072796,1,bp,NAC,7704,ZBTB16
GO:0036296,response to increased oxygen levels,1/26,28/18493,0.03865578746749332,0.10465347338760388,0.06168436116072796,1,bp,NAC,1277,COL1A1
GO:0048730,epidermis morphogenesis,1/26,28/18493,0.03865578746749332,0.10465347338760388,0.06168436116072796,1,bp,NAC,9314,KLF4
GO:0052312,modulation of transcription in other organism involved in symbiotic interaction,1/26,28/18493,0.03865578746749332,0.10465347338760388,0.06168436116072796,1,bp,NAC,3725,JUN
GO:0001784,phosphotyrosine residue binding,1/25,40/17632,0.05523420276055102,0.10578754088037738,0.05617037568869596,1,mf,NAC,9021,SOCS3
R-HSA-1482788,Acyl chain remodelling of PC,1/23,28/10554,0.05933147848927889,0.10607749184446831,0.05299143214353458,1,re,NAC,5320,PLA2G2A
GO:0001221,transcription cofactor binding,1/25,41/17632,0.05657680990760561,0.10655299199265722,0.056576809907605614,1,mf,NAC,9314,KLF4
GO:0031112,positive regulation of microtubule polymerization or depolymerization,1/26,29/18493,0.040009426759442857,0.10691407928495562,0.06301679692325503,1,bp,NAC,3303,HSPA1A
GO:0042036,negative regulation of cytokine biosynthetic process,1/26,29/18493,0.040009426759442857,0.10691407928495562,0.06301679692325503,1,bp,NAC,9314,KLF4
GO:0046471,phosphatidylglycerol metabolic process,1/26,29/18493,0.040009426759442857,0.10691407928495562,0.06301679692325503,1,bp,NAC,5320,PLA2G2A
GO:0051294,establishment of spindle orientation,1/26,29/18493,0.040009426759442857,0.10691407928495562,0.06301679692325503,1,bp,NAC,10252,SPRY1
GO:0060441,epithelial tube branching involved in lung morphogenesis,1/26,29/18493,0.040009426759442857,0.10691407928495562,0.06301679692325503,1,bp,NAC,10252,SPRY1
GO:0071295,cellular response to vitamin,1/26,29/18493,0.040009426759442857,0.10691407928495562,0.06301679692325503,1,bp,NAC,1277,COL1A1
GO:2000727,positive regulation of cardiac muscle cell differentiation,1/26,29/18493,0.040009426759442857,0.10691407928495562,0.06301679692325503,1,bp,NAC,3479,IGF1
GO:0046777,protein autophosphorylation,2/26,227/18493,0.04018877020421972,0.10719481590515537,0.06318226738984246,2,bp,NAC,3725/80310,JUN/PDGFD
GO:0015026,coreceptor activity,1/25,42/17632,0.057917585290034546,0.10728995307826072,0.056968116678722515,1,mf,NAC,4804,NGFR
GO:0031669,cellular response to nutrient levels,2/26,228/18493,0.04050990720943785,0.10765339982176578,0.0634525637786678,2,bp,NAC,3725/1277,JUN/COL1A1
GO:0051896,regulation of protein kinase B signaling,2/26,228/18493,0.04050990720943785,0.10765339982176578,0.0634525637786678,2,bp,NAC,9314/3082,KLF4/HGF
GO:0006658,phosphatidylserine metabolic process,1/26,30/18493,0.04136123324255869,0.10773332052168266,0.06349967026408403,1,bp,NAC,5320,PLA2G2A
GO:0010743,regulation of macrophage derived foam cell differentiation,1/26,30/18493,0.04136123324255869,0.10773332052168266,0.06349967026408403,1,bp,NAC,5320,PLA2G2A
GO:0010837,regulation of keratinocyte proliferation,1/26,30/18493,0.04136123324255869,0.10773332052168266,0.06349967026408403,1,bp,NAC,2810,SFN
GO:0032733,positive regulation of interleukin-10 production,1/26,30/18493,0.04136123324255869,0.10773332052168266,0.06349967026408403,1,bp,NAC,3082,HGF
GO:0034367,protein-containing complex remodeling,1/26,30/18493,0.04136123324255869,0.10773332052168266,0.06349967026408403,1,bp,NAC,5320,PLA2G2A
GO:0038111,interleukin-7-mediated signaling pathway,1/26,30/18493,0.04136123324255869,0.10773332052168266,0.06349967026408403,1,bp,NAC,8835,SOCS2
GO:0050482,arachidonic acid secretion,1/26,30/18493,0.04136123324255869,0.10773332052168266,0.06349967026408403,1,bp,NAC,5320,PLA2G2A
GO:0051402,neuron apoptotic process,2/26,230/18493,0.041155150651838446,0.10773332052168266,0.06349967026408403,2,bp,NAC,3725/4804,JUN/NGFR
GO:1902235,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,1/26,30/18493,0.04136123324255869,0.10773332052168266,0.06349967026408403,1,bp,NAC,3303,HSPA1A
GO:1903963,arachidonate transport,1/26,30/18493,0.04136123324255869,0.10773332052168266,0.06349967026408403,1,bp,NAC,5320,PLA2G2A
GO:2001171,positive regulation of ATP biosynthetic process,1/26,30/18493,0.04136123324255869,0.10773332052168266,0.06349967026408403,1,bp,NAC,3479,IGF1
GO:0097305,response to alcohol,2/26,231/18493,0.041479250731939504,0.10784605190304271,0.06356611586800781,2,bp,NAC,2353/9314,FOS/KLF4
GO:0003401,axis elongation,1/26,31/18493,0.042711209299304276,0.10812500821029418,0.06373053699085801,1,bp,NAC,10252,SPRY1
GO:0030217,T cell differentiation,2/26,234/18493,0.04245742639899358,0.10812500821029418,0.06373053699085801,2,bp,NAC,7704/3953,ZBTB16/LEPR
GO:0030431,sleep,1/26,31/18493,0.042711209299304276,0.10812500821029418,0.06373053699085801,1,bp,NAC,2353,FOS
GO:0032872,regulation of stress-activated MAPK cascade,2/26,235/18493,0.04278543290927095,0.10812500821029418,0.06373053699085801,2,bp,NAC,4616/3082,GADD45B/HGF
GO:0033157,regulation of intracellular protein transport,2/26,232/18493,0.041804332157199815,0.10812500821029418,0.06373053699085801,2,bp,NAC,3479/2810,IGF1/SFN
GO:0033500,carbohydrate homeostasis,2/26,234/18493,0.04245742639899358,0.10812500821029418,0.06373053699085801,2,bp,NAC,4804/3953,NGFR/LEPR
GO:0042593,glucose homeostasis,2/26,233/18493,0.04213039176498253,0.10812500821029418,0.06373053699085801,2,bp,NAC,4804/3953,NGFR/LEPR
GO:0045648,positive regulation of erythrocyte differentiation,1/26,31/18493,0.042711209299304276,0.10812500821029418,0.06373053699085801,1,bp,NAC,3303,HSPA1A
GO:0051085,chaperone cofactor-dependent protein refolding,1/26,31/18493,0.042711209299304276,0.10812500821029418,0.06373053699085801,1,bp,NAC,3303,HSPA1A
GO:0051204,protein insertion into mitochondrial membrane,1/26,31/18493,0.042711209299304276,0.10812500821029418,0.06373053699085801,1,bp,NAC,2810,SFN
GO:0060325,face morphogenesis,1/26,31/18493,0.042711209299304276,0.10812500821029418,0.06373053699085801,1,bp,NAC,1277,COL1A1
GO:0071356,cellular response to tumor necrosis factor,2/26,235/18493,0.04278543290927095,0.10812500821029418,0.06373053699085801,2,bp,NAC,3303/1277,HSPA1A/COL1A1
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,2/26,235/18493,0.04278543290927095,0.10812500821029418,0.06373053699085801,2,bp,NAC,6424/3303,SFRP4/HSPA1A
GO:0098760,response to interleukin-7,1/26,31/18493,0.042711209299304276,0.10812500821029418,0.06373053699085801,1,bp,NAC,8835,SOCS2
GO:0098761,cellular response to interleukin-7,1/26,31/18493,0.042711209299304276,0.10812500821029418,0.06373053699085801,1,bp,NAC,8835,SOCS2
GO:1900745,positive regulation of p38MAPK cascade,1/26,31/18493,0.042711209299304276,0.10812500821029418,0.06373053699085801,1,bp,NAC,4616,GADD45B
hsa04660,T cell receptor signaling pathway,2/25,101/7852,0.04056145073645093,0.10843979686683819,0.06883683368806924,2,kg,NAC,2353/3725,FOS/JUN
GO:0048705,skeletal system morphogenesis,2/26,236/18493,0.043114408152174225,0.10857607498008275,0.06399640265813682,2,bp,NAC,6424/1277,SFRP4/COL1A1
GO:0060828,regulation of canonical Wnt signaling pathway,2/26,236/18493,0.043114408152174225,0.10857607498008275,0.06399640265813682,2,bp,NAC,6424/1277,SFRP4/COL1A1
GO:0005126,cytokine receptor binding,2/25,281/17632,0.05970355733403265,0.10881454804428531,0.05777763612970903,2,mf,NAC,3977/8835,LIFR/SOCS2
GO:0070302,regulation of stress-activated protein kinase signaling cascade,2/26,237/18493,0.04344434899037441,0.10921636862911197,0.06437380154817994,2,bp,NAC,4616/3082,GADD45B/HGF
R-HSA-114452,Activation of BH3-only proteins,1/23,30/10554,0.06343802688379907,0.10927829358704601,0.05459040536016572,1,re,NAC,2810,SFN
R-HSA-1482839,Acyl chain remodelling of PE,1/23,30/10554,0.06343802688379907,0.10927829358704601,0.05459040536016572,1,re,NAC,5320,PLA2G2A
R-HSA-2262752,Cellular responses to stress,3/23,426/10554,0.06359132338681209,0.10927829358704601,0.05459040536016572,3,re,NAC,2353/3725/3303,FOS/JUN/HSPA1A
R-HSA-3000157,Laminin interactions,1/23,30/10554,0.06343802688379907,0.10927829358704601,0.05459040536016572,1,re,NAC,3679,ITGA7
GO:0042277,peptide binding,2/25,285/17632,0.0612093635364049,0.1097882234859326,0.058294631939433246,2,mf,NAC,4804/3953,NGFR/LEPR
GO:0035767,endothelial cell chemotaxis,1/26,32/18493,0.04405935730917454,0.10980596303478214,0.0647213175271576,1,bp,NAC,3164,NR4A1
GO:0060317,cardiac epithelial to mesenchymal transition,1/26,32/18493,0.04405935730917454,0.10980596303478214,0.0647213175271576,1,bp,NAC,10252,SPRY1
GO:0061036,positive regulation of cartilage development,1/26,32/18493,0.04405935730917454,0.10980596303478214,0.0647213175271576,1,bp,NAC,7704,ZBTB16
GO:1901030,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,1/26,32/18493,0.04405935730917454,0.10980596303478214,0.0647213175271576,1,bp,NAC,2810,SFN
GO:1903205,regulation of hydrogen peroxide-induced cell death,1/26,32/18493,0.04405935730917454,0.10980596303478214,0.0647213175271576,1,bp,NAC,3082,HGF
hsa04620,Toll-like receptor signaling pathway,2/25,104/7852,0.04277161983435201,0.10986435682941399,0.06974113450802494,2,kg,NAC,2353/3725,FOS/JUN
hsa05142,Chagas disease (American trypanosomiasis),2/25,103/7852,0.04202986983034917,0.10986435682941399,0.06974113450802494,2,kg,NAC,2353/3725,FOS/JUN
R-HSA-399719,Trafficking of AMPA receptors,1/23,31/10554,0.06548486509946538,0.11038877259624165,0.05514514955744454,1,re,NAC,7102,TSPAN7
R-HSA-399721,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",1/23,31/10554,0.06548486509946538,0.11038877259624165,0.05514514955744454,1,re,NAC,7102,TSPAN7
R-HSA-168274,Export of Viral Ribonucleoproteins from Nucleus,1/23,32/10554,0.0675274240753001,0.11066994501229739,0.05528561035404687,1,re,NAC,3303,HSPA1A
R-HSA-2559583,Cellular Senescence,2/23,195/10554,0.06667450662084333,0.11066994501229739,0.05528561035404687,2,re,NAC,2353/3725,FOS/JUN
R-HSA-8941326,RUNX2 regulates bone development,1/23,32/10554,0.0675274240753001,0.11066994501229739,0.05528561035404687,1,re,NAC,1277,COL1A1
GO:0001774,microglial cell activation,1/26,33/18493,0.04540567964869846,0.11105151819164726,0.06545546682631286,1,bp,NAC,3725,JUN
GO:0002269,leukocyte activation involved in inflammatory response,1/26,33/18493,0.04540567964869846,0.11105151819164726,0.06545546682631286,1,bp,NAC,3725,JUN
GO:0006839,mitochondrial transport,2/26,241/18493,0.04477370576987253,0.11105151819164726,0.06545546682631286,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:0010092,specification of animal organ identity,1/26,33/18493,0.04540567964869846,0.11105151819164726,0.06545546682631286,1,bp,NAC,10252,SPRY1
GO:0031128,developmental induction,1/26,33/18493,0.04540567964869846,0.11105151819164726,0.06545546682631286,1,bp,NAC,10252,SPRY1
GO:0046326,positive regulation of glucose import,1/26,33/18493,0.04540567964869846,0.11105151819164726,0.06545546682631286,1,bp,NAC,3479,IGF1
GO:0060674,placenta blood vessel development,1/26,33/18493,0.04540567964869846,0.11105151819164726,0.06545546682631286,1,bp,NAC,9021,SOCS3
GO:0060795,cell fate commitment involved in formation of primary germ layer,1/26,33/18493,0.04540567964869846,0.11105151819164726,0.06545546682631286,1,bp,NAC,9314,KLF4
GO:0070873,regulation of glycogen metabolic process,1/26,33/18493,0.04540567964869846,0.11105151819164726,0.06545546682631286,1,bp,NAC,3479,IGF1
GO:0071354,cellular response to interleukin-6,1/26,33/18493,0.04540567964869846,0.11105151819164726,0.06545546682631286,1,bp,NAC,9021,SOCS3
GO:0097009,energy homeostasis,1/26,33/18493,0.04540567964869846,0.11105151819164726,0.06545546682631286,1,bp,NAC,3953,LEPR
GO:1990841,promoter-specific chromatin binding,1/25,46/17632,0.06326241703146285,0.11169770507117659,0.059308515966996427,1,mf,NAC,9314,KLF4
GO:0019318,hexose metabolic process,2/26,244/18493,0.045780709310994074,0.11177929532278248,0.06588442982150362,2,bp,NAC,3479/3953,IGF1/LEPR
R-HSA-9006931,Signaling by Nuclear Receptors,2/23,199/10554,0.06908471665096223,0.112183438965324,0.05604168226635276,2,re,NAC,2353/3725,FOS/JUN
GO:0001047,core promoter binding,1/25,47/17632,0.06459406945806467,0.1122943053655586,0.059625294884367394,1,mf,NAC,2353,FOS
GO:0031330,negative regulation of cellular catabolic process,2/26,245/18493,0.04611826272163506,0.11241326538398545,0.06625810149196501,2,bp,NAC,3953/3082,LEPR/HGF
GO:0007611,learning or memory,2/26,247/18493,0.046796179393001014,0.11254481144016742,0.0663356367535874,2,bp,NAC,2353/3725,FOS/JUN
GO:0014904,myotube cell development,1/26,34/18493,0.04675017869144715,0.11254481144016742,0.0663356367535874,1,bp,NAC,3479,IGF1
GO:0030224,monocyte differentiation,1/26,34/18493,0.04675017869144715,0.11254481144016742,0.0663356367535874,1,bp,NAC,3725,JUN
GO:0031641,regulation of myelination,1/26,34/18493,0.04675017869144715,0.11254481144016742,0.0663356367535874,1,bp,NAC,3082,HGF
GO:0032148,activation of protein kinase B activity,1/26,34/18493,0.04675017869144715,0.11254481144016742,0.0663356367535874,1,bp,NAC,3479,IGF1
GO:0043403,skeletal muscle tissue regeneration,1/26,34/18493,0.04675017869144715,0.11254481144016742,0.0663356367535874,1,bp,NAC,3479,IGF1
GO:0048333,mesodermal cell differentiation,1/26,34/18493,0.04675017869144715,0.11254481144016742,0.0663356367535874,1,bp,NAC,9314,KLF4
GO:1903131,mononuclear cell differentiation,1/26,34/18493,0.04675017869144715,0.11254481144016742,0.0663356367535874,1,bp,NAC,3725,JUN
GO:0003007,heart morphogenesis,2/26,253/18493,0.048852187602580074,0.11269013067345011,0.06642129013688418,2,bp,NAC,3725/10252,JUN/SPRY1
GO:0006352,"DNA-templated transcription, initiation",2/26,248/18493,0.04713653651034682,0.11269013067345011,0.06642129013688418,2,bp,NAC,3164/3725,NR4A1/JUN
GO:0007435,salivary gland morphogenesis,1/26,35/18493,0.04809285680803066,0.11269013067345011,0.06642129013688418,1,bp,NAC,3082,HGF
GO:0010742,macrophage derived foam cell differentiation,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,5320,PLA2G2A
GO:0022409,positive regulation of cell-cell adhesion,2/26,251/18493,0.048163166258686996,0.11269013067345011,0.06642129013688418,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0030212,hyaluronan metabolic process,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,3082,HGF
GO:0032885,regulation of polysaccharide biosynthetic process,1/26,35/18493,0.04809285680803066,0.11269013067345011,0.06642129013688418,1,bp,NAC,3479,IGF1
GO:0033120,positive regulation of RNA splicing,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,3303,HSPA1A
GO:0034390,smooth muscle cell apoptotic process,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,3479,IGF1
GO:0034391,regulation of smooth muscle cell apoptotic process,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,3479,IGF1
GO:0034405,response to fluid shear stress,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,9314,KLF4
GO:0035137,hindlimb morphogenesis,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,7704,ZBTB16
GO:0035872,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,3303,HSPA1A
GO:0035909,aorta morphogenesis,1/26,35/18493,0.04809285680803066,0.11269013067345011,0.06642129013688418,1,bp,NAC,1281,COL3A1
GO:0036474,cell death in response to hydrogen peroxide,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,3082,HGF
GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,10252,SPRY1
GO:0046034,ATP metabolic process,2/26,250/18493,0.0478200329963338,0.11269013067345011,0.06642129013688418,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0051084,'de novo' posttranslational protein folding,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,3303,HSPA1A
GO:0051385,response to mineralocorticoid,1/26,35/18493,0.04809285680803066,0.11269013067345011,0.06642129013688418,1,bp,NAC,2353,FOS
GO:0051973,positive regulation of telomerase activity,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,9314,KLF4
GO:0060236,regulation of mitotic spindle organization,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,3303,HSPA1A
GO:0060416,response to growth hormone,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,8835,SOCS2
GO:0070423,nucleotide-binding oligomerization domain containing signaling pathway,1/26,35/18493,0.04809285680803066,0.11269013067345011,0.06642129013688418,1,bp,NAC,3303,HSPA1A
GO:0070884,regulation of calcineurin-NFAT signaling cascade,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,3479,IGF1
GO:0090077,foam cell differentiation,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,5320,PLA2G2A
GO:0090257,regulation of muscle system process,2/26,252/18493,0.04850721880668858,0.11269013067345011,0.06642129013688418,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0106056,regulation of calcineurin-mediated signaling,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,3479,IGF1
GO:1901099,negative regulation of signal transduction in absence of ligand,1/26,35/18493,0.04809285680803066,0.11269013067345011,0.06642129013688418,1,bp,NAC,3303,HSPA1A
GO:1903580,positive regulation of ATP metabolic process,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,3479,IGF1
GO:1904037,positive regulation of epithelial cell apoptotic process,1/26,36/18493,0.04943371636610805,0.11269013067345011,0.06642129013688418,1,bp,NAC,6424,SFRP4
GO:2001024,negative regulation of response to drug,1/26,35/18493,0.04809285680803066,0.11269013067345011,0.06642129013688418,1,bp,NAC,3082,HGF
GO:2001038,regulation of cellular response to drug,1/26,35/18493,0.04809285680803066,0.11269013067345011,0.06642129013688418,1,bp,NAC,3082,HGF
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,1/26,35/18493,0.04809285680803066,0.11269013067345011,0.06642129013688418,1,bp,NAC,3303,HSPA1A
GO:0007281,germ cell development,2/26,255/18493,0.04954486181766812,0.11276535584052856,0.0664656290032805,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0001818,negative regulation of cytokine production,2/26,256/18493,0.04989256119198627,0.11323816428276291,0.06674430954551733,2,bp,NAC,9314/3082,KLF4/HGF
GO:0003298,physiological muscle hypertrophy,1/26,37/18493,0.05077275973038642,0.11323816428276291,0.06674430954551733,1,bp,NAC,3479,IGF1
GO:0003301,physiological cardiac muscle hypertrophy,1/26,37/18493,0.05077275973038642,0.11323816428276291,0.06674430954551733,1,bp,NAC,3479,IGF1
GO:0034612,response to tumor necrosis factor,2/26,257/18493,0.05024116472441731,0.11323816428276291,0.06674430954551733,2,bp,NAC,3303/1277,HSPA1A/COL1A1
GO:0045740,positive regulation of DNA replication,1/26,37/18493,0.05077275973038642,0.11323816428276291,0.06674430954551733,1,bp,NAC,3725,JUN
GO:0048009,insulin-like growth factor receptor signaling pathway,1/26,37/18493,0.05077275973038642,0.11323816428276291,0.06674430954551733,1,bp,NAC,3479,IGF1
GO:0051293,establishment of spindle localization,1/26,37/18493,0.05077275973038642,0.11323816428276291,0.06674430954551733,1,bp,NAC,10252,SPRY1
GO:0060323,head morphogenesis,1/26,37/18493,0.05077275973038642,0.11323816428276291,0.06674430954551733,1,bp,NAC,1277,COL1A1
GO:0061049,cell growth involved in cardiac muscle cell development,1/26,37/18493,0.05077275973038642,0.11323816428276291,0.06674430954551733,1,bp,NAC,3479,IGF1
GO:0061756,leukocyte adhesion to vascular endothelial cell,1/26,37/18493,0.05077275973038642,0.11323816428276291,0.06674430954551733,1,bp,NAC,9314,KLF4
GO:0070741,response to interleukin-6,1/26,37/18493,0.05077275973038642,0.11323816428276291,0.06674430954551733,1,bp,NAC,9021,SOCS3
GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,1/26,37/18493,0.05077275973038642,0.11323816428276291,0.06674430954551733,1,bp,NAC,3082,HGF
GO:2000142,"regulation of DNA-templated transcription, initiation",1/26,37/18493,0.05077275973038642,0.11323816428276291,0.06674430954551733,1,bp,NAC,3725,JUN
GO:0031334,positive regulation of protein complex assembly,2/26,259/18493,0.050941072240979636,0.11326343180852637,0.06675920261245892,2,bp,NAC,3725/3303,JUN/HSPA1A
GO:0032868,response to insulin,2/26,259/18493,0.050941072240979636,0.11326343180852637,0.06675920261245892,2,bp,NAC,9021/8835,SOCS3/SOCS2
hsa04659,Th17 cell differentiation,2/25,107/7852,0.045026593615533926,0.11343238006990278,0.07200609100459879,2,kg,NAC,2353/3725,FOS/JUN
GO:0045926,negative regulation of growth,2/26,260/18493,0.051292370228994334,0.11386906190836743,0.06711617027534805,2,bp,NAC,8835/3303,SOCS2/HSPA1A
GO:0004879,nuclear receptor activity,1/25,50/17632,0.0685781316120303,0.11396071870822683,0.060510116128262036,1,mf,NAC,3164,NR4A1
GO:0045309,protein phosphorylated amino acid binding,1/25,49/17632,0.06725192437261229,0.11396071870822683,0.060510116128262036,1,mf,NAC,9021,SOCS3
GO:0098531,"transcription factor activity, direct ligand regulated sequence-specific DNA binding",1/25,50/17632,0.0685781316120303,0.11396071870822683,0.060510116128262036,1,mf,NAC,3164,NR4A1
GO:0017046,peptide hormone binding,1/25,51/17632,0.06990252853557155,0.11447805397854471,0.06078480742223614,1,mf,NAC,3953,LEPR
GO:0000060,"protein import into nucleus, translocation",1/26,38/18493,0.052109989262625445,0.1148010908488069,0.06766552241735856,1,bp,NAC,3479,IGF1
GO:0003156,regulation of animal organ formation,1/26,38/18493,0.052109989262625445,0.1148010908488069,0.06766552241735856,1,bp,NAC,10252,SPRY1
GO:0007431,salivary gland development,1/26,38/18493,0.052109989262625445,0.1148010908488069,0.06766552241735856,1,bp,NAC,3082,HGF
GO:0010559,regulation of glycoprotein biosynthetic process,1/26,38/18493,0.052109989262625445,0.1148010908488069,0.06766552241735856,1,bp,NAC,3479,IGF1
GO:0032570,response to progesterone,1/26,38/18493,0.052109989262625445,0.1148010908488069,0.06766552241735856,1,bp,NAC,2353,FOS
GO:0000082,G1/S transition of mitotic cell cycle,2/26,263/18493,0.05235160526263599,0.11515757072253618,0.0678756371184369,2,bp,NAC,9314/2810,KLF4/SFN
GO:0034976,response to endoplasmic reticulum stress,2/26,264/18493,0.052706454040851246,0.1157616638979427,0.06823169889450903,2,bp,NAC,3725/3303,JUN/HSPA1A
GO:0010677,negative regulation of cellular carbohydrate metabolic process,1/26,39/18493,0.05344540732164338,0.11632235711181205,0.06856218006809217,1,bp,NAC,3953,LEPR
GO:0031647,regulation of protein stability,2/26,265/18493,0.05306218308954995,0.11632235711181205,0.06856218006809217,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0040019,positive regulation of embryonic development,1/26,39/18493,0.05344540732164338,0.11632235711181205,0.06856218006809217,1,bp,NAC,3479,IGF1
GO:0043542,endothelial cell migration,2/26,266/18493,0.053418789449949884,0.11632235711181205,0.06856218006809217,2,bp,NAC,9314/3164,KLF4/NR4A1
GO:0046825,regulation of protein export from nucleus,1/26,39/18493,0.05344540732164338,0.11632235711181205,0.06856218006809217,1,bp,NAC,2810,SFN
GO:2001222,regulation of neuron migration,1/26,39/18493,0.05344540732164338,0.11632235711181205,0.06856218006809217,1,bp,NAC,1281,COL3A1
GO:0015980,energy derivation by oxidation of organic compounds,2/26,267/18493,0.053776270169273374,0.11669046293873907,0.0687791472841676,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0045927,positive regulation of growth,2/26,267/18493,0.053776270169273374,0.11669046293873907,0.0687791472841676,2,bp,NAC,3479/2810,IGF1/SFN
GO:0006458,'de novo' protein folding,1/26,40/18493,0.054779016263316826,0.11675940984928536,0.06881978564994169,1,bp,NAC,3303,HSPA1A
GO:0006654,phosphatidic acid biosynthetic process,1/26,40/18493,0.054779016263316826,0.11675940984928536,0.06881978564994169,1,bp,NAC,5320,PLA2G2A
GO:0010828,positive regulation of glucose transmembrane transport,1/26,40/18493,0.054779016263316826,0.11675940984928536,0.06881978564994169,1,bp,NAC,3479,IGF1
GO:0010976,positive regulation of neuron projection development,2/26,269/18493,0.05449384290354341,0.11675940984928536,0.06881978564994169,2,bp,NAC,4804/3082,NGFR/HGF
GO:0030810,positive regulation of nucleotide biosynthetic process,1/26,40/18493,0.054779016263316826,0.11675940984928536,0.06881978564994169,1,bp,NAC,3479,IGF1
GO:0032881,regulation of polysaccharide metabolic process,1/26,40/18493,0.054779016263316826,0.11675940984928536,0.06881978564994169,1,bp,NAC,3479,IGF1
GO:0043616,keratinocyte proliferation,1/26,40/18493,0.054779016263316826,0.11675940984928536,0.06881978564994169,1,bp,NAC,2810,SFN
GO:0046006,regulation of activated T cell proliferation,1/26,40/18493,0.054779016263316826,0.11675940984928536,0.06881978564994169,1,bp,NAC,3479,IGF1
GO:0061900,glial cell activation,1/26,40/18493,0.054779016263316826,0.11675940984928536,0.06881978564994169,1,bp,NAC,3725,JUN
GO:0090184,positive regulation of kidney development,1/26,40/18493,0.054779016263316826,0.11675940984928536,0.06881978564994169,1,bp,NAC,80310,PDGFD
GO:0090224,regulation of spindle organization,1/26,40/18493,0.054779016263316826,0.11675940984928536,0.06881978564994169,1,bp,NAC,3303,HSPA1A
GO:1900373,positive regulation of purine nucleotide biosynthetic process,1/26,40/18493,0.054779016263316826,0.11675940984928536,0.06881978564994169,1,bp,NAC,3479,IGF1
GO:0003707,steroid hormone receptor activity,1/25,54/17632,0.07386488107922251,0.1175595994641147,0.0624210262641317,1,mf,NAC,3164,NR4A1
GO:0005070,SH3/SH2 adaptor activity,1/25,54/17632,0.07386488107922251,0.1175595994641147,0.0624210262641317,1,mf,NAC,8835,SOCS2
GO:0001709,cell fate determination,1/26,41/18493,0.056110818440586185,0.11837413890316648,0.06977153170205239,1,bp,NAC,9314,KLF4
GO:0006110,regulation of glycolytic process,1/26,41/18493,0.056110818440586185,0.11837413890316648,0.06977153170205239,1,bp,NAC,3479,IGF1
GO:0017145,stem cell division,1/26,41/18493,0.056110818440586185,0.11837413890316648,0.06977153170205239,1,bp,NAC,7704,ZBTB16
GO:0032715,negative regulation of interleukin-6 production,1/26,41/18493,0.056110818440586185,0.11837413890316648,0.06977153170205239,1,bp,NAC,3082,HGF
GO:0035136,forelimb morphogenesis,1/26,41/18493,0.056110818440586185,0.11837413890316648,0.06977153170205239,1,bp,NAC,7704,ZBTB16
GO:0046473,phosphatidic acid metabolic process,1/26,41/18493,0.056110818440586185,0.11837413890316648,0.06977153170205239,1,bp,NAC,5320,PLA2G2A
GO:1905209,positive regulation of cardiocyte differentiation,1/26,41/18493,0.056110818440586185,0.11837413890316648,0.06977153170205239,1,bp,NAC,3479,IGF1
GO:0007162,negative regulation of cell adhesion,2/26,276/18493,0.05703245854589567,0.11926201119653633,0.0702948572395239,2,bp,NAC,9314/1277,KLF4/COL1A1
GO:0030811,regulation of nucleotide catabolic process,1/26,42/18493,0.05744081620345998,0.11926201119653633,0.0702948572395239,1,bp,NAC,3479,IGF1
GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,1/26,42/18493,0.05744081620345998,0.11926201119653633,0.0702948572395239,1,bp,NAC,10252,SPRY1
GO:0042307,positive regulation of protein import into nucleus,1/26,42/18493,0.05744081620345998,0.11926201119653633,0.0702948572395239,1,bp,NAC,3479,IGF1
GO:0045429,positive regulation of nitric oxide biosynthetic process,1/26,42/18493,0.05744081620345998,0.11926201119653633,0.0702948572395239,1,bp,NAC,9314,KLF4
GO:0048511,rhythmic process,2/26,276/18493,0.05703245854589567,0.11926201119653633,0.0702948572395239,2,bp,NAC,3725/4804,JUN/NGFR
GO:0051146,striated muscle cell differentiation,2/26,277/18493,0.057398521765581044,0.11926201119653633,0.0702948572395239,2,bp,NAC,3479/2318,IGF1/FLNC
GO:0051653,spindle localization,1/26,42/18493,0.05744081620345998,0.11926201119653633,0.0702948572395239,1,bp,NAC,10252,SPRY1
GO:0071675,regulation of mononuclear cell migration,1/26,42/18493,0.05744081620345998,0.11926201119653633,0.0702948572395239,1,bp,NAC,80310,PDGFD
GO:0140014,mitotic nuclear division,2/26,277/18493,0.057398521765581044,0.11926201119653633,0.0702948572395239,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:1904407,positive regulation of nitric oxide metabolic process,1/26,42/18493,0.05744081620345998,0.11926201119653633,0.0702948572395239,1,bp,NAC,9314,KLF4
GO:0008180,COP9 signalosome,1/26,36/19659,0.04656667538607151,0.11945364555557474,0.07672312649421395,1,cc,NAC,3303,HSPA1A
GO:0008305,integrin complex,1/26,32/19659,0.04149743647724835,0.11945364555557474,0.07672312649421395,1,cc,NAC,3679,ITGA7
GO:0061695,"transferase complex, transferring phosphorus-containing groups",2/26,259/19659,0.04566559834316751,0.11945364555557474,0.07672312649421395,2,cc,NAC,9021/8835,SOCS3/SOCS2
GO:0098636,protein complex involved in cell adhesion,1/26,35/19659,0.045301787824077455,0.11945364555557474,0.07672312649421395,1,cc,NAC,3679,ITGA7
GO:0045296,cadherin binding,2/25,323/17632,0.076149146086929,0.11951185427531913,0.0634576217391075,2,mf,NAC,3303/2810,HSPA1A/SFN
GO:0044262,cellular carbohydrate metabolic process,2/26,278/18493,0.057765427257095686,0.11976366599423717,0.07059054026577936,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0009205,purine ribonucleoside triphosphate metabolic process,2/26,280/18493,0.058501753535501175,0.12028891371670992,0.07090012932348662,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0010470,regulation of gastrulation,1/26,43/18493,0.05876901189901629,0.12028891371670992,0.07090012932348662,1,bp,NAC,9314,KLF4
GO:0010613,positive regulation of cardiac muscle hypertrophy,1/26,43/18493,0.05876901189901629,0.12028891371670992,0.07090012932348662,1,bp,NAC,3479,IGF1
GO:0010907,positive regulation of glucose metabolic process,1/26,43/18493,0.05876901189901629,0.12028891371670992,0.07090012932348662,1,bp,NAC,3479,IGF1
GO:0014742,positive regulation of muscle hypertrophy,1/26,43/18493,0.05876901189901629,0.12028891371670992,0.07090012932348662,1,bp,NAC,3479,IGF1
GO:0031113,regulation of microtubule polymerization,1/26,43/18493,0.05876901189901629,0.12028891371670992,0.07090012932348662,1,bp,NAC,3303,HSPA1A
GO:0045912,negative regulation of carbohydrate metabolic process,1/26,43/18493,0.05876901189901629,0.12028891371670992,0.07090012932348662,1,bp,NAC,3953,LEPR
GO:0050768,negative regulation of neurogenesis,2/26,279/18493,0.058133172138942736,0.12028891371670992,0.07090012932348662,2,bp,NAC,4804/1281,NGFR/COL3A1
GO:1903573,negative regulation of response to endoplasmic reticulum stress,1/26,43/18493,0.05876901189901629,0.12028891371670992,0.07090012932348662,1,bp,NAC,3303,HSPA1A
GO:0045930,negative regulation of mitotic cell cycle,2/26,281/18493,0.058871168577016145,0.12032733180826387,0.07092277353545408,2,bp,NAC,9314/2810,KLF4/SFN
GO:0005996,monosaccharide metabolic process,2/26,287/18493,0.06110500540059029,0.1205378995980615,0.07104688541797693,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0006111,regulation of gluconeogenesis,1/26,45/18493,0.06142000646186485,0.1205378995980615,0.07104688541797693,1,bp,NAC,3953,LEPR
GO:0009126,purine nucleoside monophosphate metabolic process,2/26,287/18493,0.06110500540059029,0.1205378995980615,0.07104688541797693,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0009144,purine nucleoside triphosphate metabolic process,2/26,287/18493,0.06110500540059029,0.1205378995980615,0.07104688541797693,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0009167,purine ribonucleoside monophosphate metabolic process,2/26,286/18493,0.060730648426916285,0.1205378995980615,0.07104688541797693,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0009199,ribonucleoside triphosphate metabolic process,2/26,286/18493,0.060730648426916285,0.1205378995980615,0.07104688541797693,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0009895,negative regulation of catabolic process,2/26,287/18493,0.06110500540059029,0.1205378995980615,0.07104688541797693,2,bp,NAC,3953/3082,LEPR/HGF
GO:0010632,regulation of epithelial cell migration,2/26,284/18493,0.05998438696153834,0.1205378995980615,0.07104688541797693,2,bp,NAC,9314/3725,KLF4/JUN
GO:0030522,intracellular receptor signaling pathway,2/26,288/18493,0.061480176094368164,0.1205378995980615,0.07104688541797693,2,bp,NAC,3164/3303,NR4A1/HSPA1A
GO:0032309,icosanoid secretion,1/26,44/18493,0.06009540787140799,0.1205378995980615,0.07104688541797693,1,bp,NAC,5320,PLA2G2A
GO:0032653,regulation of interleukin-10 production,1/26,45/18493,0.06142000646186485,0.1205378995980615,0.07104688541797693,1,bp,NAC,3082,HGF
GO:0033173,calcineurin-NFAT signaling cascade,1/26,44/18493,0.06009540787140799,0.1205378995980615,0.07104688541797693,1,bp,NAC,3479,IGF1
GO:0035987,endodermal cell differentiation,1/26,45/18493,0.06142000646186485,0.1205378995980615,0.07104688541797693,1,bp,NAC,3679,ITGA7
GO:0044843,cell cycle G1/S phase transition,2/26,282/18493,0.05924141439958917,0.1205378995980615,0.07104688541797693,2,bp,NAC,9314/2810,KLF4/SFN
GO:0046782,regulation of viral transcription,1/26,44/18493,0.06009540787140799,0.1205378995980615,0.07104688541797693,1,bp,NAC,3725,JUN
GO:0046850,regulation of bone remodeling,1/26,44/18493,0.06009540787140799,0.1205378995980615,0.07104688541797693,1,bp,NAC,3953,LEPR
GO:0048599,oocyte development,1/26,45/18493,0.06142000646186485,0.1205378995980615,0.07104688541797693,1,bp,NAC,3479,IGF1
GO:0050798,activated T cell proliferation,1/26,44/18493,0.06009540787140799,0.1205378995980615,0.07104688541797693,1,bp,NAC,3479,IGF1
GO:0050850,positive regulation of calcium-mediated signaling,1/26,44/18493,0.06009540787140799,0.1205378995980615,0.07104688541797693,1,bp,NAC,3479,IGF1
GO:0050890,cognition,2/26,285/18493,0.060357108002311304,0.1205378995980615,0.07104688541797693,2,bp,NAC,2353/3725,FOS/JUN
GO:0051403,stress-activated MAPK cascade,2/26,284/18493,0.05998438696153834,0.1205378995980615,0.07104688541797693,2,bp,NAC,4616/3082,GADD45B/HGF
GO:0071364,cellular response to epidermal growth factor stimulus,1/26,44/18493,0.06009540787140799,0.1205378995980615,0.07104688541797693,1,bp,NAC,1277,COL1A1
GO:0071827,plasma lipoprotein particle organization,1/26,45/18493,0.06142000646186485,0.1205378995980615,0.07104688541797693,1,bp,NAC,5320,PLA2G2A
GO:0090068,positive regulation of cell cycle process,2/26,286/18493,0.060730648426916285,0.1205378995980615,0.07104688541797693,2,bp,NAC,3479/2810,IGF1/SFN
GO:0097193,intrinsic apoptotic signaling pathway,2/26,287/18493,0.06110500540059029,0.1205378995980615,0.07104688541797693,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:0098868,bone growth,1/26,45/18493,0.06142000646186485,0.1205378995980615,0.07104688541797693,1,bp,NAC,3953,LEPR
GO:1900034,regulation of cellular response to heat,1/26,45/18493,0.06142000646186485,0.1205378995980615,0.07104688541797693,1,bp,NAC,3303,HSPA1A
GO:1901031,regulation of response to reactive oxygen species,1/26,44/18493,0.06009540787140799,0.1205378995980615,0.07104688541797693,1,bp,NAC,3082,HGF
GO:1903018,regulation of glycoprotein metabolic process,1/26,45/18493,0.06142000646186485,0.1205378995980615,0.07104688541797693,1,bp,NAC,3479,IGF1
GO:1904591,positive regulation of protein import,1/26,44/18493,0.06009540787140799,0.1205378995980615,0.07104688541797693,1,bp,NAC,3479,IGF1
GO:0001961,positive regulation of cytokine-mediated signaling pathway,1/26,46/18493,0.06274281000869864,0.1212019743541528,0.07143830125699781,1,bp,NAC,3303,HSPA1A
GO:0005978,glycogen biosynthetic process,1/26,46/18493,0.06274281000869864,0.1212019743541528,0.07143830125699781,1,bp,NAC,3479,IGF1
GO:0009250,glucan biosynthetic process,1/26,46/18493,0.06274281000869864,0.1212019743541528,0.07143830125699781,1,bp,NAC,3479,IGF1
GO:0032757,positive regulation of interleukin-8 production,1/26,46/18493,0.06274281000869864,0.1212019743541528,0.07143830125699781,1,bp,NAC,3303,HSPA1A
GO:0045981,positive regulation of nucleotide metabolic process,1/26,46/18493,0.06274281000869864,0.1212019743541528,0.07143830125699781,1,bp,NAC,3479,IGF1
GO:0060351,cartilage development involved in endochondral bone morphogenesis,1/26,46/18493,0.06274281000869864,0.1212019743541528,0.07143830125699781,1,bp,NAC,1277,COL1A1
GO:0071715,icosanoid transport,1/26,46/18493,0.06274281000869864,0.1212019743541528,0.07143830125699781,1,bp,NAC,5320,PLA2G2A
GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis,1/26,46/18493,0.06274281000869864,0.1212019743541528,0.07143830125699781,1,bp,NAC,9314,KLF4
GO:1900544,positive regulation of purine nucleotide metabolic process,1/26,46/18493,0.06274281000869864,0.1212019743541528,0.07143830125699781,1,bp,NAC,3479,IGF1
GO:1901571,fatty acid derivative transport,1/26,46/18493,0.06274281000869864,0.1212019743541528,0.07143830125699781,1,bp,NAC,5320,PLA2G2A
GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,1/26,46/18493,0.06274281000869864,0.1212019743541528,0.07143830125699781,1,bp,NAC,3303,HSPA1A
R-HSA-452723,Transcriptional regulation of pluripotent stem cells,1/23,36/10554,0.07565503814867569,0.12173583411195998,0.06081361918171061,1,re,NAC,9314,KLF4
GO:0007595,lactation,1/26,47/18493,0.06406382084730533,0.1221190138476375,0.07197881838924106,1,bp,NAC,8835,SOCS2
GO:0032613,interleukin-10 production,1/26,47/18493,0.06406382084730533,0.1221190138476375,0.07197881838924106,1,bp,NAC,3082,HGF
GO:0045646,regulation of erythrocyte differentiation,1/26,47/18493,0.06406382084730533,0.1221190138476375,0.07197881838924106,1,bp,NAC,3303,HSPA1A
GO:0046580,negative regulation of Ras protein signal transduction,1/26,47/18493,0.06406382084730533,0.1221190138476375,0.07197881838924106,1,bp,NAC,10252,SPRY1
GO:0046638,positive regulation of alpha-beta T cell differentiation,1/26,47/18493,0.06406382084730533,0.1221190138476375,0.07197881838924106,1,bp,NAC,7704,ZBTB16
GO:0051205,protein insertion into membrane,1/26,47/18493,0.06406382084730533,0.1221190138476375,0.07197881838924106,1,bp,NAC,2810,SFN
GO:0055023,positive regulation of cardiac muscle tissue growth,1/26,47/18493,0.06406382084730533,0.1221190138476375,0.07197881838924106,1,bp,NAC,3479,IGF1
GO:0097720,calcineurin-mediated signaling,1/26,47/18493,0.06406382084730533,0.1221190138476375,0.07197881838924106,1,bp,NAC,3479,IGF1
GO:0150076,neuroinflammatory response,1/26,47/18493,0.06406382084730533,0.1221190138476375,0.07197881838924106,1,bp,NAC,3725,JUN
GO:1901185,negative regulation of ERBB signaling pathway,1/26,47/18493,0.06406382084730533,0.1221190138476375,0.07197881838924106,1,bp,NAC,10252,SPRY1
GO:0009409,response to cold,1/26,48/18493,0.06538304131016814,0.12252951767606834,0.07222077563720555,1,bp,NAC,2353,FOS
GO:0019083,viral transcription,1/26,48/18493,0.06538304131016814,0.12252951767606834,0.07222077563720555,1,bp,NAC,3725,JUN
GO:0032103,positive regulation of response to external stimulus,2/26,297/18493,0.06489286582131548,0.12252951767606834,0.07222077563720555,2,bp,NAC,5320/80310,PLA2G2A/PDGFD
GO:0043470,regulation of carbohydrate catabolic process,1/26,48/18493,0.06538304131016814,0.12252951767606834,0.07222077563720555,1,bp,NAC,3479,IGF1
GO:0043525,positive regulation of neuron apoptotic process,1/26,48/18493,0.06538304131016814,0.12252951767606834,0.07222077563720555,1,bp,NAC,3725,JUN
GO:0051961,negative regulation of nervous system development,2/26,298/18493,0.06527601939168264,0.12252951767606834,0.07222077563720555,2,bp,NAC,4804/1281,NGFR/COL3A1
GO:0051972,regulation of telomerase activity,1/26,48/18493,0.06538304131016814,0.12252951767606834,0.07222077563720555,1,bp,NAC,9314,KLF4
GO:0060711,labyrinthine layer development,1/26,48/18493,0.06538304131016814,0.12252951767606834,0.07222077563720555,1,bp,NAC,9021,SOCS3
GO:0061383,trabecula morphogenesis,1/26,48/18493,0.06538304131016814,0.12252951767606834,0.07222077563720555,1,bp,NAC,1277,COL1A1
GO:0070849,response to epidermal growth factor,1/26,48/18493,0.06538304131016814,0.12252951767606834,0.07222077563720555,1,bp,NAC,1277,COL1A1
GO:1901214,regulation of neuron death,2/26,296/18493,0.06451049799816246,0.12252951767606834,0.07222077563720555,2,bp,NAC,2353/3725,FOS/JUN
GO:1903587,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/26,48/18493,0.06538304131016814,0.12252951767606834,0.07222077563720555,1,bp,NAC,4804,NGFR
GO:2000725,regulation of cardiac muscle cell differentiation,1/26,48/18493,0.06538304131016814,0.12252951767606834,0.07222077563720555,1,bp,NAC,3479,IGF1
GO:0009161,ribonucleoside monophosphate metabolic process,2/26,300/18493,0.06604467271644507,0.12355427931689779,0.07282478585407115,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0010718,positive regulation of epithelial to mesenchymal transition,1/26,49/18493,0.06670047372686305,0.12355427931689779,0.07282478585407115,1,bp,NAC,1277,COL1A1
GO:0032330,regulation of chondrocyte differentiation,1/26,49/18493,0.06670047372686305,0.12355427931689779,0.07282478585407115,1,bp,NAC,7704,ZBTB16
GO:0034260,negative regulation of GTPase activity,1/26,49/18493,0.06670047372686305,0.12355427931689779,0.07282478585407115,1,bp,NAC,10252,SPRY1
GO:0035272,exocrine system development,1/26,49/18493,0.06670047372686305,0.12355427931689779,0.07282478585407115,1,bp,NAC,3082,HGF
GO:0045599,negative regulation of fat cell differentiation,1/26,49/18493,0.06670047372686305,0.12355427931689779,0.07282478585407115,1,bp,NAC,862,RUNX1T1
GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,1/26,49/18493,0.06670047372686305,0.12355427931689779,0.07282478585407115,1,bp,NAC,9021,SOCS3
GO:0060324,face development,1/26,49/18493,0.06670047372686305,0.12355427931689779,0.07282478585407115,1,bp,NAC,1277,COL1A1
GO:0071825,protein-lipid complex subunit organization,1/26,49/18493,0.06670047372686305,0.12355427931689779,0.07282478585407115,1,bp,NAC,5320,PLA2G2A
GO:0043010,camera-type eye development,2/26,302/18493,0.06681643591399122,0.12361040644088377,0.07285786804116723,2,bp,NAC,9314/3725,KLF4/JUN
GO:0010506,regulation of autophagy,2/26,303/18493,0.06720347684657668,0.12416724339258663,0.07318607627472735,2,bp,NAC,3953/3082,LEPR/HGF
GO:0001706,endoderm formation,1/26,50/18493,0.06801612042406024,0.12471062486902025,0.07350635364494172,1,bp,NAC,3679,ITGA7
GO:0009994,oocyte differentiation,1/26,50/18493,0.06801612042406024,0.12471062486902025,0.07350635364494172,1,bp,NAC,3479,IGF1
GO:0010171,body morphogenesis,1/26,50/18493,0.06801612042406024,0.12471062486902025,0.07350635364494172,1,bp,NAC,1277,COL1A1
GO:0010948,negative regulation of cell cycle process,2/26,304/18493,0.0675912870164809,0.12471062486902025,0.07350635364494172,2,bp,NAC,9314/2810,KLF4/SFN
GO:0050863,regulation of T cell activation,2/26,305/18493,0.06797986369183293,0.12471062486902025,0.07350635364494172,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0060425,lung morphogenesis,1/26,50/18493,0.06801612042406024,0.12471062486902025,0.07350635364494172,1,bp,NAC,10252,SPRY1
GO:0009141,nucleoside triphosphate metabolic process,2/26,307/18493,0.06875930565951752,0.1259132970389388,0.074215227054355,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0045840,positive regulation of mitotic nuclear division,1/26,51/18493,0.06932998372552801,0.12647682239688612,0.07454737753706386,1,bp,NAC,3479,IGF1
GO:0048260,positive regulation of receptor-mediated endocytosis,1/26,51/18493,0.06932998372552801,0.12647682239688612,0.07454737753706386,1,bp,NAC,6424,SFRP4
GO:0060421,positive regulation of heart growth,1/26,51/18493,0.06932998372552801,0.12647682239688612,0.07454737753706386,1,bp,NAC,3479,IGF1
GO:0000186,activation of MAPKK activity,1/26,52/18493,0.07064206595213784,0.12758010158815383,0.07519766720153795,1,bp,NAC,4616,GADD45B
GO:0001701,in utero embryonic development,2/26,311/18493,0.07032726808124913,0.12758010158815383,0.07519766720153795,2,bp,NAC,3479/9021,IGF1/SOCS3
GO:0002090,regulation of receptor internalization,1/26,52/18493,0.07064206595213784,0.12758010158815383,0.07519766720153795,1,bp,NAC,6424,SFRP4
GO:0007568,aging,2/26,311/18493,0.07032726808124913,0.12758010158815383,0.07519766720153795,2,bp,NAC,2353/3725,FOS/JUN
GO:0030111,regulation of Wnt signaling pathway,2/26,311/18493,0.07032726808124913,0.12758010158815383,0.07519766720153795,2,bp,NAC,6424/1277,SFRP4/COL1A1
GO:0032964,collagen biosynthetic process,1/26,52/18493,0.07064206595213784,0.12758010158815383,0.07519766720153795,1,bp,NAC,1277,COL1A1
GO:0060760,positive regulation of response to cytokine stimulus,1/26,52/18493,0.07064206595213784,0.12758010158815383,0.07519766720153795,1,bp,NAC,3303,HSPA1A
GO:2001169,regulation of ATP biosynthetic process,1/26,52/18493,0.07064206595213784,0.12758010158815383,0.07519766720153795,1,bp,NAC,3479,IGF1
GO:0031098,stress-activated protein kinase signaling cascade,2/26,313/18493,0.0711157453184353,0.12827502561812767,0.07560726607538912,2,bp,NAC,4616/3082,GADD45B/HGF
GO:0001540,amyloid-beta binding,1/25,61/17632,0.08304744996178703,0.12855290199564295,0.06825817805078388,1,mf,NAC,4804,NGFR
GO:0016235,aggresome,1/26,42/19659,0.05412222845825432,0.12945235259375168,0.0831451327988414,1,cc,NAC,3303,HSPA1A
GO:0019898,extrinsic component of membrane,2/26,287/19659,0.05485269177701343,0.12945235259375168,0.0831451327988414,2,cc,NAC,9021/8835,SOCS3/SOCS2
GO:0043392,negative regulation of DNA binding,1/26,53/18493,0.071952369421865,0.12946043525654763,0.07630596468416712,1,bp,NAC,3725,JUN
GO:0051058,negative regulation of small GTPase mediated signal transduction,1/26,53/18493,0.071952369421865,0.12946043525654763,0.07630596468416712,1,bp,NAC,10252,SPRY1
GO:0045123,cellular extravasation,1/26,54/18493,0.07326089644979528,0.13148690743414748,0.07750039844387874,1,bp,NAC,80310,PDGFD
GO:0090183,regulation of kidney development,1/26,54/18493,0.07326089644979528,0.13148690743414748,0.07750039844387874,1,bp,NAC,80310,PDGFD
GO:0033218,amide binding,2/25,348/17632,0.08655586636175801,0.132173147282144,0.0701804321852092,2,mf,NAC,4804/3953,NGFR/LEPR
GO:0002043,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/26,55/18493,0.07456764934812543,0.13235069865848093,0.07800953023018754,1,bp,NAC,4804,NGFR
GO:0032922,circadian regulation of gene expression,1/26,55/18493,0.07456764934812543,0.13235069865848093,0.07800953023018754,1,bp,NAC,4804,NGFR
GO:0046324,regulation of glucose import,1/26,55/18493,0.07456764934812543,0.13235069865848093,0.07800953023018754,1,bp,NAC,3479,IGF1
GO:0051196,regulation of coenzyme metabolic process,1/26,55/18493,0.07456764934812543,0.13235069865848093,0.07800953023018754,1,bp,NAC,3479,IGF1
GO:0051898,negative regulation of protein kinase B signaling,1/26,55/18493,0.07456764934812543,0.13235069865848093,0.07800953023018754,1,bp,NAC,9314,KLF4
GO:1900408,negative regulation of cellular response to oxidative stress,1/26,55/18493,0.07456764934812543,0.13235069865848093,0.07800953023018754,1,bp,NAC,3082,HGF
GO:1903202,negative regulation of oxidative stress-induced cell death,1/26,55/18493,0.07456764934812543,0.13235069865848093,0.07800953023018754,1,bp,NAC,3082,HGF
GO:1903428,positive regulation of reactive oxygen species biosynthetic process,1/26,55/18493,0.07456764934812543,0.13235069865848093,0.07800953023018754,1,bp,NAC,9314,KLF4
GO:2000242,negative regulation of reproductive process,1/26,55/18493,0.07456764934812543,0.13235069865848093,0.07800953023018754,1,bp,NAC,3479,IGF1
GO:0009123,nucleoside monophosphate metabolic process,2/26,322/18493,0.07470032243469629,0.13242329886150705,0.07805232190254054,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",1/26,56/18493,0.07587263042616799,0.1328691816807772,0.07831513206993324,1,bp,NAC,2810,SFN
GO:0010656,negative regulation of muscle cell apoptotic process,1/26,56/18493,0.07587263042616799,0.1328691816807772,0.07831513206993324,1,bp,NAC,3479,IGF1
GO:0030336,negative regulation of cell migration,2/26,324/18493,0.07550486407560325,0.1328691816807772,0.07831513206993324,2,bp,NAC,9314/1281,KLF4/COL3A1
GO:0032496,response to lipopolysaccharide,2/26,324/18493,0.07550486407560325,0.1328691816807772,0.07831513206993324,2,bp,NAC,2353/3725,FOS/JUN
GO:0035904,aorta development,1/26,56/18493,0.07587263042616799,0.1328691816807772,0.07831513206993324,1,bp,NAC,1281,COL3A1
GO:0048008,platelet-derived growth factor receptor signaling pathway,1/26,56/18493,0.07587263042616799,0.1328691816807772,0.07831513206993324,1,bp,NAC,80310,PDGFD
GO:0048016,inositol phosphate-mediated signaling,1/26,56/18493,0.07587263042616799,0.1328691816807772,0.07831513206993324,1,bp,NAC,3479,IGF1
GO:0055081,anion homeostasis,1/26,56/18493,0.07587263042616799,0.1328691816807772,0.07831513206993324,1,bp,NAC,6424,SFRP4
GO:0060688,regulation of morphogenesis of a branching structure,1/26,56/18493,0.07587263042616799,0.1328691816807772,0.07831513206993324,1,bp,NAC,3082,HGF
GO:1903749,positive regulation of establishment of protein localization to mitochondrion,1/26,56/18493,0.07587263042616799,0.1328691816807772,0.07831513206993324,1,bp,NAC,2810,SFN
R-HSA-1483166,Synthesis of PA,1/23,40/10554,0.08371486471622991,0.13349127076371795,0.0666860942262998,1,re,NAC,5320,PLA2G2A
hsa04152,AMPK signaling pathway,2/25,120/7852,0.055292302685772066,0.13413503058955817,0.0851479904907601,2,kg,NAC,3479/3953,IGF1/LEPR
hsa04722,Neurotrophin signaling pathway,2/25,119/7852,0.05447517625669114,0.13413503058955817,0.0851479904907601,2,kg,NAC,3725/4804,JUN/NGFR
GO:0072431,signal transduction involved in mitotic G1 DNA damage checkpoint,1/26,57/18493,0.0771758419903551,0.13466111244508153,0.07937132352600638,1,bp,NAC,2810,SFN
GO:1902400,intracellular signal transduction involved in G1 DNA damage checkpoint,1/26,57/18493,0.0771758419903551,0.13466111244508153,0.07937132352600638,1,bp,NAC,2810,SFN
GO:1902883,negative regulation of response to oxidative stress,1/26,57/18493,0.0771758419903551,0.13466111244508153,0.07937132352600638,1,bp,NAC,3082,HGF
GO:0031646,positive regulation of neurological system process,1/26,58/18493,0.07847728634424178,0.13660159733985633,0.08051507506335771,1,bp,NAC,3082,HGF
GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,1/26,58/18493,0.07847728634424178,0.13660159733985633,0.08051507506335771,1,bp,NAC,3082,HGF
GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,1/26,59/18493,0.07977696578850757,0.13753663277516895,0.08106619927952477,1,bp,NAC,3303,HSPA1A
GO:0033619,membrane protein proteolysis,1/26,59/18493,0.07977696578850757,0.13753663277516895,0.08106619927952477,1,bp,NAC,4804,NGFR
GO:0048638,regulation of developmental growth,2/26,334/18493,0.07956993780330726,0.13753663277516895,0.08106619927952477,2,bp,NAC,3479/8835,IGF1/SOCS2
GO:0051251,positive regulation of lymphocyte activation,2/26,333/18493,0.07916029584038303,0.13753663277516895,0.08106619927952477,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,1/26,59/18493,0.07977696578850757,0.13753663277516895,0.08106619927952477,1,bp,NAC,3303,HSPA1A
GO:0072413,signal transduction involved in mitotic cell cycle checkpoint,1/26,59/18493,0.07977696578850757,0.13753663277516895,0.08106619927952477,1,bp,NAC,2810,SFN
GO:1902402,signal transduction involved in mitotic DNA damage checkpoint,1/26,59/18493,0.07977696578850757,0.13753663277516895,0.08106619927952477,1,bp,NAC,2810,SFN
GO:1902403,signal transduction involved in mitotic DNA integrity checkpoint,1/26,59/18493,0.07977696578850757,0.13753663277516895,0.08106619927952477,1,bp,NAC,2810,SFN
GO:0002237,response to molecule of bacterial origin,2/26,337/18493,0.08080297619028622,0.1382872997896584,0.08150865392278074,2,bp,NAC,2353/3725,FOS/JUN
GO:0002753,cytoplasmic pattern recognition receptor signaling pathway,1/26,60/18493,0.08107488262096396,0.1382872997896584,0.08150865392278074,1,bp,NAC,3303,HSPA1A
GO:0018149,peptide cross-linking,1/26,60/18493,0.08107488262096396,0.1382872997896584,0.08150865392278074,1,bp,NAC,1281,COL3A1
GO:0030166,proteoglycan biosynthetic process,1/26,60/18493,0.08107488262096396,0.1382872997896584,0.08150865392278074,1,bp,NAC,3479,IGF1
GO:0032835,glomerulus development,1/26,60/18493,0.08107488262096396,0.1382872997896584,0.08150865392278074,1,bp,NAC,80310,PDGFD
GO:0035019,somatic stem cell population maintenance,1/26,60/18493,0.08107488262096396,0.1382872997896584,0.08150865392278074,1,bp,NAC,9314,KLF4
GO:0060761,negative regulation of response to cytokine stimulus,1/26,60/18493,0.08107488262096396,0.1382872997896584,0.08150865392278074,1,bp,NAC,9314,KLF4
GO:0061077,chaperone-mediated protein folding,1/26,60/18493,0.08107488262096396,0.1382872997896584,0.08150865392278074,1,bp,NAC,3303,HSPA1A
GO:0090307,mitotic spindle assembly,1/26,60/18493,0.08107488262096396,0.1382872997896584,0.08150865392278074,1,bp,NAC,3303,HSPA1A
R-HSA-419037,NCAM1 interactions,1/23,42/10554,0.08771952655835091,0.1386281803645367,0.06925225780922441,1,re,NAC,1281,COL3A1
GO:0046934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",1/25,68/17632,0.09214258135293951,0.13882815590509553,0.07371406508235162,1,mf,NAC,3082,HGF
GO:2000146,negative regulation of cell motility,2/26,339/18493,0.08162840331217701,0.13906704365935232,0.08196824691013363,2,bp,NAC,9314/1281,KLF4/COL3A1
GO:0003002,regionalization,2/26,341/18493,0.08245652791004923,0.13948976526869994,0.08221740550542332,2,bp,NAC,10252/7704,SPRY1/ZBTB16
GO:0009880,embryonic pattern specification,1/26,61/18493,0.0823710391365533,0.13948976526869994,0.08221740550542332,1,bp,NAC,7704,ZBTB16
GO:0042733,embryonic digit morphogenesis,1/26,61/18493,0.0823710391365533,0.13948976526869994,0.08221740550542332,1,bp,NAC,7704,ZBTB16
GO:0046635,positive regulation of alpha-beta T cell activation,1/26,61/18493,0.0823710391365533,0.13948976526869994,0.08221740550542332,1,bp,NAC,7704,ZBTB16
GO:0048747,muscle fiber development,1/26,61/18493,0.0823710391365533,0.13948976526869994,0.08221740550542332,1,bp,NAC,2318,FLNC
GO:0055025,positive regulation of cardiac muscle tissue development,1/26,61/18493,0.0823710391365533,0.13948976526869994,0.08221740550542332,1,bp,NAC,3479,IGF1
hsa04110,Cell cycle,2/25,124/7852,0.05860462616441218,0.13958556413705447,0.08860795152131218,2,kg,NAC,4616/2810,GADD45B/SFN
R-HSA-177929,Signaling by EGFR,1/23,43/10554,0.089715574017365185,0.14052793452277557,0.0702012875403696,1,re,NAC,10252,SPRY1
GO:0001824,blastocyst development,1/26,62/18493,0.08366543762735457,0.14061057032027324,0.08287802518056737,1,bp,NAC,3479,IGF1
GO:0019080,viral gene expression,1/26,62/18493,0.08366543762735457,0.14061057032027324,0.08287802518056737,1,bp,NAC,3725,JUN
GO:0030098,lymphocyte differentiation,2/26,344/18493,0.08370372827797277,0.14061057032027324,0.08287802518056737,2,bp,NAC,7704/3953,ZBTB16/LEPR
GO:0045428,regulation of nitric oxide biosynthetic process,1/26,62/18493,0.08366543762735457,0.14061057032027324,0.08287802518056737,1,bp,NAC,9314,KLF4
GO:0046622,positive regulation of organ growth,1/26,62/18493,0.08366543762735457,0.14061057032027324,0.08287802518056737,1,bp,NAC,3479,IGF1
GO:0048645,animal organ formation,1/26,62/18493,0.08366543762735457,0.14061057032027324,0.08287802518056737,1,bp,NAC,10252,SPRY1
GO:0010676,positive regulation of cellular carbohydrate metabolic process,1/26,63/18493,0.08495808038258701,0.14156409929800584,0.08344004977407354,1,bp,NAC,3479,IGF1
GO:0031331,positive regulation of cellular catabolic process,2/26,347/18493,0.08495688437878941,0.14156409929800584,0.08344004977407354,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0031571,mitotic G1 DNA damage checkpoint,1/26,63/18493,0.08495808038258701,0.14156409929800584,0.08344004977407354,1,bp,NAC,2810,SFN
GO:0044819,mitotic G1/S transition checkpoint,1/26,63/18493,0.08495808038258701,0.14156409929800584,0.08344004977407354,1,bp,NAC,2810,SFN
GO:0046323,glucose import,1/26,63/18493,0.08495808038258701,0.14156409929800584,0.08344004977407354,1,bp,NAC,3479,IGF1
GO:0046637,regulation of alpha-beta T cell differentiation,1/26,63/18493,0.08495808038258701,0.14156409929800584,0.08344004977407354,1,bp,NAC,7704,ZBTB16
GO:0050891,multicellular organismal water homeostasis,1/26,63/18493,0.08495808038258701,0.14156409929800584,0.08344004977407354,1,bp,NAC,2810,SFN
GO:0004857,enzyme inhibitor activity,2/25,371/17632,0.09649362190653288,0.14160752305763916,0.0751898352518438,2,mf,NAC,9021/2810,SOCS3/SFN
GO:0052813,phosphatidylinositol bisphosphate kinase activity,1/25,71/17632,0.09601392628334349,0.14160752305763916,0.0751898352518438,1,mf,NAC,3082,HGF
GO:0006066,alcohol metabolic process,2/26,348/18493,0.08537591487974686,0.14209624587251984,0.08375370512090749,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0022412,cellular process involved in reproduction in multicellular organism,2/26,350/18493,0.08621592861636043,0.14223687229790613,0.08383659249130695,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0042306,regulation of protein import into nucleus,1/26,64/18493,0.08624896968861251,0.14223687229790613,0.08383659249130695,1,bp,NAC,3479,IGF1
GO:0044783,G1 DNA damage checkpoint,1/26,64/18493,0.08624896968861251,0.14223687229790613,0.08383659249130695,1,bp,NAC,2810,SFN
GO:0045600,positive regulation of fat cell differentiation,1/26,64/18493,0.08624896968861251,0.14223687229790613,0.08383659249130695,1,bp,NAC,7704,ZBTB16
GO:0045670,regulation of osteoclast differentiation,1/26,64/18493,0.08624896968861251,0.14223687229790613,0.08383659249130695,1,bp,NAC,2353,FOS
GO:0050795,regulation of behavior,1/26,64/18493,0.08624896968861251,0.14223687229790613,0.08383659249130695,1,bp,NAC,3953,LEPR
GO:0051785,positive regulation of nuclear division,1/26,64/18493,0.08624896968861251,0.14223687229790613,0.08383659249130695,1,bp,NAC,3479,IGF1
GO:1905207,regulation of cardiocyte differentiation,1/26,64/18493,0.08624896968861251,0.14223687229790613,0.08383659249130695,1,bp,NAC,3479,IGF1
R-HSA-109606,Intrinsic Pathway for Apoptosis,1/23,44/10554,0.09170744365846528,0.14238787304866976,0.0711304272143221,1,re,NAC,2810,SFN
GO:0001654,eye development,2/26,351/18493,0.08663690688152306,0.14271353496579656,0.08411754477321634,2,bp,NAC,9314/3725,KLF4/JUN
GO:0001618,virus receptor activity,1/25,74/17632,0.09986942040482505,0.14285119627525608,0.075850192712525355,1,mf,NAC,3303,HSPA1A
GO:0104005,hijacked molecular function,1/25,74/17632,0.09986942040482505,0.14285119627525608,0.075850192712525355,1,mf,NAC,3303,HSPA1A
GO:0045862,positive regulation of proteolysis,2/26,352/18493,0.08705852943961,0.14308138722250252,0.08433436253111723,2,bp,NAC,4804/3303,NGFR/HSPA1A
GO:0150063,visual system development,2/26,352/18493,0.08705852943961,0.14308138722250252,0.08433436253111723,2,bp,NAC,9314/3725,KLF4/JUN
GO:0042246,tissue regeneration,1/26,65/18493,0.08753810782894,0.14370590397856703,0.08470246227864624,1,bp,NAC,3479,IGF1
GO:0062012,regulation of small molecule metabolic process,2/26,355/18493,0.08832723817498876,0.14483659623466907,0.08536890962367336,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0010812,negative regulation of cell-substrate adhesion,1/26,66/18493,0.08882549708422782,0.14515876816822282,0.08555880269899992,1,bp,NAC,1277,COL1A1
GO:0015909,long-chain fatty acid transport,1/26,66/18493,0.08882549708422782,0.14515876816822282,0.08555880269899992,1,bp,NAC,5320,PLA2G2A
GO:0050918,positive chemotaxis,1/26,66/18493,0.08882549708422782,0.14515876816822282,0.08555880269899992,1,bp,NAC,3082,HGF
GO:0006913,nucleocytoplasmic transport,2/26,357/18493,0.0891762202770567,0.14540258289242125,0.08570251083420971,2,bp,NAC,3479/2810,IGF1/SFN
GO:0048880,sensory system development,2/26,357/18493,0.0891762202770567,0.14540258289242125,0.08570251083420971,2,bp,NAC,9314/3725,KLF4/JUN
R-HSA-8878171,Transcriptional regulation by RUNX1,2/23,239/10554,0.09468885908868722,0.14573850485824033,0.07280424863569544,2,re,NAC,3977/9021,LIFR/SOCS3
GO:0010038,response to metal ion,2/26,358/18493,0.08960165685701989,0.1459313666418507,0.08601418408039926,2,bp,NAC,2353/3725,FOS/JUN
GO:0030104,water homeostasis,1/26,67/18493,0.09011113973228868,0.14610154453223884,0.08611448953718422,1,bp,NAC,2810,SFN
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1/26,67/18493,0.09011113973228868,0.14610154453223884,0.08611448953718422,1,bp,NAC,3164,NR4A1
GO:1903672,positive regulation of sprouting angiogenesis,1/26,67/18493,0.09011113973228868,0.14610154453223884,0.08611448953718422,1,bp,NAC,9314,KLF4
GO:1904589,regulation of protein import,1/26,67/18493,0.09011113973228868,0.14610154453223884,0.08611448953718422,1,bp,NAC,3479,IGF1
GO:0051169,nuclear transport,2/26,360/18493,0.09045440886861113,0.14649350392525912,0.08634551641070093,2,bp,NAC,3479/2810,IGF1/SFN
GO:0031670,cellular response to nutrient,1/26,68/18493,0.0913950380480899,0.1475201788628565,0.08695065435400523,1,bp,NAC,1277,COL1A1
GO:0033692,cellular polysaccharide biosynthetic process,1/26,68/18493,0.0913950380480899,0.1475201788628565,0.08695065435400523,1,bp,NAC,3479,IGF1
GO:0061035,regulation of cartilage development,1/26,68/18493,0.0913950380480899,0.1475201788628565,0.08695065435400523,1,bp,NAC,7704,ZBTB16
GO:0045088,regulation of innate immune response,2/26,365/18493,0.09259713553933796,0.14925579395125987,0.08797365248759383,2,bp,NAC,9021/3303,SOCS3/HSPA1A
GO:0050771,negative regulation of axonogenesis,1/26,69/18493,0.0926771943037622,0.14925579395125987,0.08797365248759383,1,bp,NAC,4804,NGFR
GO:0035004,phosphatidylinositol 3-kinase activity,1/25,79/17632,0.1062601887693998,0.15001531905752416,0.07965415171195975,1,mf,NAC,3082,HGF
GO:0035591,signaling adaptor activity,1/25,80/17632,0.10753310481114564,0.15001531905752416,0.07965415171195975,1,mf,NAC,8835,SOCS2
hsa04060,Cytokine-cytokine receptor interaction,3/25,294/7852,0.06509394386879445,0.1503803428798876,0.0954604024709612,3,kg,NAC,3977/4804/3953,LIFR/NGFR/LEPR
hsa04068,FoxO signaling pathway,2/25,132/7852,0.06543266827598163,0.1503803428798876,0.0954604024709612,2,kg,NAC,3479/4616,IGF1/GADD45B
GO:0048662,negative regulation of smooth muscle cell proliferation,1/26,70/18493,0.09395761076859588,0.15098088233750986,0.08899044602159827,1,bp,NAC,9314,KLF4
GO:1903747,regulation of establishment of protein localization to mitochondrion,1/26,70/18493,0.09395761076859588,0.15098088233750986,0.08899044602159827,1,bp,NAC,2810,SFN
GO:0006305,DNA alkylation,1/26,71/18493,0.09523628970905162,0.15118368102327998,0.08910997867513602,1,bp,NAC,2353,FOS
GO:0006306,DNA methylation,1/26,71/18493,0.09523628970905162,0.15118368102327998,0.08910997867513602,1,bp,NAC,2353,FOS
GO:0031110,regulation of microtubule polymerization or depolymerization,1/26,71/18493,0.09523628970905162,0.15118368102327998,0.08910997867513602,1,bp,NAC,3303,HSPA1A
GO:0031346,positive regulation of cell projection organization,2/26,371/18493,0.09518851649964281,0.15118368102327998,0.08910997867513602,2,bp,NAC,4804/3082,NGFR/HGF
GO:0035914,skeletal muscle cell differentiation,1/26,71/18493,0.09523628970905162,0.15118368102327998,0.08910997867513602,1,bp,NAC,2353,FOS
GO:0038034,signal transduction in absence of ligand,1/26,71/18493,0.09523628970905162,0.15118368102327998,0.08910997867513602,1,bp,NAC,3303,HSPA1A
GO:0043900,regulation of multi-organism process,2/26,371/18493,0.09518851649964281,0.15118368102327998,0.08910997867513602,2,bp,NAC,3725/3479,JUN/IGF1
GO:0046785,microtubule polymerization,1/26,71/18493,0.09523628970905162,0.15118368102327998,0.08910997867513602,1,bp,NAC,3303,HSPA1A
GO:0051155,positive regulation of striated muscle cell differentiation,1/26,71/18493,0.09523628970905162,0.15118368102327998,0.08910997867513602,1,bp,NAC,3479,IGF1
GO:0060350,endochondral bone morphogenesis,1/26,71/18493,0.09523628970905162,0.15118368102327998,0.08910997867513602,1,bp,NAC,1277,COL1A1
GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,1/26,71/18493,0.09523628970905162,0.15118368102327998,0.08910997867513602,1,bp,NAC,3303,HSPA1A
GO:0034774,secretory granule lumen,2/26,321/19659,0.06680819879654958,0.15160322034601634,0.09737227354962692,2,cc,NAC,3479/3082,IGF1/HGF
GO:0002696,positive regulation of leukocyte activation,2/26,372/18493,0.09562251259495047,0.15162998425770716,0.08937303664166567,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0008013,beta-catenin binding,1/25,82/17632,0.11007371755095707,0.15168695223485545,0.08054174454948079,1,mf,NAC,9314,KLF4
GO:0042692,muscle cell differentiation,2/26,373/18493,0.09605710214419085,0.15215191920314752,0.08968067309781756,2,bp,NAC,3479/2318,IGF1/FLNC
GO:0001707,mesoderm formation,1/26,72/18493,0.09651323338875895,0.15237264308531637,0.08981077113683891,1,bp,NAC,9314,KLF4
GO:0048844,artery morphogenesis,1/26,72/18493,0.09651323338875895,0.15237264308531637,0.08981077113683891,1,bp,NAC,1281,COL3A1
GO:0051271,negative regulation of cellular component movement,2/26,374/18493,0.09649228278225773,0.15237264308531637,0.08981077113683891,2,bp,NAC,9314/1281,KLF4/COL3A1
GO:1901990,regulation of mitotic cell cycle phase transition,2/26,375/18493,0.09692805214905144,0.15286030519243848,0.0900982066568117,2,bp,NAC,9314/2810,KLF4/SFN
GO:0000271,polysaccharide biosynthetic process,1/26,74/18493,0.09906192400631741,0.15304749072924628,0.09020853668105992,1,bp,NAC,3479,IGF1
GO:0005977,glycogen metabolic process,1/26,73/18493,0.09778844406852061,0.15304749072924628,0.09020853668105992,1,bp,NAC,3479,IGF1
GO:0006073,cellular glucan metabolic process,1/26,74/18493,0.09906192400631741,0.15304749072924628,0.09020853668105992,1,bp,NAC,3479,IGF1
GO:0006096,glycolytic process,1/26,74/18493,0.09906192400631741,0.15304749072924628,0.09020853668105992,1,bp,NAC,3479,IGF1
GO:0006809,nitric oxide biosynthetic process,1/26,73/18493,0.09778844406852061,0.15304749072924628,0.09020853668105992,1,bp,NAC,9314,KLF4
GO:0007492,endoderm development,1/26,74/18493,0.09906192400631741,0.15304749072924628,0.09020853668105992,1,bp,NAC,3679,ITGA7
GO:0010611,regulation of cardiac muscle hypertrophy,1/26,74/18493,0.09906192400631741,0.15304749072924628,0.09020853668105992,1,bp,NAC,3479,IGF1
GO:0010827,regulation of glucose transmembrane transport,1/26,74/18493,0.09906192400631741,0.15304749072924628,0.09020853668105992,1,bp,NAC,3479,IGF1
GO:0014706,striated muscle tissue development,2/26,379/18493,0.09867696987625857,0.15304749072924628,0.09020853668105992,2,bp,NAC,2353/3479,FOS/IGF1
GO:0030808,regulation of nucleotide biosynthetic process,1/26,74/18493,0.09906192400631741,0.15304749072924628,0.09020853668105992,1,bp,NAC,3479,IGF1
GO:0031397,negative regulation of protein ubiquitination,1/26,73/18493,0.09778844406852061,0.15304749072924628,0.09020853668105992,1,bp,NAC,3303,HSPA1A
GO:0044042,glucan metabolic process,1/26,74/18493,0.09906192400631741,0.15304749072924628,0.09020853668105992,1,bp,NAC,3479,IGF1
GO:0048332,mesoderm morphogenesis,1/26,74/18493,0.09906192400631741,0.15304749072924628,0.09020853668105992,1,bp,NAC,9314,KLF4
GO:0055021,regulation of cardiac muscle tissue growth,1/26,74/18493,0.09906192400631741,0.15304749072924628,0.09020853668105992,1,bp,NAC,3479,IGF1
GO:0072395,signal transduction involved in cell cycle checkpoint,1/26,74/18493,0.09906192400631741,0.15304749072924628,0.09020853668105992,1,bp,NAC,2810,SFN
GO:0072401,signal transduction involved in DNA integrity checkpoint,1/26,73/18493,0.09778844406852061,0.15304749072924628,0.09020853668105992,1,bp,NAC,2810,SFN
GO:0072422,signal transduction involved in DNA damage checkpoint,1/26,73/18493,0.09778844406852061,0.15304749072924628,0.09020853668105992,1,bp,NAC,2810,SFN
GO:1900371,regulation of purine nucleotide biosynthetic process,1/26,73/18493,0.09778844406852061,0.15304749072924628,0.09020853668105992,1,bp,NAC,3479,IGF1
GO:1903578,regulation of ATP metabolic process,1/26,74/18493,0.09906192400631741,0.15304749072924628,0.09020853668105992,1,bp,NAC,3479,IGF1
GO:0001937,negative regulation of endothelial cell proliferation,1/26,75/18493,0.10033367545731031,0.15418689423311904,0.09088011856903395,1,bp,NAC,4804,NGFR
GO:0006757,ATP generation from ADP,1/26,75/18493,0.10033367545731031,0.15418689423311904,0.09088011856903395,1,bp,NAC,3479,IGF1
GO:0032642,regulation of chemokine production,1/26,75/18493,0.10033367545731031,0.15418689423311904,0.09088011856903395,1,bp,NAC,9314,KLF4
GO:0051193,regulation of cofactor metabolic process,1/26,75/18493,0.10033367545731031,0.15418689423311904,0.09088011856903395,1,bp,NAC,3479,IGF1
GO:1903201,regulation of oxidative stress-induced cell death,1/26,75/18493,0.10033367545731031,0.15418689423311904,0.09088011856903395,1,bp,NAC,3082,HGF
GO:0031983,vesicle lumen,2/26,339/19659,0.07346312600317649,0.15479730122097904,0.09942377955317121,2,cc,NAC,3479/3082,IGF1/HGF
GO:0060205,cytoplasmic vesicle lumen,2/26,338/19659,0.07308782469445724,0.15479730122097904,0.09942377955317121,2,cc,NAC,3479/3082,IGF1/HGF
GO:0050867,positive regulation of cell activation,2/26,384/18493,0.10087608229382979,0.15485551781914508,0.0912742155581349,2,bp,NAC,3479/7704,IGF1/ZBTB16
R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,1/23,49/10554,0.101604416208813,0.15503432473241294,0.07744801235517505,1,re,NAC,2810,SFN
GO:0014743,regulation of muscle hypertrophy,1/26,76/18493,0.10160370067384372,0.1553115890596997,0.09154303093718301,1,bp,NAC,3479,IGF1
GO:0034308,primary alcohol metabolic process,1/26,76/18493,0.10160370067384372,0.1553115890596997,0.09154303093718301,1,bp,NAC,3479,IGF1
GO:0043407,negative regulation of MAP kinase activity,1/26,76/18493,0.10160370067384372,0.1553115890596997,0.09154303093718301,1,bp,NAC,10252,SPRY1
GO:0051851,modification by host of symbiont morphology or physiology,1/26,76/18493,0.10160370067384372,0.1553115890596997,0.09154303093718301,1,bp,NAC,3725,JUN
GO:0040013,negative regulation of locomotion,2/26,386/18493,0.10175970127743558,0.1553854486172905,0.09158656489241766,2,bp,NAC,9314/1281,KLF4/COL3A1
R-HSA-383280,Nuclear Receptor transcription pathway,1/23,50/10554,0.10357139368879387,0.15668492891381636,0.07827257822634895,1,re,NAC,3164,NR4A1
GO:0008306,associative learning,1/26,77/18493,0.1028720019054491,0.15675216341030943,0.09239212753804577,1,bp,NAC,2353,FOS
GO:0046209,nitric oxide metabolic process,1/26,77/18493,0.1028720019054491,0.15675216341030943,0.09239212753804577,1,bp,NAC,9314,KLF4
GO:0045787,positive regulation of cell cycle,2/26,390/18493,0.1035336504522058,0.15759394261870566,0.09288828510479934,2,bp,NAC,3479/2810,IGF1/SFN
GO:0003151,outflow tract morphogenesis,1/26,78/18493,0.10413858139884913,0.15768307760602235,0.09294082263242956,1,bp,NAC,3725,JUN
GO:0031100,animal organ regeneration,1/26,78/18493,0.10413858139884913,0.15768307760602235,0.09294082263242956,1,bp,NAC,3082,HGF
GO:0042866,pyruvate biosynthetic process,1/26,78/18493,0.10413858139884913,0.15768307760602235,0.09294082263242956,1,bp,NAC,3479,IGF1
GO:0071260,cellular response to mechanical stimulus,1/26,78/18493,0.10413858139884913,0.15768307760602235,0.09294082263242956,1,bp,NAC,1277,COL1A1
GO:1905897,regulation of response to endoplasmic reticulum stress,1/26,78/18493,0.10413858139884913,0.15768307760602235,0.09294082263242956,1,bp,NAC,3303,HSPA1A
hsa04910,Insulin signaling pathway,2/25,137/7852,0.06983190000595985,0.15772377415139208,0.10012196189602228,2,kg,NAC,9021/8835,SOCS3/SOCS2
hsa05418,Fluid shear stress and atherosclerosis,2/25,139/7852,0.0716188427264853,0.15901810842660297,0.10094359634955109,2,kg,NAC,2353/3725,FOS/JUN
GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,1/26,79/18493,0.10540344139796032,0.15926404810183953,0.093872670873025,1,bp,NAC,3303,HSPA1A
GO:0046470,phosphatidylcholine metabolic process,1/26,79/18493,0.10540344139796032,0.15926404810183953,0.093872670873025,1,bp,NAC,5320,PLA2G2A
GO:0042116,macrophage activation,1/26,80/18493,0.10666658414389552,0.1601663693232479,0.09440451283013043,1,bp,NAC,3725,JUN
GO:0045785,positive regulation of cell adhesion,2/26,397/18493,0.10665921252213952,0.1601663693232479,0.09440451283013043,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0045913,positive regulation of carbohydrate metabolic process,1/26,80/18493,0.10666658414389552,0.1601663693232479,0.09440451283013043,1,bp,NAC,3479,IGF1
GO:0051702,interaction with symbiont,1/26,80/18493,0.10666658414389552,0.1601663693232479,0.09440451283013043,1,bp,NAC,3725,JUN
GO:0060420,regulation of heart growth,1/26,80/18493,0.10666658414389552,0.1601663693232479,0.09440451283013043,1,bp,NAC,3479,IGF1
GO:2001057,reactive nitrogen species metabolic process,1/26,80/18493,0.10666658414389552,0.1601663693232479,0.09440451283013043,1,bp,NAC,9314,KLF4
R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),1/23,54/10554,0.11139818873378515,0.16030471061691035,0.08008085454546814,1,re,NAC,3479,IGF1
R-HSA-2428924,IGF1R signaling cascade,1/23,53/10554,0.10944764076097335,0.16030471061691035,0.08008085454546814,1,re,NAC,3479,IGF1
R-HSA-2428928,IRS-related events triggered by IGF1R,1/23,52/10554,0.10749299773563759,0.16030471061691035,0.08008085454546814,1,re,NAC,3479,IGF1
R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR),1/23,53/10554,0.10944764076097335,0.16030471061691035,0.08008085454546814,1,re,NAC,3303,HSPA1A
R-HSA-8848021,Signaling by PTK6,1/23,54/10554,0.11139818873378515,0.16030471061691035,0.08008085454546814,1,re,NAC,9021,SOCS3
R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,1/23,54/10554,0.11139818873378515,0.16030471061691035,0.08008085454546814,1,re,NAC,9021,SOCS3
GO:0032088,negative regulation of NF-kappaB transcription factor activity,1/26,81/18493,0.10792801187496903,0.16122165749024878,0.09502651584937886,1,bp,NAC,9314,KLF4
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,1/26,81/18493,0.10792801187496903,0.16122165749024878,0.09502651584937886,1,bp,NAC,3303,HSPA1A
GO:0043537,negative regulation of blood vessel endothelial cell migration,1/26,81/18493,0.10792801187496903,0.16122165749024878,0.09502651584937886,1,bp,NAC,9314,KLF4
GO:0050772,positive regulation of axonogenesis,1/26,81/18493,0.10792801187496903,0.16122165749024878,0.09502651584937886,1,bp,NAC,4804,NGFR
GO:1903845,negative regulation of cellular response to transforming growth factor beta stimulus,1/26,81/18493,0.10792801187496903,0.16122165749024878,0.09502651584937886,1,bp,NAC,3303,HSPA1A
GO:0032602,chemokine production,1/26,82/18493,0.10918772682669964,0.1622635322460634,0.09564061279849673,1,bp,NAC,9314,KLF4
GO:0051222,positive regulation of protein transport,2/26,402/18493,0.10890787647803345,0.1622635322460634,0.09564061279849673,2,bp,NAC,3479/2810,IGF1/SFN
GO:0060415,muscle tissue morphogenesis,1/26,82/18493,0.10918772682669964,0.1622635322460634,0.09564061279849673,1,bp,NAC,1281,COL3A1
GO:0071158,positive regulation of cell cycle arrest,1/26,82/18493,0.10918772682669964,0.1622635322460634,0.09564061279849673,1,bp,NAC,2810,SFN
GO:0110110,positive regulation of animal organ morphogenesis,1/26,82/18493,0.10918772682669964,0.1622635322460634,0.09564061279849673,1,bp,NAC,10252,SPRY1
GO:0034637,cellular carbohydrate biosynthetic process,1/26,83/18493,0.11044573123181045,0.16329220304047384,0.09624692713039566,1,bp,NAC,3479,IGF1
GO:0042058,regulation of epidermal growth factor receptor signaling pathway,1/26,83/18493,0.11044573123181045,0.16329220304047384,0.09624692713039566,1,bp,NAC,10252,SPRY1
GO:0045582,positive regulation of T cell differentiation,1/26,83/18493,0.11044573123181045,0.16329220304047384,0.09624692713039566,1,bp,NAC,7704,ZBTB16
GO:0046849,bone remodeling,1/26,83/18493,0.11044573123181045,0.16329220304047384,0.09624692713039566,1,bp,NAC,3953,LEPR
GO:1903321,negative regulation of protein modification by small protein conjugation or removal,1/26,83/18493,0.11044573123181045,0.16329220304047384,0.09624692713039566,1,bp,NAC,3303,HSPA1A
GO:0035258,steroid hormone receptor binding,1/25,90/17632,0.12016691085432785,0.1636007340546873,0.08686764640071894,1,mf,NAC,3164,NR4A1
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,1/26,84/18493,0.11170202732023926,0.16414055542067746,0.09674695902535463,1,bp,NAC,3082,HGF
GO:0009896,positive regulation of catabolic process,2/26,407/18493,0.11116965678296765,0.16414055542067746,0.09674695902535463,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0034103,regulation of tissue remodeling,1/26,84/18493,0.11170202732023926,0.16414055542067746,0.09674695902535463,1,bp,NAC,3953,LEPR
GO:0046031,ADP metabolic process,1/26,84/18493,0.11170202732023926,0.16414055542067746,0.09674695902535463,1,bp,NAC,3479,IGF1
GO:0051781,positive regulation of cell division,1/26,84/18493,0.11170202732023926,0.16414055542067746,0.09674695902535463,1,bp,NAC,80310,PDGFD
GO:0097306,cellular response to alcohol,1/26,84/18493,0.11170202732023926,0.16414055542067746,0.09674695902535463,1,bp,NAC,9314,KLF4
R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,1/23,56/10554,0.11528703226665493,0.1645629412193381,0.08220807054668094,1,re,NAC,3303,HSPA1A
GO:0009897,external side of plasma membrane,2/26,359/19659,0.08110123229375256,0.16499905880453106,0.10597620190835183,2,cc,NAC,3977/3953,LIFR/LEPR
GO:0045445,myoblast differentiation,1/26,85/18493,0.11295661731913509,0.1651432611869422,0.09733796917171775,1,bp,NAC,3479,IGF1
GO:0048477,oogenesis,1/26,85/18493,0.11295661731913509,0.1651432611869422,0.09733796917171775,1,bp,NAC,3479,IGF1
GO:0071674,mononuclear cell migration,1/26,85/18493,0.11295661731913509,0.1651432611869422,0.09733796917171775,1,bp,NAC,80310,PDGFD
GO:0090049,regulation of cell migration involved in sprouting angiogenesis,1/26,85/18493,0.11295661731913509,0.1651432611869422,0.09733796917171775,1,bp,NAC,9314,KLF4
GO:1904035,regulation of epithelial cell apoptotic process,1/26,85/18493,0.11295661731913509,0.1651432611869422,0.09733796917171775,1,bp,NAC,6424,SFRP4
GO:1901987,regulation of cell cycle phase transition,2/26,412/18493,0.1134442773023094,0.16568835237574137,0.09765925427260386,2,bp,NAC,9314/2810,KLF4/SFN
GO:0000790,nuclear chromatin,2/26,369/19659,0.08501129513852365,0.16587163858882686,0.10653664565919302,2,cc,NAC,9314/3725,KLF4/JUN
GO:0005924,cell-substrate adherens junction,2/26,405/19659,0.09955198563361084,0.16587163858882686,0.10653664565919302,2,cc,NAC,2318/3303,FLNC/HSPA1A
GO:0005925,focal adhesion,2/26,402/19659,0.09831392572744882,0.16587163858882686,0.10653664565919302,2,cc,NAC,2318/3303,FLNC/HSPA1A
GO:0016234,inclusion body,1/26,80/19659,0.10065398490121913,0.16587163858882686,0.10653664565919302,1,cc,NAC,3303,HSPA1A
GO:0016528,sarcoplasm,1/26,76/19659,0.0958615385644902,0.16587163858882686,0.10653664565919302,1,cc,NAC,2318,FLNC
GO:0016607,nuclear speck,2/26,382/19659,0.09018057339883824,0.16587163858882686,0.10653664565919302,2,cc,NAC,7704/3303,ZBTB16/HSPA1A
GO:0030055,cell-substrate junction,2/26,409/19659,0.10120981337623335,0.16587163858882686,0.10653664565919302,2,cc,NAC,2318/3303,FLNC/HSPA1A
GO:0006029,proteoglycan metabolic process,1/26,86/18493,0.11420950345286529,0.16613338052669818,0.09792156068539384,1,bp,NAC,3479,IGF1
GO:0045844,positive regulation of striated muscle tissue development,1/26,86/18493,0.11420950345286529,0.16613338052669818,0.09792156068539384,1,bp,NAC,3479,IGF1
GO:0048524,positive regulation of viral process,1/26,86/18493,0.11420950345286529,0.16613338052669818,0.09792156068539384,1,bp,NAC,3725,JUN
GO:0048636,positive regulation of muscle organ development,1/26,86/18493,0.11420950345286529,0.16613338052669818,0.09792156068539384,1,bp,NAC,3479,IGF1
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,1/26,87/18493,0.11546068794301734,0.16694366002181765,0.09839915183836938,1,bp,NAC,2810,SFN
GO:0000280,nuclear division,2/26,416/18493,0.11527303499532277,0.16694366002181765,0.09839915183836938,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0006094,gluconeogenesis,1/26,87/18493,0.11546068794301734,0.16694366002181765,0.09839915183836938,1,bp,NAC,3953,LEPR
GO:0055013,cardiac muscle cell development,1/26,87/18493,0.11546068794301734,0.16694366002181765,0.09839915183836938,1,bp,NAC,3479,IGF1
GO:1900407,regulation of cellular response to oxidative stress,1/26,87/18493,0.11546068794301734,0.16694366002181765,0.09839915183836938,1,bp,NAC,3082,HGF
GO:1901863,positive regulation of muscle tissue development,1/26,87/18493,0.11546068794301734,0.16694366002181765,0.09839915183836938,1,bp,NAC,3479,IGF1
hsa00592,alpha-Linolenic acid metabolism,1/25,25/7852,0.07674224904298066,0.16755391041050777,0.10636206446307846,1,kg,NAC,5320,PLA2G2A
GO:0001892,embryonic placenta development,1/26,88/18493,0.11671017300840225,0.16790905249364352,0.09896816895711709,1,bp,NAC,9021,SOCS3
GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,1/26,88/18493,0.11671017300840225,0.16790905249364352,0.09896816895711709,1,bp,NAC,4804,NGFR
GO:0010717,regulation of epithelial to mesenchymal transition,1/26,88/18493,0.11671017300840225,0.16790905249364352,0.09896816895711709,1,bp,NAC,1277,COL1A1
GO:0030510,regulation of BMP signaling pathway,1/26,88/18493,0.11671017300840225,0.16790905249364352,0.09896816895711709,1,bp,NAC,6424,SFRP4
GO:0048644,muscle organ morphogenesis,1/26,88/18493,0.11671017300840225,0.16790905249364352,0.09896816895711709,1,bp,NAC,1281,COL3A1
GO:0001656,metanephros development,1/26,89/18493,0.11795796086506027,0.1689669242781515,0.0995916948001214,1,bp,NAC,10252,SPRY1
GO:0001819,positive regulation of cytokine production,2/26,422/18493,0.11803094918390623,0.1689669242781515,0.0995916948001214,2,bp,NAC,3303/3082,HSPA1A/HGF
GO:0009791,post-embryonic development,1/26,89/18493,0.11795796086506027,0.1689669242781515,0.0995916948001214,1,bp,NAC,9314,KLF4
GO:0032386,regulation of intracellular transport,2/26,422/18493,0.11803094918390623,0.1689669242781515,0.0995916948001214,2,bp,NAC,3479/2810,IGF1/SFN
GO:0033273,response to vitamin,1/26,89/18493,0.11795796086506027,0.1689669242781515,0.0995916948001214,1,bp,NAC,1277,COL1A1
GO:0019319,hexose biosynthetic process,1/26,90/18493,0.11920405372625886,0.16980399755872808,0.1000850786208938,1,bp,NAC,3953,LEPR
GO:0045638,negative regulation of myeloid cell differentiation,1/26,90/18493,0.11920405372625886,0.16980399755872808,0.1000850786208938,1,bp,NAC,7704,ZBTB16
GO:0051899,membrane depolarization,1/26,90/18493,0.11920405372625886,0.16980399755872808,0.1000850786208938,1,bp,NAC,3725,JUN
GO:0060333,interferon-gamma-mediated signaling pathway,1/26,90/18493,0.11920405372625886,0.16980399755872808,0.1000850786208938,1,bp,NAC,9021,SOCS3
GO:1901184,regulation of ERBB signaling pathway,1/26,90/18493,0.11920405372625886,0.16980399755872808,0.1000850786208938,1,bp,NAC,10252,SPRY1
GO:0031349,positive regulation of defense response,2/26,427/18493,0.1203424629396759,0.1707339084842947,0.10063318237247702,2,bp,NAC,5320/3303,PLA2G2A/HSPA1A
GO:0044070,regulation of anion transport,1/26,91/18493,0.12044845380250313,0.1707339084842947,0.10063318237247702,1,bp,NAC,6424,SFRP4
GO:0046634,regulation of alpha-beta T cell activation,1/26,91/18493,0.12044845380250313,0.1707339084842947,0.10063318237247702,1,bp,NAC,7704,ZBTB16
GO:0048525,negative regulation of viral process,1/26,91/18493,0.12044845380250313,0.1707339084842947,0.10063318237247702,1,bp,NAC,3725,JUN
GO:1904029,regulation of cyclin-dependent protein kinase activity,1/26,91/18493,0.12044845380250313,0.1707339084842947,0.10063318237247702,1,bp,NAC,2810,SFN
R-HSA-193648,NRAGE signals death through JNK,1/23,59/10554,0.12108978891819144,0.17146314110815908,0.08565509279265753,1,re,NAC,4804,NGFR
GO:0006165,nucleoside diphosphate phosphorylation,1/26,92/18493,0.12169116330153229,0.17215720455305011,0.1014720948892034,1,bp,NAC,3479,IGF1
GO:0010660,regulation of muscle cell apoptotic process,1/26,92/18493,0.12169116330153229,0.17215720455305011,0.1014720948892034,1,bp,NAC,3479,IGF1
GO:0007589,body fluid secretion,1/26,93/18493,0.12293218442832765,0.173064528907392,0.10200688576953915,1,bp,NAC,8835,SOCS2
GO:0015908,fatty acid transport,1/26,93/18493,0.12293218442832765,0.173064528907392,0.10200688576953915,1,bp,NAC,5320,PLA2G2A
GO:0036473,cell death in response to oxidative stress,1/26,93/18493,0.12293218442832765,0.173064528907392,0.10200688576953915,1,bp,NAC,3082,HGF
GO:0044728,DNA methylation or demethylation,1/26,93/18493,0.12293218442832765,0.173064528907392,0.10200688576953915,1,bp,NAC,2353,FOS
GO:1901655,cellular response to ketone,1/26,93/18493,0.12293218442832765,0.173064528907392,0.10200688576953915,1,bp,NAC,9314,KLF4
GO:0007389,pattern specification process,2/26,434/18493,0.12359828861790864,0.17328771999295772,0.10213843801605561,2,bp,NAC,10252/7704,SPRY1/ZBTB16
GO:0042035,regulation of cytokine biosynthetic process,1/26,94/18493,0.12417151938511317,0.17328771999295772,0.10213843801605561,1,bp,NAC,9314,KLF4
GO:0045621,positive regulation of lymphocyte differentiation,1/26,94/18493,0.12417151938511317,0.17328771999295772,0.10213843801605561,1,bp,NAC,7704,ZBTB16
GO:0046939,nucleotide phosphorylation,1/26,94/18493,0.12417151938511317,0.17328771999295772,0.10213843801605561,1,bp,NAC,3479,IGF1
GO:0050830,defense response to Gram-positive bacterium,1/26,94/18493,0.12417151938511317,0.17328771999295772,0.10213843801605561,1,bp,NAC,5320,PLA2G2A
GO:0060840,artery development,1/26,94/18493,0.12417151938511317,0.17328771999295772,0.10213843801605561,1,bp,NAC,1281,COL3A1
GO:1900542,regulation of purine nucleotide metabolic process,1/26,94/18493,0.12417151938511317,0.17328771999295772,0.10213843801605561,1,bp,NAC,3479,IGF1
GO:1903426,regulation of reactive oxygen species biosynthetic process,1/26,94/18493,0.12417151938511317,0.17328771999295772,0.10213843801605561,1,bp,NAC,9314,KLF4
GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,1/26,94/18493,0.12417151938511317,0.17328771999295772,0.10213843801605561,1,bp,NAC,3303,HSPA1A
hsa05226,Gastric cancer,2/25,149/7852,0.0807765856105595,0.17347102811448023,0.11011820989187576,2,kg,NAC,4616/3082,GADD45B/HGF
GO:0002683,negative regulation of immune system process,2/26,437/18493,0.12500052368452969,0.17410787227488062,0.10262184834088597,2,bp,NAC,7704/1281,ZBTB16/COL3A1
GO:1904951,positive regulation of establishment of protein localization,2/26,437/18493,0.12500052368452969,0.17410787227488062,0.10262184834088597,2,bp,NAC,3479/2810,IGF1/SFN
GO:0030316,osteoclast differentiation,1/26,95/18493,0.12540917037136234,0.17450861412331325,0.1028580517282249,1,bp,NAC,2353,FOS
GO:0001657,ureteric bud development,1/26,96/18493,0.12664513958379509,0.1745453069908465,0.10287967906671334,1,bp,NAC,10252,SPRY1
GO:0009135,purine nucleoside diphosphate metabolic process,1/26,96/18493,0.12664513958379509,0.1745453069908465,0.10287967906671334,1,bp,NAC,3479,IGF1
GO:0009179,purine ribonucleoside diphosphate metabolic process,1/26,96/18493,0.12664513958379509,0.1745453069908465,0.10287967906671334,1,bp,NAC,3479,IGF1
GO:0010657,muscle cell apoptotic process,1/26,96/18493,0.12664513958379509,0.1745453069908465,0.10287967906671334,1,bp,NAC,3479,IGF1
GO:0010771,negative regulation of cell morphogenesis involved in differentiation,1/26,96/18493,0.12664513958379509,0.1745453069908465,0.10287967906671334,1,bp,NAC,4804,NGFR
GO:0046364,monosaccharide biosynthetic process,1/26,96/18493,0.12664513958379509,0.1745453069908465,0.10287967906671334,1,bp,NAC,3953,LEPR
GO:0048259,regulation of receptor-mediated endocytosis,1/26,96/18493,0.12664513958379509,0.1745453069908465,0.10287967906671334,1,bp,NAC,6424,SFRP4
GO:0120162,positive regulation of cold-induced thermogenesis,1/26,96/18493,0.12664513958379509,0.1745453069908465,0.10287967906671334,1,bp,NAC,3953,LEPR
GO:1902882,regulation of response to oxidative stress,1/26,96/18493,0.12664513958379509,0.1745453069908465,0.10287967906671334,1,bp,NAC,3082,HGF
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,1/26,96/18493,0.12664513958379509,0.1745453069908465,0.10287967906671334,1,bp,NAC,3303,HSPA1A
GO:0042102,positive regulation of T cell proliferation,1/26,97/18493,0.12787942921638829,0.17540876079776452,0.10338861197402616,1,bp,NAC,3479,IGF1
GO:0055024,regulation of cardiac muscle tissue development,1/26,97/18493,0.12787942921638829,0.17540876079776452,0.10338861197402616,1,bp,NAC,3479,IGF1
GO:0062014,negative regulation of small molecule metabolic process,1/26,97/18493,0.12787942921638829,0.17540876079776452,0.10338861197402616,1,bp,NAC,3953,LEPR
GO:0072163,mesonephric epithelium development,1/26,97/18493,0.12787942921638829,0.17540876079776452,0.10338861197402616,1,bp,NAC,10252,SPRY1
GO:0072164,mesonephric tubule development,1/26,97/18493,0.12787942921638829,0.17540876079776452,0.10338861197402616,1,bp,NAC,10252,SPRY1
R-HSA-8943724,Regulation of PTEN gene transcription,1/23,61/10554,0.12493804907935468,0.17550821180195061,0.08767582391533664,1,re,NAC,3725,JUN
GO:0002768,immune response-regulating cell surface receptor signaling pathway,2/26,445/18493,0.12875945697475777,0.17609515673659845,0.10379318426025572,2,bp,NAC,2353/3725,FOS/JUN
GO:0006140,regulation of nucleotide metabolic process,1/26,98/18493,0.12911204146037503,0.17609515673659845,0.10379318426025572,1,bp,NAC,3479,IGF1
GO:0009185,ribonucleoside diphosphate metabolic process,1/26,98/18493,0.12911204146037503,0.17609515673659845,0.10379318426025572,1,bp,NAC,3479,IGF1
GO:0010596,negative regulation of endothelial cell migration,1/26,98/18493,0.12911204146037503,0.17609515673659845,0.10379318426025572,1,bp,NAC,9314,KLF4
GO:0044773,mitotic DNA damage checkpoint,1/26,98/18493,0.12911204146037503,0.17609515673659845,0.10379318426025572,1,bp,NAC,2810,SFN
GO:2000379,positive regulation of reactive oxygen species metabolic process,1/26,98/18493,0.12911204146037503,0.17609515673659845,0.10379318426025572,1,bp,NAC,9314,KLF4
GO:0004620,phospholipase activity,1/25,99/17632,0.1313903931632393,0.1767513622315005,0.09385028083088522,1,mf,NAC,5320,PLA2G2A
GO:0044264,cellular polysaccharide metabolic process,1/26,99/18493,0.13034297850424714,0.17760615484573053,0.10468378970372416,1,bp,NAC,3479,IGF1
hsa04921,Oxytocin signaling pathway,2/25,153/7852,0.0845392450639885,0.17788620664267915,0.11292093471090117,2,kg,NAC,2353/3725,FOS/JUN
hsa05165,Human papillomavirus infection,3/25,330/7852,0.08554832838541057,0.17788620664267915,0.11292093471090117,3,kg,NAC,3679/1277/1278,ITGA7/COL1A1/COL1A2
GO:0043254,regulation of protein complex assembly,2/26,451/18493,0.13159691898716988,0.1788082430305896,0.10539231890339307,2,bp,NAC,3725/3303,JUN/HSPA1A
GO:0050848,regulation of calcium-mediated signaling,1/26,100/18493,0.13157224253376154,0.1788082430305896,0.10539231890339307,1,bp,NAC,3479,IGF1
GO:0055017,cardiac muscle tissue growth,1/26,100/18493,0.13157224253376154,0.1788082430305896,0.10539231890339307,1,bp,NAC,3479,IGF1
R-HSA-375165,NCAM signaling for neurite out-growth,1/23,63/10554,0.1287701893573,0.1794671143011189,0.08965350937433236,1,re,NAC,1281,COL3A1
hsa00591,Linoleic acid metabolism,1/25,29/7852,0.08848390017952634,0.18001086599930308,0.11426965378822773,1,kg,NAC,5320,PLA2G2A
hsa04310,Wnt signaling pathway,2/25,158/7852,0.0893183686256084,0.18001086599930308,0.11426965378822773,2,kg,NAC,3725/6424,JUN/SFRP4
GO:0046632,alpha-beta T cell differentiation,1/26,101/18493,0.13279983573194176,0.18010353661766162,0.1061557847956163,1,bp,NAC,7704,ZBTB16
GO:1904659,glucose transmembrane transport,1/26,101/18493,0.13279983573194176,0.18010353661766162,0.1061557847956163,1,bp,NAC,3479,IGF1
GO:0003012,muscle system process,2/26,456/18493,0.13397307726520735,0.18091597014285524,0.10663464556693077,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,1/26,102/18493,0.13402576027907986,0.18091597014285524,0.10663464556693077,1,bp,NAC,2810,SFN
GO:0035567,non-canonical Wnt signaling pathway,1/26,102/18493,0.13402576027907986,0.18091597014285524,0.10663464556693077,1,bp,NAC,6424,SFRP4
GO:0042136,neurotransmitter biosynthetic process,1/26,102/18493,0.13402576027907986,0.18091597014285524,0.10663464556693077,1,bp,NAC,9314,KLF4
GO:2001023,regulation of response to drug,1/26,102/18493,0.13402576027907986,0.18091597014285524,0.10663464556693077,1,bp,NAC,3082,HGF
GO:0048285,organelle fission,2/26,458/18493,0.1349264346061905,0.1819615375109653,0.1072509189983295,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:1901800,positive regulation of proteasomal protein catabolic process,1/26,103/18493,0.13525001835274342,0.18222761576378035,0.10740774959852248,1,bp,NAC,3303,HSPA1A
GO:0042562,hormone binding,1/25,104/17632,0.13756613748388125,0.1828820415962186,0.09710550881215148,1,mf,NAC,3953,LEPR
GO:0030282,bone mineralization,1/26,104/18493,0.13647261212777473,0.18336124702083698,0.10807592923575614,1,bp,NAC,3479,IGF1
GO:0030330,"DNA damage response, signal transduction by p53 class mediator",1/26,104/18493,0.13647261212777473,0.18336124702083698,0.10807592923575614,1,bp,NAC,2810,SFN
GO:0034605,cellular response to heat,1/26,104/18493,0.13647261212777473,0.18336124702083698,0.10807592923575614,1,bp,NAC,3303,HSPA1A
R-HSA-5683057,MAPK family signaling cascades,2/23,293/10554,0.13283642787196848,0.1836878729167064,0.0917620060957677,2,re,NAC,3725/3082,JUN/HGF
GO:0042089,cytokine biosynthetic process,1/26,105/18493,0.1376935437762975,0.18431519820890285,0.10863820268650365,1,bp,NAC,9314,KLF4
GO:0043467,regulation of generation of precursor metabolites and energy,1/26,105/18493,0.1376935437762975,0.18431519820890285,0.10863820268650365,1,bp,NAC,3479,IGF1
GO:0051225,spindle assembly,1/26,105/18493,0.1376935437762975,0.18431519820890285,0.10863820268650365,1,bp,NAC,3303,HSPA1A
GO:0097006,regulation of plasma lipoprotein particle levels,1/26,105/18493,0.1376935437762975,0.18431519820890285,0.10863820268650365,1,bp,NAC,5320,PLA2G2A
GO:0006914,autophagy,2/26,466/18493,0.1387560077531037,0.18474764305982927,0.10889309230940078,2,bp,NAC,3953/3082,LEPR/HGF
GO:0019359,nicotinamide nucleotide biosynthetic process,1/26,106/18493,0.1389128154677164,0.18474764305982927,0.10889309230940078,1,bp,NAC,3479,IGF1
GO:0019363,pyridine nucleotide biosynthetic process,1/26,106/18493,0.1389128154677164,0.18474764305982927,0.10889309230940078,1,bp,NAC,3479,IGF1
GO:0031109,microtubule polymerization or depolymerization,1/26,106/18493,0.1389128154677164,0.18474764305982927,0.10889309230940078,1,bp,NAC,3303,HSPA1A
GO:0032963,collagen metabolic process,1/26,106/18493,0.1389128154677164,0.18474764305982927,0.10889309230940078,1,bp,NAC,1277,COL1A1
GO:0042107,cytokine metabolic process,1/26,106/18493,0.1389128154677164,0.18474764305982927,0.10889309230940078,1,bp,NAC,9314,KLF4
GO:0061919,process utilizing autophagic mechanism,2/26,466/18493,0.1387560077531037,0.18474764305982927,0.10889309230940078,2,bp,NAC,3953/3082,LEPR/HGF
GO:0003300,cardiac muscle hypertrophy,1/26,107/18493,0.14013042936872455,0.185172353094386,0.10914342291298385,1,bp,NAC,3479,IGF1
GO:0006275,regulation of DNA replication,1/26,107/18493,0.14013042936872455,0.185172353094386,0.10914342291298385,1,bp,NAC,3725,JUN
GO:0031623,receptor internalization,1/26,107/18493,0.14013042936872455,0.185172353094386,0.10914342291298385,1,bp,NAC,6424,SFRP4
GO:0044774,mitotic DNA integrity checkpoint,1/26,107/18493,0.14013042936872455,0.185172353094386,0.10914342291298385,1,bp,NAC,2810,SFN
GO:0048640,negative regulation of developmental growth,1/26,107/18493,0.14013042936872455,0.185172353094386,0.10914342291298385,1,bp,NAC,8835,SOCS2
GO:0060419,heart growth,1/26,107/18493,0.14013042936872455,0.185172353094386,0.10914342291298385,1,bp,NAC,3479,IGF1
GO:0071156,regulation of cell cycle arrest,1/26,107/18493,0.14013042936872455,0.185172353094386,0.10914342291298385,1,bp,NAC,2810,SFN
GO:0047485,protein N-terminus binding,1/25,107/17632,0.14125132732885715,0.18559767428094018,0.09854743767129569,1,mf,NAC,3303,HSPA1A
GO:0007052,mitotic spindle organization,1/26,108/18493,0.1413463876433041,0.18575850397931495,0.1094889092280603,1,bp,NAC,3303,HSPA1A
GO:0008645,hexose transmembrane transport,1/26,108/18493,0.1413463876433041,0.18575850397931495,0.1094889092280603,1,bp,NAC,3479,IGF1
GO:0014902,myotube differentiation,1/26,108/18493,0.1413463876433041,0.18575850397931495,0.1094889092280603,1,bp,NAC,3479,IGF1
GO:0046620,regulation of organ growth,1/26,108/18493,0.1413463876433041,0.18575850397931495,0.1094889092280603,1,bp,NAC,3479,IGF1
GO:0048871,multicellular organismal homeostasis,2/26,471/18493,0.14116229155137394,0.18575850397931495,0.1094889092280603,2,bp,NAC,3953/2810,LEPR/SFN
GO:1904019,epithelial cell apoptotic process,1/26,108/18493,0.1413463876433041,0.18575850397931495,0.1094889092280603,1,bp,NAC,6424,SFRP4
GO:0051249,regulation of lymphocyte activation,2/26,472/18493,0.14164470289721748,0.18598117041008627,0.10962015223499998,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0005976,polysaccharide metabolic process,1/26,109/18493,0.1425606924527285,0.18657043465151102,0.10996747361011118,1,bp,NAC,3479,IGF1
GO:0014897,striated muscle hypertrophy,1/26,109/18493,0.1425606924527285,0.18657043465151102,0.10996747361011118,1,bp,NAC,3479,IGF1
GO:0022604,regulation of cell morphogenesis,2/26,474/18493,0.14261066487915222,0.18657043465151102,0.10996747361011118,2,bp,NAC,4804/3679,NGFR/ITGA7
GO:0072525,pyridine-containing compound biosynthetic process,1/26,109/18493,0.1425606924527285,0.18657043465151102,0.10996747361011118,1,bp,NAC,3479,IGF1
hsa05161,Hepatitis B,2/25,163/7852,0.09417836634699131,0.18692978774933125,0.11866173750258872,2,kg,NAC,2353/3725,FOS/JUN
GO:0015749,monosaccharide transmembrane transport,1/26,110/18493,0.14377334595556945,0.1877510753066848,0.11066336130707323,1,bp,NAC,3479,IGF1
GO:1903510,mucopolysaccharide metabolic process,1/26,110/18493,0.14377334595556945,0.1877510753066848,0.11066336130707323,1,bp,NAC,3082,HGF
GO:0014896,muscle hypertrophy,1/26,111/18493,0.14498435030769719,0.1888198713844829,0.11129332609597124,1,bp,NAC,3479,IGF1
GO:0021987,cerebral cortex development,1/26,111/18493,0.14498435030769719,0.1888198713844829,0.11129332609597124,1,bp,NAC,1281,COL3A1
GO:0030218,erythrocyte differentiation,1/26,111/18493,0.14498435030769719,0.1888198713844829,0.11129332609597124,1,bp,NAC,3303,HSPA1A
GO:0006304,DNA modification,1/26,112/18493,0.1461937076622828,0.18903003598268284,0.11141720033118704,1,bp,NAC,2353,FOS
GO:0010822,positive regulation of mitochondrion organization,1/26,112/18493,0.1461937076622828,0.18903003598268284,0.11141720033118704,1,bp,NAC,2810,SFN
GO:0031667,response to nutrient levels,2/26,481/18493,0.14600329526471675,0.18903003598268284,0.11141720033118704,2,bp,NAC,3725/1277,JUN/COL1A1
GO:0034219,carbohydrate transmembrane transport,1/26,112/18493,0.1461937076622828,0.18903003598268284,0.11141720033118704,1,bp,NAC,3479,IGF1
GO:0043087,regulation of GTPase activity,2/26,481/18493,0.14600329526471675,0.18903003598268284,0.11141720033118704,2,bp,NAC,3725/10252,JUN/SPRY1
GO:0046717,acid secretion,1/26,112/18493,0.1461937076622828,0.18903003598268284,0.11141720033118704,1,bp,NAC,5320,PLA2G2A
GO:0051149,positive regulation of muscle cell differentiation,1/26,112/18493,0.1461937076622828,0.18903003598268284,0.11141720033118704,1,bp,NAC,3479,IGF1
GO:0051817,modification of morphology or physiology of other organism involved in symbiotic interaction,1/26,112/18493,0.1461937076622828,0.18903003598268284,0.11141720033118704,1,bp,NAC,3725,JUN
R-HSA-3371453,Regulation of HSF1-mediated heat shock response,1/23,68/10554,0.13828043802481427,0.18973362426660562,0.09478218518224724,1,re,NAC,3303,HSPA1A
GO:0006090,pyruvate metabolic process,1/26,113/18493,0.14740142016980617,0.19008065174712271,0.11203644936475554,1,bp,NAC,3479,IGF1
GO:0008543,fibroblast growth factor receptor signaling pathway,1/26,113/18493,0.14740142016980617,0.19008065174712271,0.11203644936475554,1,bp,NAC,10252,SPRY1
GO:0051153,regulation of striated muscle cell differentiation,1/26,113/18493,0.14740142016980617,0.19008065174712271,0.11203644936475554,1,bp,NAC,3479,IGF1
R-HSA-909733,Interferon alpha/beta signaling,1/23,69/10554,0.1401705343366041,0.19084757367368405,0.09533866303056472,1,re,NAC,9021,SOCS3
GO:0042552,myelination,1/26,114/18493,0.1486074899780535,0.19146482860565286,0.1128523044194241,1,bp,NAC,3082,HGF
R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,1/23,70/10554,0.14205666478107293,0.19193915775763287,0.0958839681929299,1,re,NAC,2810,SFN
GO:0009150,purine ribonucleotide metabolic process,2/26,488/18493,0.14941373346153086,0.19233186207403125,0.11336334723406445,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0010633,negative regulation of epithelial cell migration,1/26,115/18493,0.14981191923212434,0.1925009790311268,0.11346302736050659,1,bp,NAC,9314,KLF4
GO:1903409,reactive oxygen species biosynthetic process,1/26,115/18493,0.14981191923212434,0.1925009790311268,0.11346302736050659,1,bp,NAC,9314,KLF4
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,1/23,71/10554,0.14393883730206092,0.19265100695072715,0.09623957528314649,1,re,NAC,3082,HGF
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,2/23,309/10554,0.14476036115506616,0.19265100695072715,0.09623957528314649,2,re,NAC,7704/9021,ZBTB16/SOCS3
hsa04215,Apoptosis - multiple species,1/25,33/7852,0.10008212533522143,0.19280527086638247,0.1223914535833203,1,kg,NAC,4804,NGFR
hsa05225,Hepatocellular carcinoma,2/25,168/7852,0.09911573191795187,0.19280527086638247,0.1223914535833203,2,kg,NAC,4616/3082,GADD45B/HGF
GO:0006754,ATP biosynthetic process,1/26,116/18493,0.151014710074434,0.19335778761083255,0.11396804346905402,1,bp,NAC,3479,IGF1
GO:0007272,ensheathment of neurons,1/26,116/18493,0.151014710074434,0.19335778761083255,0.11396804346905402,1,bp,NAC,3082,HGF
GO:0008366,axon ensheathment,1/26,116/18493,0.151014710074434,0.19335778761083255,0.11396804346905402,1,bp,NAC,3082,HGF
GO:0009132,nucleoside diphosphate metabolic process,1/26,116/18493,0.151014710074434,0.19335778761083255,0.11396804346905402,1,bp,NAC,3479,IGF1
GO:0016605,PML body,1/26,98/19659,0.12191938569833471,0.19441199341085805,0.12486764964836558,1,cc,NAC,7704,ZBTB16
GO:0002062,chondrocyte differentiation,1/26,117/18493,0.15221586464471537,0.1945504806752208,0.1146710350407254,1,bp,NAC,7704,ZBTB16
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,1/26,117/18493,0.15221586464471537,0.1945504806752208,0.1146710350407254,1,bp,NAC,3303,HSPA1A
GO:0051051,negative regulation of transport,2/26,495/18493,0.15284134336542426,0.1951770428993869,0.11504034041850285,2,bp,NAC,6424/3303,SFRP4/HSPA1A
GO:0019730,antimicrobial humoral response,1/26,118/18493,0.15341538508002417,0.19539135098894517,0.11516665689102944,1,bp,NAC,5320,PLA2G2A
GO:0043488,regulation of mRNA stability,1/26,118/18493,0.15341538508002417,0.19539135098894517,0.11516665689102944,1,bp,NAC,3303,HSPA1A
GO:1903052,positive regulation of proteolysis involved in cellular protein catabolic process,1/26,118/18493,0.15341538508002417,0.19539135098894517,0.11516665689102944,1,bp,NAC,3303,HSPA1A
GO:0031072,heat shock protein binding,1/25,115/17632,0.15100474374301442,0.19613259819494977,0.10414120258138929,1,mf,NAC,3303,HSPA1A
GO:0033209,tumor necrosis factor-mediated signaling pathway,1/26,119/18493,0.15461327351474086,0.19639696626916467,0.11575938194950945,1,bp,NAC,3303,HSPA1A
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,1/26,119/18493,0.15461327351474086,0.19639696626916467,0.11575938194950945,1,bp,NAC,3303,HSPA1A
GO:1905477,positive regulation of protein localization to membrane,1/26,119/18493,0.15461327351474086,0.19639696626916467,0.11575938194950945,1,bp,NAC,2810,SFN
GO:0007173,epidermal growth factor receptor signaling pathway,1/26,120/18493,0.15580953208057402,0.19739521930840062,0.1163477675903182,1,bp,NAC,10252,SPRY1
GO:0022612,gland morphogenesis,1/26,120/18493,0.15580953208057402,0.19739521930840062,0.1163477675903182,1,bp,NAC,3082,HGF
GO:0034101,erythrocyte homeostasis,1/26,120/18493,0.15580953208057402,0.19739521930840062,0.1163477675903182,1,bp,NAC,3303,HSPA1A
GO:0002687,positive regulation of leukocyte migration,1/26,121/18493,0.15700416290656327,0.19838617081801296,0.11693184959766166,1,bp,NAC,80310,PDGFD
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,1/26,121/18493,0.15700416290656327,0.19838617081801296,0.11693184959766166,1,bp,NAC,3303,HSPA1A
GO:0046718,viral entry into host cell,1/26,121/18493,0.15700416290656327,0.19838617081801296,0.11693184959766166,1,bp,NAC,3303,HSPA1A
GO:1903038,negative regulation of leukocyte cell-cell adhesion,1/26,122/18493,0.15819716811908424,0.19971873455453942,0.11771728308718522,1,bp,NAC,9314,KLF4
GO:0032675,regulation of interleukin-6 production,1/26,123/18493,0.1593885498418487,0.20087133399282767,0.11839664286114801,1,bp,NAC,3082,HGF
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1/26,123/18493,0.1593885498418487,0.20087133399282767,0.11839664286114801,1,bp,NAC,3303,HSPA1A
hsa05020,Prion diseases,1/25,35/7852,0.10582797885386497,0.20091978593994653,0.1275424916774269,1,kg,NAC,3303,HSPA1A
R-HSA-204998,"Cell death signalling via NRAGE, NRIF and NADE",1/23,76/10554,0.1532906080298042,0.20248087777071153,0.10115012627261237,1,re,NAC,4804,NGFR
GO:0005179,hormone activity,1/25,121/17632,0.1582499240938544,0.20320728889324488,0.10789767551853711,1,mf,NAC,3479,IGF1
GO:0030326,embryonic limb morphogenesis,1/26,125/18493,0.16176645129966694,0.20333535646813536,0.11984897547233714,1,bp,NAC,7704,ZBTB16
GO:0035113,embryonic appendage morphogenesis,1/26,125/18493,0.16176645129966694,0.20333535646813536,0.11984897547233714,1,bp,NAC,7704,ZBTB16
GO:0048706,embryonic skeletal system development,1/26,125/18493,0.16176645129966694,0.20333535646813536,0.11984897547233714,1,bp,NAC,1277,COL1A1
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,1/26,126/18493,0.16295297526886376,0.20447055940258296,0.12051808148031297,1,bp,NAC,4804,NGFR
GO:0043487,regulation of RNA stability,1/26,126/18493,0.16295297526886376,0.20447055940258296,0.12051808148031297,1,bp,NAC,3303,HSPA1A
GO:0009206,purine ribonucleoside triphosphate biosynthetic process,1/26,127/18493,0.16413788421659692,0.2055997976775602,0.12118367182658106,1,bp,NAC,3479,IGF1
GO:0031644,regulation of neurological system process,1/26,127/18493,0.16413788421659692,0.2055997976775602,0.12118367182658106,1,bp,NAC,3082,HGF
GO:0009145,purine nucleoside triphosphate biosynthetic process,1/26,128/18493,0.16532118025331477,0.20672310494413626,0.12184576634559732,1,bp,NAC,3479,IGF1
GO:0030010,establishment of cell polarity,1/26,128/18493,0.16532118025331477,0.20672310494413626,0.12184576634559732,1,bp,NAC,10252,SPRY1
GO:0016363,nuclear matrix,1/26,108/19659,0.13352370893400567,0.20731312702911406,0.1331538371641054,1,cc,NAC,862,RUNX1T1
GO:0016298,lipase activity,1/25,127/17632,0.165435728196765,0.20771374762482717,0.11029048546451,1,mf,NAC,5320,PLA2G2A
GO:0051082,unfolded protein binding,1/25,127/17632,0.165435728196765,0.20771374762482717,0.11029048546451,1,mf,NAC,3303,HSPA1A
GO:0032273,positive regulation of protein polymerization,1/26,129/18493,0.16650286548682502,0.2078405146172046,0.12250438473261212,1,bp,NAC,3303,HSPA1A
GO:0055007,cardiac muscle cell differentiation,1/26,129/18493,0.16650286548682502,0.2078405146172046,0.12250438473261212,1,bp,NAC,3479,IGF1
hsa05216,Thyroid cancer,1/25,37/7852,0.11153860433647278,0.2087365309725419,0.13250450740723835,1,kg,NAC,4616,GADD45B
GO:0042770,signal transduction in response to DNA damage,1/26,130/18493,0.16768294202229328,0.20895205987752088,0.12315954654487136,1,bp,NAC,2810,SFN
GO:0050921,positive regulation of chemotaxis,1/26,130/18493,0.16768294202229328,0.20895205987752088,0.12315954654487136,1,bp,NAC,80310,PDGFD
GO:0007498,mesoderm development,1/26,131/18493,0.1688614119622498,0.20987684535876527,0.12370462928101712,1,bp,NAC,9314,KLF4
GO:0048565,digestive tract development,1/26,131/18493,0.1688614119622498,0.20987684535876527,0.12370462928101712,1,bp,NAC,1281,COL3A1
GO:0050777,negative regulation of immune response,1/26,131/18493,0.1688614119622498,0.20987684535876527,0.12370462928101712,1,bp,NAC,1281,COL3A1
GO:0009201,ribonucleoside triphosphate biosynthetic process,1/26,133/18493,0.17121354045258108,0.21080301951627517,0.12425053052423704,1,bp,NAC,3479,IGF1
GO:0030260,entry into host cell,1/26,133/18493,0.17121354045258108,0.21080301951627517,0.12425053052423704,1,bp,NAC,3303,HSPA1A
GO:0032635,interleukin-6 production,1/26,132/18493,0.17003827740659083,0.21080301951627517,0.12425053052423704,1,bp,NAC,3082,HGF
GO:0032946,positive regulation of mononuclear cell proliferation,1/26,133/18493,0.17121354045258108,0.21080301951627517,0.12425053052423704,1,bp,NAC,3479,IGF1
GO:0034620,cellular response to unfolded protein,1/26,133/18493,0.17121354045258108,0.21080301951627517,0.12425053052423704,1,bp,NAC,3303,HSPA1A
GO:0044409,entry into host,1/26,133/18493,0.17121354045258108,0.21080301951627517,0.12425053052423704,1,bp,NAC,3303,HSPA1A
GO:0050671,positive regulation of lymphocyte proliferation,1/26,132/18493,0.17003827740659083,0.21080301951627517,0.12425053052423704,1,bp,NAC,3479,IGF1
GO:0050729,positive regulation of inflammatory response,1/26,133/18493,0.17121354045258108,0.21080301951627517,0.12425053052423704,1,bp,NAC,5320,PLA2G2A
GO:0051806,entry into cell of other organism involved in symbiotic interaction,1/26,133/18493,0.17121354045258108,0.21080301951627517,0.12425053052423704,1,bp,NAC,3303,HSPA1A
GO:0051828,entry into other organism involved in symbiotic interaction,1/26,133/18493,0.17121354045258108,0.21080301951627517,0.12425053052423704,1,bp,NAC,3303,HSPA1A
GO:0090090,negative regulation of canonical Wnt signaling pathway,1/26,133/18493,0.17121354045258108,0.21080301951627517,0.12425053052423704,1,bp,NAC,6424,SFRP4
GO:0007292,female gamete generation,1/26,134/18493,0.17238720319485923,0.21170615677462287,0.12478285346602129,1,bp,NAC,3479,IGF1
GO:0046631,alpha-beta T cell activation,1/26,134/18493,0.17238720319485923,0.21170615677462287,0.12478285346602129,1,bp,NAC,7704,ZBTB16
GO:1905330,regulation of morphogenesis of an epithelium,1/26,134/18493,0.17238720319485923,0.21170615677462287,0.12478285346602129,1,bp,NAC,3082,HGF
GO:0033135,regulation of peptidyl-serine phosphorylation,1/26,135/18493,0.1735592677254405,0.21260273627148613,0.12531131116268066,1,bp,NAC,3082,HGF
GO:0043484,regulation of RNA splicing,1/26,135/18493,0.1735592677254405,0.21260273627148613,0.12531131116268066,1,bp,NAC,3303,HSPA1A
GO:0072655,establishment of protein localization to mitochondrion,1/26,135/18493,0.1735592677254405,0.21260273627148613,0.12531131116268066,1,bp,NAC,2810,SFN
GO:0070851,growth factor receptor binding,1/25,132/17632,0.17137887808077445,0.21281113432008256,0.11299706247084032,1,mf,NAC,80310,PDGFD
GO:0035023,regulation of Rho protein signal transduction,1/26,136/18493,0.17472973613371645,0.2136737366448753,0.12594257519718366,1,bp,NAC,1281,COL3A1
GO:0072006,nephron development,1/26,136/18493,0.17472973613371645,0.2136737366448753,0.12594257519718366,1,bp,NAC,80310,PDGFD
GO:0045580,regulation of T cell differentiation,1/26,137/18493,0.17589861050646427,0.21492099488639116,0.12667772832053403,1,bp,NAC,7704,ZBTB16
GO:1903364,positive regulation of cellular protein catabolic process,1/26,138/18493,0.17706589292784314,0.21616419923424504,0.127410492016829,1,bp,NAC,3303,HSPA1A
hsa05167,Kaposi sarcoma-associated herpesvirus infection,2/25,186/7852,0.1174787480544715,0.21675656331177137,0.13759556851450333,2,kg,NAC,2353/3725,FOS/JUN
GO:0070585,protein localization to mitochondrion,1/26,139/18493,0.17823158547940254,0.21721974480302186,0.12803264675262915,1,bp,NAC,2810,SFN
GO:0070665,positive regulation of leukocyte proliferation,1/26,139/18493,0.17823158547940254,0.21721974480302186,0.12803264675262915,1,bp,NAC,3479,IGF1
GO:0009166,nucleotide catabolic process,1/26,140/18493,0.17939569024008362,0.21790234092292987,0.12843497936734674,1,bp,NAC,3479,IGF1
GO:0046330,positive regulation of JNK cascade,1/26,140/18493,0.17939569024008362,0.21790234092292987,0.12843497936734674,1,bp,NAC,4616,GADD45B
GO:0061013,regulation of mRNA catabolic process,1/26,140/18493,0.17939569024008362,0.21790234092292987,0.12843497936734674,1,bp,NAC,3303,HSPA1A
GO:0072073,kidney epithelium development,1/26,140/18493,0.17939569024008362,0.21790234092292987,0.12843497936734674,1,bp,NAC,10252,SPRY1
GO:0008643,carbohydrate transport,1/26,141/18493,0.18055820928622046,0.21839521877620802,0.12872548912804174,1,bp,NAC,3479,IGF1
GO:0009127,purine nucleoside monophosphate biosynthetic process,1/26,141/18493,0.18055820928622046,0.21839521877620802,0.12872548912804174,1,bp,NAC,3479,IGF1
GO:0009168,purine ribonucleoside monophosphate biosynthetic process,1/26,141/18493,0.18055820928622046,0.21839521877620802,0.12872548912804174,1,bp,NAC,3479,IGF1
GO:0030879,mammary gland development,1/26,141/18493,0.18055820928622046,0.21839521877620802,0.12872548912804174,1,bp,NAC,8835,SOCS2
GO:0045807,positive regulation of endocytosis,1/26,141/18493,0.18055820928622046,0.21839521877620802,0.12872548912804174,1,bp,NAC,6424,SFRP4
GO:0007605,sensory perception of sound,1/26,142/18493,0.18171914469154749,0.21888207494983558,0.12901244961846092,1,bp,NAC,1277,COL1A1
GO:0062013,positive regulation of small molecule metabolic process,1/26,142/18493,0.18171914469154749,0.21888207494983558,0.12901244961846092,1,bp,NAC,3479,IGF1
GO:0106106,cold-induced thermogenesis,1/26,142/18493,0.18171914469154749,0.21888207494983558,0.12901244961846092,1,bp,NAC,3953,LEPR
GO:0120161,regulation of cold-induced thermogenesis,1/26,142/18493,0.18171914469154749,0.21888207494983558,0.12901244961846092,1,bp,NAC,3953,LEPR
GO:2000241,regulation of reproductive process,1/26,142/18493,0.18171914469154749,0.21888207494983558,0.12901244961846092,1,bp,NAC,3479,IGF1
GO:0038127,ERBB signaling pathway,1/26,143/18493,0.18287849852719784,0.21972828757264487,0.1295112203076172,1,bp,NAC,10252,SPRY1
GO:0055123,digestive system development,1/26,143/18493,0.18287849852719784,0.21972828757264487,0.1295112203076172,1,bp,NAC,1281,COL3A1
GO:2001056,positive regulation of cysteine-type endopeptidase activity,1/26,143/18493,0.18287849852719784,0.21972828757264487,0.1295112203076172,1,bp,NAC,4804,NGFR
R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,1/23,84/10554,0.16805049602140731,0.2203328725614007,0.1100681611368282,1,re,NAC,9314,KLF4
GO:0052689,carboxylic ester hydrolase activity,1/25,139/17632,0.1796310701076289,0.2206338143713268,0.11715069789627973,1,mf,NAC,5320,PLA2G2A
GO:0008203,cholesterol metabolic process,1/26,144/18493,0.18403627286170965,0.22075173876928264,0.13011445812859201,1,bp,NAC,3953,LEPR
GO:0019827,stem cell population maintenance,1/26,144/18493,0.18403627286170965,0.22075173876928264,0.13011445812859201,1,bp,NAC,9314,KLF4
GO:0009142,nucleoside triphosphate biosynthetic process,1/26,145/18493,0.185192469761028,0.2215860148135683,0.1306061932154234,1,bp,NAC,3479,IGF1
GO:0019362,pyridine nucleotide metabolic process,1/26,145/18493,0.185192469761028,0.2215860148135683,0.1306061932154234,1,bp,NAC,3479,IGF1
GO:0046496,nicotinamide nucleotide metabolic process,1/26,145/18493,0.185192469761028,0.2215860148135683,0.1306061932154234,1,bp,NAC,3479,IGF1
GO:0000077,DNA damage checkpoint,1/26,146/18493,0.1863470912885088,0.2216808348963876,0.13066208162547413,1,bp,NAC,2810,SFN
GO:0002262,myeloid cell homeostasis,1/26,146/18493,0.1863470912885088,0.2216808348963876,0.13066208162547413,1,bp,NAC,3303,HSPA1A
GO:0009267,cellular response to starvation,1/26,146/18493,0.1863470912885088,0.2216808348963876,0.13066208162547413,1,bp,NAC,3725,JUN
GO:0035107,appendage morphogenesis,1/26,146/18493,0.1863470912885088,0.2216808348963876,0.13066208162547413,1,bp,NAC,7704,ZBTB16
GO:0035108,limb morphogenesis,1/26,146/18493,0.1863470912885088,0.2216808348963876,0.13066208162547413,1,bp,NAC,7704,ZBTB16
GO:0051092,positive regulation of NF-kappaB transcription factor activity,1/26,146/18493,0.1863470912885088,0.2216808348963876,0.13066208162547413,1,bp,NAC,3303,HSPA1A
GO:1901292,nucleoside phosphate catabolic process,1/26,146/18493,0.1863470912885088,0.2216808348963876,0.13066208162547413,1,bp,NAC,3479,IGF1
GO:0010770,positive regulation of cell morphogenesis involved in differentiation,1/26,147/18493,0.18750013950492028,0.22250222146842102,0.13114621945981264,1,bp,NAC,4804,NGFR
GO:0043524,negative regulation of neuron apoptotic process,1/26,147/18493,0.18750013950492028,0.22250222146842102,0.13114621945981264,1,bp,NAC,3725,JUN
GO:2000058,regulation of ubiquitin-dependent protein catabolic process,1/26,147/18493,0.18750013950492028,0.22250222146842102,0.13114621945981264,1,bp,NAC,3303,HSPA1A
GO:0005814,centriole,1/26,133/19659,0.16189298974672717,0.22305804877500554,0.14326654337020875,1,cc,NAC,3303,HSPA1A
GO:0030018,Z disc,1/26,126/19659,0.15404091574259404,0.22305804877500554,0.14326654337020875,1,cc,NAC,2318,FLNC
GO:0031674,I band,1/26,137/19659,0.16634837535763125,0.22305804877500554,0.14326654337020875,1,cc,NAC,2318,FLNC
GO:0034399,nuclear periphery,1/26,134/19659,0.16300897777635825,0.22305804877500554,0.14326654337020875,1,cc,NAC,862,RUNX1T1
GO:0042383,sarcolemma,1/26,133/19659,0.16189298974672717,0.22305804877500554,0.14326654337020875,1,cc,NAC,2318,FLNC
GO:1904813,ficolin-1-rich granule lumen,1/26,124/19659,0.151784505141365,0.22305804877500554,0.14326654337020875,1,cc,NAC,3303,HSPA1A
R-HSA-5628897,TP53 Regulates Metabolic Genes,1/23,86/10554,0.17170182996818573,0.22346488164977113,0.11163276870996595,1,re,NAC,2810,SFN
GO:0010977,negative regulation of neuron projection development,1/26,148/18493,0.18865161646844752,0.22350105300818535,0.1317349460776991,1,bp,NAC,4804,NGFR
GO:0042133,neurotransmitter metabolic process,1/26,148/18493,0.18865161646844752,0.22350105300818535,0.1317349460776991,1,bp,NAC,9314,KLF4
hsa04975,Fat digestion and absorption,1/25,41/7852,0.12285499818112211,0.22352784391287495,0.14189393064778724,1,kg,NAC,5320,PLA2G2A
GO:0001764,neuron migration,1/26,149/18493,0.18980152423469554,0.22394407152139464,0.1319960679792004,1,bp,NAC,1281,COL3A1
GO:0001890,placenta development,1/26,149/18493,0.18980152423469554,0.22394407152139464,0.1319960679792004,1,bp,NAC,9021,SOCS3
GO:0016202,regulation of striated muscle tissue development,1/26,149/18493,0.18980152423469554,0.22394407152139464,0.1319960679792004,1,bp,NAC,3479,IGF1
GO:0051384,response to glucocorticoid,1/26,149/18493,0.18980152423469554,0.22394407152139464,0.1319960679792004,1,bp,NAC,2353,FOS
GO:1902652,secondary alcohol metabolic process,1/26,149/18493,0.18980152423469554,0.22394407152139464,0.1319960679792004,1,bp,NAC,3953,LEPR
GO:0048754,branching morphogenesis of an epithelial tube,1/26,150/18493,0.19094986485669163,0.22456451099283292,0.1323617645126812,1,bp,NAC,10252,SPRY1
GO:0072524,pyridine-containing compound metabolic process,1/26,150/18493,0.19094986485669163,0.22456451099283292,0.1323617645126812,1,bp,NAC,3479,IGF1
GO:1903707,negative regulation of hemopoiesis,1/26,150/18493,0.19094986485669163,0.22456451099283292,0.1323617645126812,1,bp,NAC,7704,ZBTB16
GO:1990845,adaptive thermogenesis,1/26,150/18493,0.19094986485669163,0.22456451099283292,0.1323617645126812,1,bp,NAC,3953,LEPR
R-HSA-3371556,Cellular response to heat stress,1/23,88/10554,0.17533783244164358,0.2248898285664559,0.11234460659876477,1,re,NAC,3303,HSPA1A
R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,1/23,88/10554,0.17533783244164358,0.2248898285664559,0.11234460659876477,1,re,NAC,3303,HSPA1A
GO:0008360,regulation of cell shape,1/26,151/18493,0.19209664038488916,0.22536215615885777,0.1328319087984514,1,bp,NAC,3679,ITGA7
GO:0035967,cellular response to topologically incorrect protein,1/26,151/18493,0.19209664038488916,0.22536215615885777,0.1328319087984514,1,bp,NAC,3303,HSPA1A
GO:1901861,regulation of muscle tissue development,1/26,151/18493,0.19209664038488916,0.22536215615885777,0.1328319087984514,1,bp,NAC,3479,IGF1
R-HSA-5687128,MAPK6/MAPK4 signaling,1/23,89/10554,0.1771501035914469,0.22557962831428852,0.11268919880107187,1,re,NAC,3725,JUN
GO:0016052,carbohydrate catabolic process,1/26,152/18493,0.1932418528671701,0.22633765721373902,0.13340688407097867,1,bp,NAC,3479,IGF1
GO:0030509,BMP signaling pathway,1/26,152/18493,0.1932418528671701,0.22633765721373902,0.13340688407097867,1,bp,NAC,6424,SFRP4
GO:0042129,regulation of T cell proliferation,1/26,153/18493,0.19438550434884794,0.22730817080663498,0.13397891965697273,1,bp,NAC,3479,IGF1
GO:0048634,regulation of muscle organ development,1/26,153/18493,0.19438550434884794,0.22730817080663498,0.13397891965697273,1,bp,NAC,3479,IGF1
GO:0043271,negative regulation of ion transport,1/26,154/18493,0.1955275968726713,0.22845856055648964,0.1346569770067065,1,bp,NAC,6424,SFRP4
R-HSA-446728,Cell junction organization,1/23,91/10554,0.18076322401990008,0.22853636179658796,0.11416624674941059,1,re,NAC,2318,FLNC
R-HSA-877300,Interferon gamma signaling,1/23,92/10554,0.18256408857571993,0.22917619629718033,0.11448587861411329,1,re,NAC,9021,SOCS3
GO:0009156,ribonucleoside monophosphate biosynthetic process,1/26,155/18493,0.19666813247882842,0.22941965656180227,0.1352234617222426,1,bp,NAC,3479,IGF1
GO:0071695,anatomical structure maturation,1/26,155/18493,0.19666813247882842,0.22941965656180227,0.1352234617222426,1,bp,NAC,3479,IGF1
R-HSA-1912408,Pre-NOTCH Transcription and Translation,1/23,93/10554,0.1843611661863832,0.22980229869711144,0.11479865055341876,1,re,NAC,3725,JUN
R-HSA-5625740,RHO GTPases activate PKNs,1/23,95/10554,0.1879439909662114,0.23101448889596818,0.1154042049792526,1,re,NAC,2810,SFN
R-HSA-69473,G2/M DNA damage checkpoint,1/23,95/10554,0.1879439909662114,0.23101448889596818,0.1154042049792526,1,re,NAC,2810,SFN
GO:0006606,protein import into nucleus,1/26,157/18493,0.19894454108609771,0.23151368773164438,0.13645771578740828,1,bp,NAC,3479,IGF1
GO:0030203,glycosaminoglycan metabolic process,1/26,157/18493,0.19894454108609771,0.23151368773164438,0.13645771578740828,1,bp,NAC,3082,HGF
GO:0045931,positive regulation of mitotic cell cycle,1/26,157/18493,0.19894454108609771,0.23151368773164438,0.13645771578740828,1,bp,NAC,3479,IGF1
R-HSA-193704,p75 NTR receptor-mediated signalling,1/23,97/10554,0.19151175900213024,0.23217521468066474,0.11598405015269606,1,re,NAC,4804,NGFR
R-HSA-6803157,Antimicrobial peptides,1/23,97/10554,0.19151175900213024,0.23217521468066474,0.11598405015269606,1,re,NAC,5320,PLA2G2A
R-HSA-983169,Class I MHC mediated antigen processing & presentation,2/23,371/10554,0.19288582478900695,0.23225027882757981,0.11602154874526734,2,re,NAC,7704/9021,ZBTB16/SOCS3
GO:0015718,monocarboxylic acid transport,1/26,158/18493,0.20008041815480204,0.2322735666913752,0.13690560009237418,1,bp,NAC,5320,PLA2G2A
GO:0031570,DNA integrity checkpoint,1/26,158/18493,0.20008041815480204,0.2322735666913752,0.13690560009237418,1,bp,NAC,2810,SFN
GO:0043535,regulation of blood vessel endothelial cell migration,1/26,158/18493,0.20008041815480204,0.2322735666913752,0.13690560009237418,1,bp,NAC,9314,KLF4
GO:0072562,blood microparticle,1/26,147/19659,0.1773874275690288,0.2325746272571711,0.14937888637391902,1,cc,NAC,3303,HSPA1A
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",1/23,99/10554,0.19506453070515894,0.23328663469468336,0.11653926443266967,1,re,NAC,3082,HGF
GO:1903034,regulation of response to wounding,1/26,160/18493,0.2023475279722028,0.2347166260963735,0.13834557674863754,1,bp,NAC,9314,KLF4
GO:0007519,skeletal muscle tissue development,1/26,161/18493,0.20347876477320193,0.23527232176901472,0.13867311229482723,1,bp,NAC,2353,FOS
GO:0035821,modification of morphology or physiology of other organism,1/26,161/18493,0.20347876477320193,0.23527232176901472,0.13867311229482723,1,bp,NAC,3725,JUN
GO:0050954,sensory perception of mechanical stimulus,1/26,161/18493,0.20347876477320193,0.23527232176901472,0.13867311229482723,1,bp,NAC,1277,COL1A1
GO:2001242,regulation of intrinsic apoptotic signaling pathway,1/26,161/18493,0.20347876477320193,0.23527232176901472,0.13867311229482723,1,bp,NAC,3303,HSPA1A
R-HSA-5663202,Diseases of signal transduction,2/23,378/10554,0.19846770997063964,0.23576365546847797,0.11777666999317367,2,re,NAC,3164/3082,NR4A1/HGF
GO:0006733,oxidoreduction coenzyme metabolic process,1/26,162/18493,0.20460845886636692,0.2360111959585671,0.13910861606632544,1,bp,NAC,3479,IGF1
GO:0016125,sterol metabolic process,1/26,162/18493,0.20460845886636692,0.2360111959585671,0.13910861606632544,1,bp,NAC,3953,LEPR
GO:0043902,positive regulation of multi-organism process,1/26,162/18493,0.20460845886636692,0.2360111959585671,0.13910861606632544,1,bp,NAC,3725,JUN
GO:0035257,nuclear hormone receptor binding,1/25,152/17632,0.1947477194818955,0.2366289494780021,0.12564368998831968,1,mf,NAC,3164,NR4A1
GO:0030178,negative regulation of Wnt signaling pathway,1/26,164/18493,0.20686322700586535,0.23842143495963553,0.14052924787349858,1,bp,NAC,6424,SFRP4
GO:0007051,spindle organization,1/26,165/18493,0.20798830508420274,0.23876461753102987,0.1407315249407828,1,bp,NAC,3303,HSPA1A
GO:0010634,positive regulation of epithelial cell migration,1/26,165/18493,0.20798830508420274,0.23876461753102987,0.1407315249407828,1,bp,NAC,3725,JUN
GO:0051100,negative regulation of binding,1/26,165/18493,0.20798830508420274,0.23876461753102987,0.1407315249407828,1,bp,NAC,3725,JUN
GO:0071772,response to BMP,1/26,165/18493,0.20798830508420274,0.23876461753102987,0.1407315249407828,1,bp,NAC,6424,SFRP4
GO:0071773,cellular response to BMP stimulus,1/26,165/18493,0.20798830508420274,0.23876461753102987,0.1407315249407828,1,bp,NAC,6424,SFRP4
hsa05169,Epstein-Barr virus infection,2/25,201/7852,0.13340460767333207,0.23939730966036302,0.15196775783984473,2,kg,NAC,3725/4616,JUN/GADD45B
GO:0007093,mitotic cell cycle checkpoint,1/26,166/18493,0.209111848518719,0.2396730718129559,0.14126698181775424,1,bp,NAC,2810,SFN
GO:0045619,regulation of lymphocyte differentiation,1/26,166/18493,0.209111848518719,0.2396730718129559,0.14126698181775424,1,bp,NAC,7704,ZBTB16
GO:0006022,aminoglycan metabolic process,1/26,167/18493,0.2102338593190961,0.2405768905610275,0.14179970644002643,1,bp,NAC,3082,HGF
GO:0009124,nucleoside monophosphate biosynthetic process,1/26,167/18493,0.2102338593190961,0.2405768905610275,0.14179970644002643,1,bp,NAC,3479,IGF1
hsa00565,Ether lipid metabolism,1/25,47/7852,0.13957051692146238,0.24109492181071634,0.15304539030170022,1,kg,NAC,5320,PLA2G2A
hsa04024,cAMP signaling pathway,2/25,212/7852,0.1453931207866152,0.24109492181071634,0.15304539030170022,2,kg,NAC,2353/3725,FOS/JUN
hsa04913,Ovarian steroidogenesis,1/25,49/7852,0.14507408145640266,0.24109492181071634,0.15304539030170022,1,kg,NAC,3479,IGF1
hsa05030,Cocaine addiction,1/25,49/7852,0.14507408145640266,0.24109492181071634,0.15304539030170022,1,kg,NAC,3725,JUN
hsa05144,Malaria,1/25,49/7852,0.14507408145640266,0.24109492181071634,0.15304539030170022,1,kg,NAC,3082,HGF
hsa05170,Human immunodeficiency virus 1 infection,2/25,212/7852,0.1453931207866152,0.24109492181071634,0.15304539030170022,2,kg,NAC,2353/3725,FOS/JUN
GO:0051897,positive regulation of protein kinase B signaling,1/26,168/18493,0.21135433949249482,0.24166744206629953,0.1424424942113069,1,bp,NAC,3082,HGF
hsa04810,Regulation of actin cytoskeleton,2/25,214/7852,0.14759822609886764,0.24169209523689575,0.15342447186592822,2,kg,NAC,80310/3679,PDGFD/ITGA7
GO:0006986,response to unfolded protein,1/26,169/18493,0.21247329104355583,0.24237071855798506,0.14285701615410287,1,bp,NAC,3303,HSPA1A
GO:0021543,pallium development,1/26,169/18493,0.21247329104355583,0.24237071855798506,0.14285701615410287,1,bp,NAC,1281,COL3A1
GO:0030324,lung development,1/26,169/18493,0.21247329104355583,0.24237071855798506,0.14285701615410287,1,bp,NAC,10252,SPRY1
GO:0022408,negative regulation of cell-cell adhesion,1/26,170/18493,0.21359071597440438,0.2428773862498546,0.14315565385701026,1,bp,NAC,9314,KLF4
GO:0048771,tissue remodeling,1/26,170/18493,0.21359071597440438,0.2428773862498546,0.14315565385701026,1,bp,NAC,3953,LEPR
GO:0060538,skeletal muscle organ development,1/26,170/18493,0.21359071597440438,0.2428773862498546,0.14315565385701026,1,bp,NAC,2353,FOS
GO:2001235,positive regulation of apoptotic signaling pathway,1/26,170/18493,0.21359071597440438,0.2428773862498546,0.14315565385701026,1,bp,NAC,2810,SFN
GO:0001659,temperature homeostasis,1/26,171/18493,0.21470661628465182,0.24357047743612625,0.14356417242469272,1,bp,NAC,3953,LEPR
GO:0010950,positive regulation of endopeptidase activity,1/26,171/18493,0.21470661628465182,0.24357047743612625,0.14356417242469272,1,bp,NAC,4804,NGFR
GO:0032874,positive regulation of stress-activated MAPK cascade,1/26,171/18493,0.21470661628465182,0.24357047743612625,0.14356417242469272,1,bp,NAC,4616,GADD45B
GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,1/26,172/18493,0.2158209939714001,0.24464233644990596,0.14419594255500168,1,bp,NAC,4616,GADD45B
R-HSA-199418,Negative regulation of the PI3K/AKT network,1/23,106/10554,0.20738200232139792,0.24471076273924952,0.12224623294735036,1,re,NAC,3082,HGF
GO:0030323,respiratory tube development,1/26,173/18493,0.21693385102924323,0.2457107904514898,0.14482570571893624,1,bp,NAC,10252,SPRY1
GO:0048736,appendage development,1/26,175/18493,0.21915501122407444,0.2476434465124036,0.1459648428216232,1,bp,NAC,7704,ZBTB16
GO:0060173,limb development,1/26,175/18493,0.21915501122407444,0.2476434465124036,0.1459648428216232,1,bp,NAC,7704,ZBTB16
GO:0070507,regulation of microtubule cytoskeleton organization,1/26,175/18493,0.21915501122407444,0.2476434465124036,0.1459648428216232,1,bp,NAC,3303,HSPA1A
hsa05166,Human T-cell leukemia virus 1 infection,2/25,219/7852,0.15314285284462828,0.2476754780573618,0.15722268193275676,2,kg,NAC,2353/3725,FOS/JUN
R-HSA-1912422,Pre-NOTCH Expression and Processing,1/23,109/10554,0.21260554249757635,0.24921311935146367,0.1244954030658516,1,re,NAC,3725,JUN
GO:0008217,regulation of blood pressure,1/26,177/18493,0.22137011277587182,0.24936539635876895,0.14697978645211754,1,bp,NAC,1278,COL1A2
GO:0015698,inorganic anion transport,1/26,177/18493,0.22137011277587182,0.24936539635876895,0.14697978645211754,1,bp,NAC,6424,SFRP4
GO:0050792,regulation of viral process,1/26,177/18493,0.22137011277587182,0.24936539635876895,0.14697978645211754,1,bp,NAC,3725,JUN
GO:1905475,regulation of protein localization to membrane,1/26,177/18493,0.22137011277587182,0.24936539635876895,0.14697978645211754,1,bp,NAC,2810,SFN
GO:0042098,T cell proliferation,1/26,178/18493,0.22247539652056658,0.25002491992147785,0.14736851974800605,1,bp,NAC,3479,IGF1
GO:0051170,import into nucleus,1/26,178/18493,0.22247539652056658,0.25002491992147785,0.14736851974800605,1,bp,NAC,3479,IGF1
GO:0071346,cellular response to interferon-gamma,1/26,178/18493,0.22247539652056658,0.25002491992147785,0.14736851974800605,1,bp,NAC,9021,SOCS3
GO:0002221,pattern recognition receptor signaling pathway,1/26,179/18493,0.22357917155144125,0.25067967719404016,0.1477544437194328,1,bp,NAC,3303,HSPA1A
GO:0031345,negative regulation of cell projection organization,1/26,179/18493,0.22357917155144125,0.25067967719404016,0.1477544437194328,1,bp,NAC,4804,NGFR
GO:0061136,regulation of proteasomal protein catabolic process,1/26,179/18493,0.22357917155144125,0.25067967719404016,0.1477544437194328,1,bp,NAC,3303,HSPA1A
GO:0002685,regulation of leukocyte migration,1/26,180/18493,0.22468143984562383,0.25113502532706056,0.14802283288781773,1,bp,NAC,80310,PDGFD
GO:0006611,protein export from nucleus,1/26,180/18493,0.22468143984562383,0.25113502532706056,0.14802283288781773,1,bp,NAC,2810,SFN
GO:0048639,positive regulation of developmental growth,1/26,180/18493,0.22468143984562383,0.25113502532706056,0.14802283288781773,1,bp,NAC,3479,IGF1
GO:0050770,regulation of axonogenesis,1/26,180/18493,0.22468143984562383,0.25113502532706056,0.14802283288781773,1,bp,NAC,4804,NGFR
GO:0051147,regulation of muscle cell differentiation,1/26,182/18493,0.22688146412001564,0.2533977962269215,0.1493565447360051,1,bp,NAC,3479,IGF1
GO:0042594,response to starvation,1/26,183/18493,0.22797922404207793,0.2544269298474234,0.14996313186469573,1,bp,NAC,3725,JUN
GO:0030308,negative regulation of cell growth,1/26,184/18493,0.22907548511116038,0.25486193139198493,0.15021952844200592,1,bp,NAC,3303,HSPA1A
GO:0034404,nucleobase-containing small molecule biosynthetic process,1/26,184/18493,0.22907548511116038,0.25486193139198493,0.15021952844200592,1,bp,NAC,3479,IGF1
GO:0043112,receptor metabolic process,1/26,184/18493,0.22907548511116038,0.25486193139198493,0.15021952844200592,1,bp,NAC,6424,SFRP4
GO:0046328,regulation of JNK cascade,1/26,184/18493,0.22907548511116038,0.25486193139198493,0.15021952844200592,1,bp,NAC,4616,GADD45B
GO:2000377,regulation of reactive oxygen species metabolic process,1/26,185/18493,0.23017024929200613,0.2558826423176925,0.15082115110529637,1,bp,NAC,9314,KLF4
GO:0006367,transcription initiation from RNA polymerase II promoter,1/26,186/18493,0.23126351854688987,0.2569001210647899,0.1514208686729768,1,bp,NAC,3164,NR4A1
hsa05134,Legionellosis,1/25,55/7852,0.1613827520124842,0.2578187867516516,0.16366158419751287,1,kg,NAC,3303,HSPA1A
GO:1902115,regulation of organelle assembly,1/26,187/18493,0.23235529483562012,0.25791437726753835,0.15201868682362837,1,bp,NAC,3303,HSPA1A
GO:0010952,positive regulation of peptidase activity,1/26,189/18493,0.23453437634154684,0.259933260415401,0.1532086474929015,1,bp,NAC,4804,NGFR
GO:0035966,response to topologically incorrect protein,1/26,189/18493,0.23453437634154684,0.259933260415401,0.1532086474929015,1,bp,NAC,3303,HSPA1A
GO:0007565,female pregnancy,1/26,191/18493,0.23670750943906516,0.26193936819062197,0.15439107816174094,1,bp,NAC,2353,FOS
GO:0043401,steroid hormone mediated signaling pathway,1/26,191/18493,0.23670750943906516,0.26193936819062197,0.15439107816174094,1,bp,NAC,3164,NR4A1
GO:0034764,positive regulation of transmembrane transport,1/26,192/18493,0.2377918502080839,0.26293765505767436,0.15497948374118312,1,bp,NAC,3479,IGF1
GO:0051168,nuclear export,1/26,194/18493,0.23995608991204065,0.26492474196103644,0.15615070321663016,1,bp,NAC,2810,SFN
GO:0060541,respiratory system development,1/26,194/18493,0.23995608991204065,0.26492474196103644,0.15615070321663016,1,bp,NAC,10252,SPRY1
GO:0031396,regulation of protein ubiquitination,1/26,195/18493,0.2410359927298058,0.2659135607867812,0.15673352818741598,1,bp,NAC,3303,HSPA1A
hsa05213,Endometrial cancer,1/25,58/7852,0.16942467296731867,0.26740520673155116,0.169746977354701,1,kg,NAC,4616,GADD45B
GO:0044450,microtubule organizing center part,1/26,179/19659,0.21177583423824486,0.26804177099992593,0.17215885380905147,1,cc,NAC,3303,HSPA1A
GO:0098802,plasma membrane receptor complex,1/26,184/19659,0.21702257144564197,0.26804177099992593,0.17215885380905147,1,cc,NAC,3679,ITGA7
GO:0101002,ficolin-1-rich granule,1/26,185/19659,0.21806788149146517,0.26804177099992593,0.17215885380905147,1,cc,NAC,3303,HSPA1A
GO:0006575,cellular modified amino acid metabolic process,1/26,197/18493,0.24319137398568436,0.2680864420636689,0.15801425771415137,1,bp,NAC,5320,PLA2G2A
GO:0004713,protein tyrosine kinase activity,1/25,177/17632,0.2230699858157793,0.26815859997003255,0.14238509732922083,1,mf,NAC,3082,HGF
GO:0034341,response to interferon-gamma,1/26,198/18493,0.24426685629200084,0.26906646841935666,0.15859190026833,1,bp,NAC,9021,SOCS3
GO:0007163,establishment or maintenance of cell polarity,1/26,199/18493,0.2453408689586536,0.2696320441030748,0.15892525924447196,1,bp,NAC,10252,SPRY1
GO:0097164,ammonium ion metabolic process,1/26,199/18493,0.2453408689586536,0.2696320441030748,0.15892525924447196,1,bp,NAC,5320,PLA2G2A
GO:0097529,myeloid leukocyte migration,1/26,199/18493,0.2453408689586536,0.2696320441030748,0.15892525924447196,1,bp,NAC,80310,PDGFD
R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,1/23,122/10554,0.2348628144026087,0.26993972824195933,0.13484946281489496,1,re,NAC,3725,JUN
R-HSA-5619507,Activation of HOX genes during differentiation,1/23,122/10554,0.2348628144026087,0.26993972824195933,0.13484946281489496,1,re,NAC,3725,JUN
R-HSA-8878166,Transcriptional regulation by RUNX2,1/23,121/10554,0.2331723095737197,0.26993972824195933,0.13484946281489496,1,re,NAC,1277,COL1A1
GO:1902905,positive regulation of supramolecular fiber organization,1/26,200/18493,0.24641341391367033,0.27060468514263797,0.1594985487801375,1,bp,NAC,3303,HSPA1A
GO:0030017,sarcomere,1/26,197/19659,0.2305074030964741,0.2714132573165416,0.17432430443167704,1,cc,NAC,2318,FLNC
GO:0032993,protein-DNA complex,1/26,201/19659,0.23461145971429864,0.2714132573165416,0.17432430443167704,1,cc,NAC,2353,FOS
GO:0070382,exocytic vesicle,1/26,197/19659,0.2305074030964741,0.2714132573165416,0.17432430443167704,1,cc,NAC,3479,IGF1
GO:1901215,negative regulation of neuron death,1/26,201/18493,0.2474844930826552,0.27157423841693645,0.1600700183396321,1,bp,NAC,3725,JUN
GO:0002064,epithelial cell development,1/26,202/18493,0.24855410838879188,0.2723337725171045,0.16051769937908633,1,bp,NAC,2810,SFN
GO:0043523,regulation of neuron apoptotic process,1/26,202/18493,0.24855410838879188,0.2723337725171045,0.16051769937908633,1,bp,NAC,3725,JUN
hsa04730,Long-term depression,1/25,60/7852,0.17474476772646852,0.27251862585913544,0.1729929404810904,1,kg,NAC,3479,IGF1
GO:0043903,"regulation of symbiosis, encompassing mutualism through parasitism",1/26,203/18493,0.24962226175284508,0.27308940387365843,0.16096308008163987,1,bp,NAC,3725,JUN
GO:0046434,organophosphate catabolic process,1/26,203/18493,0.24962226175284508,0.27308940387365843,0.16096308008163987,1,bp,NAC,3479,IGF1
R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),1/23,125/10554,0.23991296699472087,0.27396513005203604,0.13686036826863535,1,re,NAC,3479,IGF1
GO:0032886,regulation of microtubule-based process,1/26,204/18493,0.2506889550931637,0.27404860772684486,0.16152844953371315,1,bp,NAC,3303,HSPA1A
GO:0050670,regulation of lymphocyte proliferation,1/26,205/18493,0.2517541903256846,0.27500476657075157,0.16209202421064836,1,bp,NAC,3479,IGF1
GO:0016323,basolateral plasma membrane,1/26,213/19659,0.24679773626280976,0.2751367726715286,0.1767158575588766,1,cc,NAC,3953,LEPR
GO:0030016,myofibril,1/26,218/19659,0.25182009702139907,0.2751367726715286,0.1767158575588766,1,cc,NAC,2318,FLNC
GO:0044449,contractile fiber part,1/26,214/19659,0.2478047947250731,0.2751367726715286,0.1767158575588766,1,cc,NAC,2318,FLNC
GO:0008022,protein C-terminus binding,1/25,187/17632,0.2341289870540516,0.2755893285115399,0.14633061690878227,1,mf,NAC,7704,ZBTB16
GO:0017137,Rab GTPase binding,1/25,185/17632,0.23192934715716773,0.2755893285115399,0.14633061690878227,1,mf,NAC,4804,NGFR
GO:0032944,regulation of mononuclear cell proliferation,1/26,206/18493,0.2528179693639352,0.2759578894040533,0.16265380941640228,1,bp,NAC,3479,IGF1
GO:0005516,calmodulin binding,1/25,192/17632,0.23960166096833413,0.2762753845859363,0.14669489447040868,1,mf,NAC,4804,NGFR
GO:0051015,actin filament binding,1/25,190/17632,0.23741711158896417,0.2762753845859363,0.14669489447040868,1,mf,NAC,2318,FLNC
hsa00590,Arachidonic acid metabolism,1/25,63/7852,0.1826636161035079,0.2765752466410519,0.17556805532055522,1,kg,NAC,5320,PLA2G2A
hsa04137,Mitophagy - animal,1/25,65/7852,0.187902266801936,0.2765752466410519,0.17556805532055522,1,kg,NAC,3725,JUN
hsa04927,Cortisol synthesis and secretion,1/25,65/7852,0.187902266801936,0.2765752466410519,0.17556805532055522,1,kg,NAC,3164,NR4A1
hsa05217,Basal cell carcinoma,1/25,63/7852,0.1826636161035079,0.2765752466410519,0.17556805532055522,1,kg,NAC,4616,GADD45B
hsa05321,Inflammatory bowel disease (IBD),1/25,65/7852,0.187902266801936,0.2765752466410519,0.17556805532055522,1,kg,NAC,3725,JUN
hsa05223,Non-small cell lung cancer,1/25,66/7852,0.19050948952313196,0.2772971458614476,0.17602631195704593,1,kg,NAC,4616,GADD45B
R-HSA-1483206,Glycerophospholipid biosynthesis,1/23,129/10554,0.24659692642065456,0.27801054762073796,0.13888127267405287,1,re,NAC,5320,PLA2G2A
R-HSA-1500931,Cell-Cell communication,1/23,129/10554,0.24659692642065456,0.27801054762073796,0.13888127267405287,1,re,NAC,2318,FLNC
GO:0032271,regulation of protein polymerization,1/26,208/18493,0.2549411664997052,0.27806508182847667,0.16389582092673097,1,bp,NAC,3303,HSPA1A
GO:0007601,visual perception,1/26,209/18493,0.25600058841225715,0.27837893675876946,0.164080811832867,1,bp,NAC,1277,COL1A1
GO:0010810,regulation of cell-substrate adhesion,1/26,209/18493,0.25600058841225715,0.27837893675876946,0.164080811832867,1,bp,NAC,1277,COL1A1
GO:0051701,interaction with host,1/26,209/18493,0.25600058841225715,0.27837893675876946,0.164080811832867,1,bp,NAC,3303,HSPA1A
GO:1903050,regulation of proteolysis involved in cellular protein catabolic process,1/26,209/18493,0.25600058841225715,0.27837893675876946,0.164080811832867,1,bp,NAC,3303,HSPA1A
GO:0050920,regulation of chemotaxis,1/26,210/18493,0.2570585617606097,0.27931890408174687,0.16463484297921105,1,bp,NAC,80310,PDGFD
GO:0009952,anterior/posterior pattern specification,1/26,211/18493,0.2581150884462864,0.28025588610082114,0.16518711454168106,1,bp,NAC,7704,ZBTB16
GO:0045732,positive regulation of protein catabolic process,1/26,212/18493,0.25917017036841705,0.28118989161024494,0.16573763170374436,1,bp,NAC,3303,HSPA1A
hsa05120,Epithelial cell signaling in Helicobacter pylori infection,1/25,68/7852,0.19569984876346003,0.2817217603078381,0.17883502663173326,1,kg,NAC,3725,JUN
GO:0043292,contractile fiber,1/26,229/19659,0.26275619288596097,0.28186573418675814,0.1810377596917626,1,cc,NAC,2318,FLNC
GO:0007254,JNK cascade,1/26,213/18493,0.2602238094237431,0.28190912687572167,0.16616155999240118,1,bp,NAC,4616,GADD45B
GO:0050953,sensory perception of light stimulus,1/26,213/18493,0.2602238094237431,0.28190912687572167,0.16616155999240118,1,bp,NAC,1277,COL1A1
GO:0017038,protein import,1/26,214/18493,0.26127600750661994,0.2828366682911122,0.16670826711837083,1,bp,NAC,3479,IGF1
GO:0000075,cell cycle checkpoint,1/26,216/18493,0.2633760883205266,0.28446983192104786,0.1676708787921411,1,bp,NAC,2810,SFN
GO:0007584,response to nutrient,1/26,216/18493,0.2633760883205266,0.28446983192104786,0.1676708787921411,1,bp,NAC,1277,COL1A1
GO:0070663,regulation of leukocyte proliferation,1/26,216/18493,0.2633760883205266,0.28446983192104786,0.1676708787921411,1,bp,NAC,3479,IGF1
GO:0009108,coenzyme biosynthetic process,1/26,217/18493,0.2644239748283602,0.2851747351848459,0.16808635957935258,1,bp,NAC,3479,IGF1
GO:0045665,negative regulation of neuron differentiation,1/26,217/18493,0.2644239748283602,0.2851747351848459,0.16808635957935258,1,bp,NAC,4804,NGFR
GO:0006457,protein folding,1/26,218/18493,0.2654704279173543,0.28587599066025543,0.1684996903041809,1,bp,NAC,3303,HSPA1A
GO:0072331,signal transduction by p53 class mediator,1/26,218/18493,0.2654704279173543,0.28587599066025543,0.1684996903041809,1,bp,NAC,2810,SFN
GO:0019722,calcium-mediated signaling,1/26,220/18493,0.26755904136631903,0.28769575014277077,0.16957228443327774,1,bp,NAC,3479,IGF1
GO:0051495,positive regulation of cytoskeleton organization,1/26,220/18493,0.26755904136631903,0.28769575014277077,0.16957228443327774,1,bp,NAC,3303,HSPA1A
GO:0044706,multi-multicellular organism process,1/26,221/18493,0.26860120548411426,0.288386562138078,0.16997945961087432,1,bp,NAC,2353,FOS
GO:1903320,regulation of protein modification by small protein conjugation or removal,1/26,221/18493,0.26860120548411426,0.288386562138078,0.16997945961087432,1,bp,NAC,3303,HSPA1A
GO:0010594,regulation of endothelial cell migration,1/26,222/18493,0.2696419436987274,0.28928871729164585,0.17051120368504932,1,bp,NAC,9314,KLF4
GO:0031424,keratinization,1/26,224/18493,0.2717191499080698,0.2910844345340347,0.171569626949338,1,bp,NAC,2810,SFN
GO:0048738,cardiac muscle tissue development,1/26,224/18493,0.2717191499080698,0.2910844345340347,0.171569626949338,1,bp,NAC,3479,IGF1
GO:0048588,developmental cell growth,1/26,226/18493,0.2737906749501089,0.293086011834575,0.17274938728696548,1,bp,NAC,3479,IGF1
hsa05412,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/25,72/7852,0.20598488490810274,0.2933045643800159,0.18618771061487546,1,kg,NAC,3679,ITGA7
GO:0060560,developmental growth involved in morphogenesis,1/26,227/18493,0.27482431169677235,0.29397441199291513,0.17327302395614066,1,bp,NAC,10252,SPRY1
R-HSA-6807070,PTEN Regulation,1/23,140/10554,0.264689171310054,0.29646181223005963,0.14809867515506997,1,re,NAC,3725,JUN
R-HSA-73887,Death Receptor Signalling,1/23,141/10554,0.26631315335920613,0.29646181223005963,0.14809867515506997,1,re,NAC,4804,NGFR
R-HSA-168255,Influenza Life Cycle,1/23,143/10554,0.26955083120416223,0.2981906070196045,0.14896230145493178,1,re,NAC,3303,HSPA1A
GO:0002758,innate immune response-activating signal transduction,1/26,233/18493,0.2809964884466497,0.3003540243174189,0.177033265235784,1,bp,NAC,3303,HSPA1A
hsa05212,Pancreatic cancer,1/25,75/7852,0.21361568000049858,0.30089950623726147,0.1910089272217248,1,kg,NAC,4616,GADD45B
hsa05220,Chronic myeloid leukemia,1/25,76/7852,0.21614359667787886,0.3012213953702354,0.19121326021895216,1,kg,NAC,4616,GADD45B
hsa04612,Antigen processing and presentation,1/25,77/7852,0.2186637111432922,0.301525749050224,0.19140646183180146,1,kg,NAC,3303,HSPA1A
GO:0034329,cell junction assembly,1/26,238/18493,0.28610135348097854,0.3055841991658416,0.18011601045045048,1,bp,NAC,2318,FLNC
GO:0009152,purine ribonucleotide biosynthetic process,1/26,239/18493,0.2871181359958782,0.3064433951494469,0.1806224337314463,1,bp,NAC,3479,IGF1
GO:0009755,hormone-mediated signaling pathway,1/26,240/18493,0.2881335259632338,0.3072998358942693,0.18112723303247594,1,bp,NAC,3164,NR4A1
GO:0007050,cell cycle arrest,1/26,241/18493,0.2891475252140394,0.3079261098773866,0.18149636851656153,1,bp,NAC,2810,SFN
GO:0046474,glycerophospholipid biosynthetic process,1/26,241/18493,0.2891475252140394,0.3079261098773866,0.18149636851656153,1,bp,NAC,5320,PLA2G2A
GO:1903362,regulation of cellular protein catabolic process,1/26,242/18493,0.2901601355769824,0.3087766044524967,0.18199766305403023,1,bp,NAC,3303,HSPA1A
GO:0050714,positive regulation of protein secretion,1/26,246/18493,0.2941967246432696,0.3128414691674562,0.18439355661619042,1,bp,NAC,3479,IGF1
GO:0021537,telencephalon development,1/26,248/18493,0.2962067332259818,0.31451531717813963,0.1853801482875127,1,bp,NAC,1281,COL3A1
GO:0048872,homeostasis of number of cells,1/26,248/18493,0.2962067332259818,0.31451531717813963,0.1853801482875127,1,bp,NAC,3303,HSPA1A
R-HSA-168254,Influenza Infection,1/23,154/10554,0.2871151993989053,0.3156483869168089,0.15768340470420428,1,re,NAC,3303,HSPA1A
R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,1/23,156/10554,0.2902650083320647,0.31714139799244107,0.1584292443137975,1,re,NAC,7102,TSPAN7
GO:0002218,activation of innate immune response,1/26,252/18493,0.3002102510409659,0.3185319060677307,0.187747587338313,1,bp,NAC,3303,HSPA1A
GO:0009260,ribonucleotide biosynthetic process,1/26,253/18493,0.3012077036736579,0.31935541249161525,0.18823297464582203,1,bp,NAC,3479,IGF1
GO:0051091,positive regulation of DNA-binding transcription factor activity,1/26,255/18493,0.30319850937025283,0.3212301387821401,0.18933796705399514,1,bp,NAC,3303,HSPA1A
GO:0045165,cell fate commitment,1/26,257/18493,0.30518386095674954,0.323096339956412,0.1904379346279906,1,bp,NAC,9314,KLF4
GO:0000151,ubiquitin ligase complex,1/26,275/19659,0.3068463844336272,0.3232845835997144,0.2076404105189959,1,cc,NAC,3303,HSPA1A
GO:0006164,purine nucleotide biosynthetic process,1/26,258/18493,0.30617449594332147,0.3239074762802147,0.19091603080892403,1,bp,NAC,3479,IGF1
GO:0046390,ribose phosphate biosynthetic process,1/26,259/18493,0.3071637727793771,0.32447827534453966,0.19125246852565053,1,bp,NAC,3479,IGF1
GO:0071383,cellular response to steroid hormone stimulus,1/26,259/18493,0.3071637727793771,0.32447827534453966,0.19125246852565053,1,bp,NAC,3164,NR4A1
GO:0030100,regulation of endocytosis,1/26,260/18493,0.30815169325254443,0.3252837552036735,0.1917272306996157,1,bp,NAC,6424,SFRP4
hsa04012,ErbB signaling pathway,1/25,85/7852,0.23854650322348347,0.3255165825237118,0.2066356771343771,1,kg,NAC,3725,JUN
GO:0046651,lymphocyte proliferation,1/26,264/18493,0.3120898471900295,0.32895956865976084,0.19389381148709692,1,bp,NAC,3479,IGF1
GO:1903311,regulation of mRNA metabolic process,1/26,264/18493,0.3120898471900295,0.32895956865976084,0.19389381148709692,1,bp,NAC,3303,HSPA1A
GO:0002793,positive regulation of peptide secretion,1/26,265/18493,0.3130710125843492,0.329752898656362,0.19436141234587334,1,bp,NAC,3479,IGF1
GO:0032943,mononuclear cell proliferation,1/26,266/18493,0.31405083229429054,0.33054365499683536,0.1948274962522836,1,bp,NAC,3479,IGF1
hsa04211,Longevity regulating pathway,1/25,89/7852,0.24830484846627243,0.33191770560287437,0.21069906583067152,1,kg,NAC,3479,IGF1
hsa04540,Gap junction,1/25,88/7852,0.2458765788205376,0.33191770560287437,0.21069906583067152,1,kg,NAC,80310,PDGFD
GO:0006260,DNA replication,1/26,268/18493,0.316006441746401,0.3323595447813824,0.19589780952208993,1,bp,NAC,3725,JUN
hsa00564,Glycerophospholipid metabolism,1/25,97/7852,0.2674626067286362,0.3329889018586028,0.21137905381140712,1,kg,NAC,5320,PLA2G2A
hsa04064,NF-kappa B signaling pathway,1/25,100/7852,0.2745252015322832,0.3329889018586028,0.21137905381140712,1,kg,NAC,4616,GADD45B
hsa04066,HIF-1 signaling pathway,1/25,100/7852,0.2745252015322832,0.3329889018586028,0.21137905381140712,1,kg,NAC,3479,IGF1
hsa04713,Circadian entrainment,1/25,97/7852,0.2674626067286362,0.3329889018586028,0.21137905381140712,1,kg,NAC,2353,FOS
hsa04750,Inflammatory mediator regulation of TRP channels,1/25,100/7852,0.2745252015322832,0.3329889018586028,0.21137905381140712,1,kg,NAC,3479,IGF1
hsa04912,GnRH signaling pathway,1/25,93/7852,0.2579430770839315,0.3329889018586028,0.21137905381140712,1,kg,NAC,3725,JUN
hsa04914,Progesterone-mediated oocyte maturation,1/25,99/7852,0.27217829806933125,0.3329889018586028,0.21137905381140712,1,kg,NAC,3479,IGF1
hsa04925,Aldosterone synthesis and secretion,1/25,98/7852,0.26982410702931736,0.3329889018586028,0.21137905381140712,1,kg,NAC,3164,NR4A1
hsa04972,Pancreatic secretion,1/25,98/7852,0.26982410702931736,0.3329889018586028,0.21137905381140712,1,kg,NAC,5320,PLA2G2A
hsa05222,Small cell lung cancer,1/25,93/7852,0.2579430770839315,0.3329889018586028,0.21137905381140712,1,kg,NAC,4616,GADD45B
GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,1/26,270/18493,0.31795668969474644,0.33416715457357543,0.19696324243750155,1,bp,NAC,9314,KLF4
GO:0021700,developmental maturation,1/26,271/18493,0.3189298075166165,0.33470233617925643,0.19727868667822096,1,bp,NAC,3479,IGF1
GO:0072522,purine-containing compound biosynthetic process,1/26,271/18493,0.3189298075166165,0.33470233617925643,0.19727868667822096,1,bp,NAC,3479,IGF1
R-HSA-109581,Apoptosis,1/23,169/10554,0.3104166144719549,0.3350228095215611,0.16736197442647122,1,re,NAC,2810,SFN
R-HSA-69481,G2/M Checkpoints,1/23,168/10554,0.30888612929708803,0.3350228095215611,0.16736197442647122,1,re,NAC,2810,SFN
GO:0045017,glycerolipid biosynthetic process,1/26,273/18493,0.32087203965948885,0.336495896241746,0.1983358384676155,1,bp,NAC,5320,PLA2G2A
R-HSA-5357801,Programmed Cell Death,1/23,172/10554,0.31498864276499405,0.3378969076933573,0.1687977415774131,1,re,NAC,2810,SFN
GO:0051258,protein polymerization,1/26,275/18493,0.32280894551360506,0.33828126969944233,0.199388164946675,1,bp,NAC,3303,HSPA1A
GO:0072593,reactive oxygen species metabolic process,1/26,276/18493,0.32377540546621475,0.33904783025235696,0.19983998748506723,1,bp,NAC,9314,KLF4
hsa04625,C-type lectin receptor signaling pathway,1/25,104/7852,0.2838403711352706,0.3411292533827564,0.21654649270580761,1,kg,NAC,3725,JUN
GO:0051188,cofactor biosynthetic process,1/26,279/18493,0.32666683441556554,0.34182758670171215,0.20147841853958012,1,bp,NAC,3479,IGF1
GO:0004252,serine-type endopeptidase activity,1/25,250/17632,0.3004031700465245,0.3428844264167401,0.18206252730092395,1,mf,NAC,3082,HGF
GO:0031965,nuclear membrane,1/26,302/19659,0.33153265049589353,0.34316537507469685,0.22040951833522013,1,cc,NAC,3164,NR4A1
hsa04928,"Parathyroid hormone synthesis, secretion and action",1/25,106/7852,0.2884547897408547,0.3435234314186542,0.21806630037825378,1,kg,NAC,2353,FOS
GO:0005088,Ras guanyl-nucleotide exchange factor activity,1/25,254/17632,0.30441967610998844,0.3439942340042869,0.1826518056659931,1,mf,NAC,3082,HGF
GO:0018105,peptidyl-serine phosphorylation,1/26,282/18493,0.32954637362923955,0.3445908819905744,0.2031071471338105,1,bp,NAC,3082,HGF
GO:0070661,leukocyte proliferation,1/26,283/18493,0.3305035859891121,0.34534154567870295,0.2035495998164584,1,bp,NAC,3479,IGF1
hsa04931,Insulin resistance,1/25,108/7852,0.2930406582637899,0.34584077686987813,0.2195373352568933,1,kg,NAC,9021,SOCS3
GO:0008654,phospholipid biosynthetic process,1/26,284/18493,0.33145948421889115,0.34608975088846594,0.20399060343427836,1,bp,NAC,5320,PLA2G2A
GO:0034330,cell junction organization,1/26,287/18493,0.3343193114373566,0.34882340303984494,0.20560185990895774,1,bp,NAC,2318,FLNC
GO:0019058,viral life cycle,1/26,289/18493,0.33621932396204957,0.35055237317719473,0.20662094140655313,1,bp,NAC,3303,HSPA1A
hsa04725,Cholinergic synapse,1/25,112/7852,0.30212742140910864,0.35286708554393537,0.2239975874485407,1,kg,NAC,2353,FOS
hsa05145,Toxoplasmosis,1/25,113/7852,0.304381531805074,0.35286708554393537,0.2239975874485407,1,kg,NAC,3303,HSPA1A
GO:0010769,regulation of cell morphogenesis involved in differentiation,1/26,293/18493,0.34000371750220126,0.3539865543691749,0.20864510043425127,1,bp,NAC,4804,NGFR
GO:0072330,monocarboxylic acid biosynthetic process,1/26,293/18493,0.34000371750220126,0.3539865543691749,0.20864510043425127,1,bp,NAC,3479,IGF1
GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1/25,267/17632,0.3173210065991795,0.3540944268768075,0.18801473993458806,1,mf,NAC,7704,ZBTB16
GO:0001664,G protein-coupled receptor binding,1/25,274/17632,0.3241724052437057,0.3540944268768075,0.18801473993458806,1,mf,NAC,3303,HSPA1A
GO:0005096,GTPase activator activity,1/25,279/17632,0.3290257948855291,0.3540944268768075,0.18801473993458806,1,mf,NAC,3725,JUN
GO:0008236,serine-type peptidase activity,1/25,273/17632,0.32319769139410937,0.3540944268768075,0.18801473993458806,1,mf,NAC,3082,HGF
GO:0017171,serine hydrolase activity,1/25,277/17632,0.3270884678179945,0.3540944268768075,0.18801473993458806,1,mf,NAC,3082,HGF
GO:0030216,keratinocyte differentiation,1/26,299/18493,0.34564143466585806,0.35959667644039883,0.21195179236520573,1,bp,NAC,2810,SFN
GO:0043414,macromolecule methylation,1/26,300/18493,0.3465765408931135,0.36030976117346025,0.21237209543579227,1,bp,NAC,2353,FOS
GO:0018209,peptidyl-serine modification,1/26,301/18493,0.34751036213957,0.3610204842097908,0.2127910064861298,1,bp,NAC,3082,HGF
GO:0006402,mRNA catabolic process,1/26,307/18493,0.35308639980424994,0.36654940641549116,0.21604983797185456,1,bp,NAC,3303,HSPA1A
GO:0009416,response to light stimulus,1/26,308/18493,0.35401127353157225,0.36724533983181795,0.21646003179349227,1,bp,NAC,2353,FOS
GO:0045089,positive regulation of innate immune response,1/26,309/18493,0.3549348757800288,0.3679389552805902,0.21686885936952757,1,bp,NAC,3303,HSPA1A
GO:0060562,epithelial tube morphogenesis,1/26,313/18493,0.3586166035163808,0.3714886998378589,0.21896113321588068,1,bp,NAC,10252,SPRY1
GO:0015849,organic acid transport,1/26,316/18493,0.3613646308084888,0.373798682621254,0.2203226724718045,1,bp,NAC,5320,PLA2G2A
GO:0046942,carboxylic acid transport,1/26,316/18493,0.3613646308084888,0.373798682621254,0.2203226724718045,1,bp,NAC,5320,PLA2G2A
GO:0090150,establishment of protein localization to membrane,1/26,317/18493,0.3622781214614563,0.37447516423272315,0.22072140110153574,1,bp,NAC,2810,SFN
GO:0008202,steroid metabolic process,1/26,318/18493,0.3631903556627105,0.3751493795427998,0.22111879393849232,1,bp,NAC,3953,LEPR
GO:0042742,defense response to bacterium,1/26,319/18493,0.3641013350713913,0.37528444750572687,0.22119840506592794,1,bp,NAC,5320,PLA2G2A
GO:0071214,cellular response to abiotic stimulus,1/26,319/18493,0.3641013350713913,0.37528444750572687,0.22119840506592794,1,bp,NAC,1277,COL1A1
GO:0104004,cellular response to environmental stimulus,1/26,319/18493,0.3641013350713913,0.37528444750572687,0.22119840506592794,1,bp,NAC,1277,COL1A1
R-HSA-913531,Interferon Signaling,1/23,197/10554,0.35197751121675,0.3753013222009925,0.1874832653278821,1,re,NAC,9021,SOCS3
GO:0016042,lipid catabolic process,1/26,321/18493,0.36591953613708816,0.3768892866850951,0.22214432187442595,1,bp,NAC,5320,PLA2G2A
hsa04114,Oocyte meiosis,1/25,125/7852,0.3308915063507576,0.380234976596046,0.2413705355651879,1,kg,NAC,3479,IGF1
GO:0030695,GTPase regulator activity,1/25,309/17632,0.3574509664051898,0.38105621890364577,0.20233073570105087,1,mf,NAC,3725,JUN
GO:0009101,glycoprotein biosynthetic process,1/26,326/18493,0.3704431956674139,0.3812764132297278,0.22473016149806324,1,bp,NAC,3479,IGF1
GO:0003713,transcription coactivator activity,1/25,321/17632,0.3684942184698994,0.389157445673819,0.20663227203919593,1,mf,NAC,3725,JUN
hsa04270,Vascular smooth muscle contraction,1/25,132/7852,0.34590485768024326,0.39063393410441266,0.24797172193048292,1,kg,NAC,5320,PLA2G2A
hsa04728,Dopaminergic synapse,1/25,131/7852,0.3437800683665745,0.39063393410441266,0.24797172193048292,1,kg,NAC,2353,FOS
GO:0005085,guanyl-nucleotide exchange factor activity,1/25,327/17632,0.3739472893018503,0.39125966380656557,0.20774849405658352,1,mf,NAC,3082,HGF
hsa03040,Spliceosome,1/25,134/7852,0.3501346393020158,0.392031091868069,0.2488586280239249,1,kg,NAC,3303,HSPA1A
GO:0006401,RNA catabolic process,1/26,340/18493,0.3829449616993711,0.3938628508426176,0.23214880073008357,1,bp,NAC,3303,HSPA1A
GO:0006909,phagocytosis,1/26,342/18493,0.3847113235148645,0.39539774916805515,0.2330534933273433,1,bp,NAC,3953,LEPR
R-HSA-1483257,Phospholipid metabolism,1/23,212/10554,0.3732454670364862,0.3955954950027429,0.19762129991216418,1,re,NAC,5320,PLA2G2A
hsa04120,Ubiquitin mediated proteolysis,1/25,137/7852,0.3564301136151349,0.3956978379964633,0.2511862531275259,1,kg,NAC,9021,SOCS3
GO:1902903,regulation of supramolecular fiber organization,1/26,343/18493,0.38559268022185633,0.39602152139511654,0.23342115423806703,1,bp,NAC,3303,HSPA1A
GO:0009165,nucleotide biosynthetic process,1/26,344/18493,0.38647282293889396,0.39664316038465436,0.23378755778589977,1,bp,NAC,3479,IGF1
GO:0001505,regulation of neurotransmitter levels,1/26,346/18493,0.3882294728225286,0.39788006341115684,0.23451660738681457,1,bp,NAC,9314,KLF4
GO:0006898,receptor-mediated endocytosis,1/26,346/18493,0.3882294728225286,0.39788006341115684,0.23451660738681457,1,bp,NAC,6424,SFRP4
GO:1901293,nucleoside phosphate biosynthetic process,1/26,347/18493,0.3891059831937532,0.39849533977898216,0.23487926070789483,1,bp,NAC,3479,IGF1
GO:0006959,humoral immune response,1/26,349/18493,0.39085538279136045,0.3997195729042758,0.2356008424748549,1,bp,NAC,5320,PLA2G2A
GO:0070482,response to oxygen levels,1/26,349/18493,0.39085538279136045,0.3997195729042758,0.2356008424748549,1,bp,NAC,1277,COL1A1
GO:0006732,coenzyme metabolic process,1/26,351/18493,0.3925999648339963,0.40121936916108825,0.2364848453748837,1,bp,NAC,3479,IGF1
GO:0030133,transport vesicle,1/26,381/19659,0.3990029157751783,0.4058822763919917,0.26069156021608747,1,cc,NAC,3479,IGF1
GO:0032259,methylation,1/26,358/18493,0.39866824734410367,0.40713254134291693,0.23997015968565258,1,bp,NAC,2353,FOS
GO:0006869,lipid transport,1/26,359/18493,0.3995303717206713,0.4077244175338958,0.24031902058386245,1,bp,NAC,5320,PLA2G2A
GO:0042623,"ATPase activity, coupled",1/25,357/17632,0.4005414988399111,0.4114653578991814,0.21847718118540607,1,mf,NAC,3303,HSPA1A
GO:0060589,nucleoside-triphosphatase regulator activity,1/25,353/17632,0.3970593209254253,0.4114653578991814,0.21847718118540607,1,mf,NAC,3725,JUN
R-HSA-112315,Transmission across Chemical Synapses,1/23,227/10554,0.3938448046635086,0.414943633484768,0.20728673929658348,1,re,NAC,7102,TSPAN7
hsa04072,Phospholipase D signaling pathway,1/25,148/7852,0.37901638158047635,0.417236520899516,0.2648588601933448,1,kg,NAC,80310,PDGFD
GO:1903532,positive regulation of secretion by cell,1/26,373/18493,0.41147602861508814,0.4196183104534079,0.24732946335948763,1,bp,NAC,3479,IGF1
GO:0030900,forebrain development,1/26,374/18493,0.4123204890596798,0.4201825322832754,0.2476620243534205,1,bp,NAC,1281,COL3A1
GO:0042176,regulation of protein catabolic process,1/26,375/18493,0.41316378434553724,0.4207447712142626,0.24799341659636304,1,bp,NAC,3303,HSPA1A
hsa04150,mTOR signaling pathway,1/25,153/7852,0.3890294526840099,0.4219822724137626,0.2678714304595199,1,kg,NAC,3479,IGF1
hsa04934,Cushing syndrome,1/25,155/7852,0.39299112392732094,0.4219822724137626,0.2678714304595199,1,kg,NAC,3164,NR4A1
hsa05160,Hepatitis C,1/25,155/7852,0.39299112392732094,0.4219822724137626,0.2678714304595199,1,kg,NAC,9021,SOCS3
R-HSA-157118,Signaling by NOTCH,1/23,235/10554,0.4045646887765013,0.42371567996118775,0.21166884993600818,1,re,NAC,3725,JUN
hsa04218,Cellular senescence,1/25,160/7852,0.4027877047005438,0.42898527899001004,0.27231689064050457,1,kg,NAC,4616,GADD45B
GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,1/26,389/18493,0.4248484374437147,0.4323387131391258,0.25482706365861585,1,bp,NAC,3303,HSPA1A
GO:0010876,lipid localization,1/26,393/18493,0.42814560739745355,0.43538697073609967,0.256623753404653,1,bp,NAC,5320,PLA2G2A
hsa04141,Protein processing in endoplasmic reticulum,1/25,165/7852,0.41243240355639743,0.4357148779507102,0.2765887935564974,1,kg,NAC,3303,HSPA1A
GO:0009100,glycoprotein metabolic process,1/26,394/18493,0.4289670556962196,0.43591511364059504,0.25693504892701663,1,bp,NAC,3479,IGF1
hsa05164,Influenza A,1/25,167/7852,0.41624826305138773,0.4362281796778544,0.2769146339457653,1,kg,NAC,9021,SOCS3
hsa04530,Tight junction,1/25,170/7852,0.4219274785535795,0.43867063246443583,0.27846508609634735,1,kg,NAC,3725,JUN
R-HSA-5673001,RAF/MAP kinase cascade,1/23,248/10554,0.42159874629939476,0.4389586946764287,0.21928355844674405,1,re,NAC,3082,HGF
GO:0051047,positive regulation of secretion,1/26,404/18493,0.4371193800390826,0.4438868862747334,0.2616337338950174,1,bp,NAC,3479,IGF1
R-HSA-5684996,MAPK1/MAPK3 signaling,1/23,254/10554,0.42930246411624795,0.44436570847120405,0.2219846536519842,1,re,NAC,3082,HGF
GO:0043547,positive regulation of GTPase activity,1/26,405/18493,0.4379284295232433,0.44439572700565405,0.2619336524204461,1,bp,NAC,3725,JUN
GO:0046394,carboxylic acid biosynthetic process,1/26,412/18493,0.443560548907484,0.4497947098197466,0.2651158956372727,1,bp,NAC,3479,IGF1
GO:0016053,organic acid biosynthetic process,1/26,413/18493,0.4443606941277931,0.4502896640634869,0.26540762925432937,1,bp,NAC,3479,IGF1
hsa04621,NOD-like receptor signaling pathway,1/25,178/7852,0.4368139249558528,0.45057184385210014,0.28601989284303664,1,kg,NAC,3725,JUN
GO:0048568,embryonic organ development,1/26,422/18493,0.4515123891713,0.45721570356083213,0.269489943084329,1,bp,NAC,9021,SOCS3
GO:0003779,actin binding,1/25,421/17632,0.45369866047776075,0.4577495413748836,0.24305285382737188,1,mf,NAC,2318,FLNC
GO:0005543,phospholipid binding,1/25,417/17632,0.45051342407673933,0.4577495413748836,0.24305285382737188,1,mf,NAC,5320,PLA2G2A
GO:0042391,regulation of membrane potential,1/26,424/18493,0.45308959165001805,0.45849108047053017,0.2702416697816598,1,bp,NAC,3725,JUN
GO:0005635,nuclear envelope,1/26,461/19659,0.46063082273245315,0.46063082273245315,0.29585565777641953,1,cc,NAC,3164,NR4A1
GO:0048608,reproductive structure development,1/26,428/18493,0.45623092408107846,0.4613463373854213,0.2719246019676992,1,bp,NAC,9021,SOCS3
GO:0061458,reproductive system development,1/26,431/18493,0.458575530464281,0.46339250032209905,0.27313064176259694,1,bp,NAC,9021,SOCS3
GO:0050708,regulation of protein secretion,1/26,438/18493,0.4640085370576047,0.4685544569448031,0.27617317810949477,1,bp,NAC,3479,IGF1
GO:0019932,second-messenger-mediated signaling,1/26,439/18493,0.46478038851351766,0.4690056647727314,0.2764391269186031,1,bp,NAC,3479,IGF1
GO:0016887,ATPase activity,1/25,445/17632,0.47244105188123997,0.47244105188123997,0.25085365586614516,1,mf,NAC,3303,HSPA1A
GO:0007409,axonogenesis,1/26,449/18493,0.47244035240247106,0.4764021163639173,0.2807987088463692,1,bp,NAC,4804,NGFR
GO:0010498,proteasomal protein catabolic process,1/26,452/18493,0.47471771117569517,0.4783642857727152,0.28195524156862817,1,bp,NAC,3303,HSPA1A
GO:0015711,organic anion transport,1/26,460/18493,0.4807445490915182,0.4840993610181862,0.2853355828155483,1,bp,NAC,5320,PLA2G2A
GO:0008380,RNA splicing,1/26,463/18493,0.48298742588618415,0.4860187277222899,0.2864668869676553,1,bp,NAC,3303,HSPA1A
GO:0002791,regulation of peptide secretion,1/26,465/18493,0.4844774987639605,0.48717841861769684,0.2871504265551294,1,bp,NAC,3479,IGF1
hsa05203,Viral carcinogenesis,1/25,201/7852,0.47759065307654935,0.488784184008031,0.31027682231124504,1,kg,NAC,3725,JUN
R-HSA-69620,Cell Cycle Checkpoints,1/23,293/10554,0.4770357041454284,0.49090302112640016,0.24523255292665844,1,re,NAC,2810,SFN
GO:0043312,neutrophil degranulation,1/26,485/18493,0.49915289270886354,0.5015860892610655,0.2956425284480001,1,bp,NAC,3303,HSPA1A
GO:0002283,neutrophil activation involved in immune response,1/26,488/18493,0.501319255498837,0.5034124465447611,0.2967190114222323,1,bp,NAC,3303,HSPA1A
GO:0051656,establishment of organelle localization,1/26,491/18493,0.5034766068083398,0.5052272208793007,0.29778866722870845,1,bp,NAC,10252,SPRY1
GO:0008015,blood circulation,1/26,492/18493,0.5041937275850861,0.5055952389890751,0.29800558274294986,1,bp,NAC,1278,COL1A2
GO:0042119,neutrophil activation,1/26,498/18493,0.5084755838029648,0.5091813098040793,0.3001192678423577,1,bp,NAC,3303,HSPA1A
GO:0060627,regulation of vesicle-mediated transport,1/26,498/18493,0.5084755838029648,0.5091813098040793,0.3001192678423577,1,bp,NAC,6424,SFRP4
GO:0002446,neutrophil mediated immunity,1/26,499/18493,0.5091857607866336,0.5095388715777478,0.3003300202318417,1,bp,NAC,3303,HSPA1A
GO:0003013,circulatory system process,1/26,500/18493,0.5098949510844855,0.5098949510844855,0.3005398989504791,1,bp,NAC,1278,COL1A2
R-HSA-195258,RHO GTPase Effectors,1/23,316/10554,0.5033699287098765,0.515008539778313,0.2572745604601742,1,re,NAC,2810,SFN
hsa04144,Endocytosis,1/25,244/7852,0.546348830596942,0.5548193551023209,0.3521954925920719,1,kg,NAC,3303,HSPA1A
R-HSA-112316,Neuronal System,1/23,368/10554,0.558312899208194,0.5679389836773008,0.2837161738263055,1,re,NAC,7102,TSPAN7
R-HSA-5663205,Infectious disease,1/23,382/10554,0.5720810886474768,0.5786191582320193,0.289051497421883,1,re,NAC,3303,HSPA1A
R-HSA-194315,Signaling by Rho GTPases,1/23,444/10554,0.6282716936151365,0.6318414191470406,0.31563888913679106,1,re,NAC,2810,SFN
R-HSA-6798695,Neutrophil degranulation,1/23,479/10554,0.6567998225371328,0.6567998225371328,0.32810695862693523,1,re,NAC,3303,HSPA1A
hsa04080,Neuroactive ligand-receptor interaction,1/25,338/7852,0.6677044655236365,0.6728406537199721,0.42711459737949214,1,kg,NAC,3953,LEPR
hsa05168,Herpes simplex virus 1 infection,1/25,492/7852,0.8021543581208095,0.8021543581208095,0.5092020433229727,1,kg,NAC,9021,SOCS3
